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Abstract 
This thesis describes an investigation into the effects of fluorine substituents on the 
regioselectivity of intramolecular C–H activation reactions at different transition metals, 
including Pd, Ir, Rh and Ru. A range of mono- and di-fluorinated N,N-
dimethylbenzylamines (e.g. I) were synthesised initially and their behaviour towards 
cyclometallation at Pd was studied (Chapter 2), revealing an unprecedented difference in the 
regioselectivity of the C–H activation between the formation of acetate- and chloro-bridged 
palladacycles. The spectroscopic and crystallographic properties of all of these palladacycles 
are described and analysed in detail. Acetate-bridged palladacycles present a “clam-shell” 
structure, which shows a dramatic variation with the number and the position of the fluorine 
atoms on the aromatic ring of the ligand. Conversely the planar chloride-bridged 
palladacycles do not show any structural variation.  
 
Biological assays have been performed on two of the fluorinated amino-derived 
palladacycles against ovarian cancer cells, revealing promising activity.  
A series of fluorinated diphenylbenzylphosphines and their corresponding chloride-
bridged phosphapalladacycles (e.g. II) have also been synthesised (Chapter 3), and a similar 
regioselectivity observed to that seen for the corresponding amino-derived palladacycles.  
Various successful attempts at cyclometallation reactions using the fluorinated 
amines as substrates at Rh, Ir and Ru demonstrate a preference for C–H activation ortho to 
fluorine (Chapter 4). Finally the synthesis of the novel pentafluorobenzyl phosphine III, and 
some preliminary work towards C–F activation reactions using this substrate at Pt is 
described (Chapter 5).  
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‘Fluorine leaves nobody indifferent;  
it inflames emotions, be that affections or aversions. 
As a substituent it is rarely boring, always good for a surprise,  
but often completely unpredictable.’ 
M. Schlosser
1
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Chapter 1: Introduction 
1.1 C–H activation and functionalisation reactions 
he “invisibility of C–H bonds reflects both their ubiquitous nature and their lack of 
reactivity”.2 This quote from Alan Goldman and Karen Goldberg hints at how the 
ability to activate any C–H bond selectively could represent one of the most useful and 
powerful tools available for chemical synthesis. 
 The “Holy Grail” for direct C–H bond activation, as defined by Bergman et al., is 
the development of new reagents able to make these transformations selectively in complex 
molecules.
3
 Transition metal-catalysed C–H bond activation seems to be the solution to 
address this considerable challenge. C–H activation processes describe the replacement of 
the unreactive C–H bond with a more reactive C–M bond, which can then be functionalised.4 
C–H bond functionalisation, instead, describes the process where a C–H bond is transformed 
into a C–R bond, via a C–H activation step (Scheme 1). The two terms are often used to 
describe the same concept in an erroneous manner. 
 
Scheme 1: Representation of C–H activation and C–H functionalisation processes. 
The formation of a C–C bond via the functionalisation of a C–H bond is an appealing 
method for the synthesis of synthetic building blocks, due to the atom economy and 
efficiency of the overall process.
5
 Analogous traditional methods for C–C bond formation 
often involve cross-coupling reactions,
6-9
 processes that require pre-activation of substrates 
(c in Scheme 2).
10-13
 By contrast direct arylations or oxidative arene cross-coupling reactions 
(a and b in Scheme 2) do not require any pre-activation and extensive investigations are 
currently being dedicated to understanding the mechanisms of these processes.
8,14
 
T 
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Scheme 2: Biaryl C–H functionalisations and cross-coupling reactions. 
To make a C–H activation (or functionalisation) process synthetically useful, one of the C–H 
bonds in the molecule must be selectively activated over the other functional groups; in a 
traditional cross-coupling, for example, one position in the molecule has a special reactivity 
as a result of the presence of the electrophilic heteroatom.
15
 The problem arises for 
molecules such as benzene derivatives, which possess multiple unreactive C–H bonds with 
little difference in reactivity between them. Hence the C–H functionalisation of arenes is 
normally limited to three categories of substrates: highly electron rich systems (such as 
thiophene and furan derivatives or indoles),
16-18
 highly electron poor arenes (such as 
polyfluorinated benzenes), or those bearing directing groups (Figure 1).
19-21
 
 
Figure 1: Substrates able to undergo C–H arylation reactions. 
Directing groups, such as amides and acetanilidines, have a dual activity that leads to both 
high reactivity and regioselectivity; they are in fact able to coordinate to the metal centre and 
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direct it in proximity to the bond to activate.
22-24
 A general example scheme of selective 
olefination is illustrated in Scheme 3. 
 
Scheme 3: Regioselective olefination catalysed by transition metals. 
This strategy does however have limitations, as the directing group needs to be pre-installed 
in the molecule, increasing the synthetic challenge and complexity of the substrate. Another 
potential limitation is that the activation usually occurs ortho to the directing group. The 
following selected recent examples illustrate the use of directing groups in C–H 
functionalisation reactions. 
Glorius et al. reported in 2015 several papers on regioselective C–H 
functionalisation using directing groups, and in particular the highly challenging activation 
of sp
3
 C–H bonds using Rh(II)25 and the activation and allylation of arenes at Co(III) using 
an amide as an ortho directing group (Scheme 4).
26
 
 
Scheme 4: Regioselective C–H functionalisation and allylation reaction (Glorius et al.). 
In the same year Yu and co-workers reported the ortho monoselective C–H functionalisation 
of α-phenylglycine and mandelic acid (Scheme 5). They reported several different protocols 
such as acetoxylation, arylation and iodination of these substrates catalysed by Pd, 
suggesting that the reactions can proceed via two different catalytic cycles at Pd (Pd(II/0) 
and Pd(II/IV)).
27
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Scheme 5: Monoselective C–H functionalisation of α-phenylglicine and mandelic acid (Yu et al.). 
In recent years several research groups have investigated approaches to obtain 
regioselectivity other than that ortho to the directing group.
28
 Yu and co-workers in 2016 
reported the use of an amino acid reagent as a transient directing group that can react with 
ketones and aldehydes in a reversible manner. The resulting imines can facilitate the 
activation of  inert benzylic sp
3
 C–H bonds with Pd(II) (Scheme 6).29 
 
Scheme 6: Activation of inert benzylic sp
3
 C–H bonds with Pd(II) (Yu et al.) 
In 2009 Phipps and Gaunt achieved the meta-C–H arylation of arenes containing electron-
donating groups, catalysed by copper(II) in the presence of an oxidant (Scheme 7).
30
 
 
Scheme 7: Copper(II) catalysed meta-selective C–H arylation (Gaunt et al.). 
In 2015, Dong et al. also reported the meta selective C–H arylation of tertiary amines using 
the Catellani reaction,
31
 promoted by an “acetate cocktail” and Pd(OAc)2/AsPh3 (Scheme 
8).
32
 
 30 
 
 
Scheme 8: Palladium(II) catalysed meta-selective C–H arylation (Dong et al.). 
Previously, Yu and co-workers developed a different method to obtain meta 
functionalisation by using a recyclable nitrile-containing template to functionalise distal    
C–H bonds, which, especially in direct cyclometallation reactions, are geometrically 
inaccessible. They reported direct acetoxylation and olefination of meta C–H bonds of 
benzylic amines and anilines through conformational control.
33
 NMR spectroscopic and X-
ray crystallographic studies revealed that by inserting a fluorine substituent into the 
template, the selectivity could be switched from meta to ortho.  
1.2 Regioselectivity in the C–H activation of fluorinated 
aromatics 
Fluorine substituents in fluoroarenes can also act as directing groups in C–H 
activation reactions
14
 and their behaviour toward these transformations has been studied 
experimentally and computationally with different transition metals.
20,34
 The following 
section gives an overview of a number of key studies into the nature and origin of this ‘ortho 
fluorine effect’.  
In 1994, Jones and Perutz investigated the thermal and photochemical behaviour of 
Rh(I) complexes with fluorinated aromatics, and found that the products in which the C–H 
activation had occurred ortho to the fluorine atoms were favoured.  
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Scheme 9: C–H activation of fluoroaromatic at Rh(I) (Perutz et al.). 
Complex [(Cp*)Rh(PMe3)] (generated thermally) and complex [(Cp*)Rh(PMe3)] (generated 
photochemically) both react with fluoroaromatics (arylF) to give (Cp*)Rh(PMe3)(arylF)H 
(Scheme 9). In particular, the reaction of 1,3-difluorobenzene, which initially gives the 
kinetic product with activation meta to both fluorine atoms (1.15), can be driven to the 
thermodynamic product 1.17, where the C–H activation occurs ortho to the two fluorine. 
However, further investigation did not reveal any evidence for an interaction of the fluorine 
lone pair with a coordination site on the metal, and so the regioselectivity was not explored 
any further in this context.
35
 
Eisenstein and Perutz later in 2003 investigated the reaction of [CpRe(CO)2] with 
fluorinated benzenes revealing that the stronger the C–H bond to activate, the stronger the 
resulting Re–C bond that was formed (Scheme 10). They also found that this bond strength 
was in fact heavily influenced by the number of fluorine atoms on the ring, with more 
fluorine atoms leading to a stronger C–H and C–M bond.36 
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Scheme 10: C–H activation reaction of fluorinated substrates at Re (Perutz et al.). 
Depending on the number of fluorines present on the ring there was in fact a difference in 
the product outcome: in a non-fluorinated ring, simple 2-coordination (1.19 in Scheme 10) 
was favoured, whilst if at least two fluorines were present, C–H activation was observed 
(1.20 in Scheme 10). They also demonstrated that the rate-determing step was the 
isomerisation between the cis and trans isomers (Scheme 10) which had an energetic barrier 
that decreased as the number of fluorine atoms in the ortho position to the Re increased. 
Later the same authors reported a similar correlation for C–H activation reactions of 
polyfluoroarenes at different metal fragments. They showed a correlation between the M–C 
bond dissociation energies and the C–H bond dissociation energies of the polyfluoroarenes. 
The data points were divided into three main groups of molecules with zero, one and two 
fluorine atoms, again showing a correlation of the C–H bond strength with the M–aryl bond 
strength, and higher bond strengths in molecules bearing the most fluorine atoms.
37
  
 
Figure 2: Correlation between Rh–C bond dissociation energies and C–H bond dissociation 
energies of fluoroaromatics. (Image taken with permission from ref. 37. Copyright 2009, ACS.)  
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This behaviour has been also observed experimentally by Legzdins and co-workers in 
intermolecular C–H activation reactions at W of alkylidene complexes where the ability of 
the substituent to ortho-direct the reaction diminished in the order F > OMe > Cl (Scheme 
11).
38
  
 
Scheme 11: C–H activation reactions at W of alkylidene complexes (Legzdins et al.). 
Fagnou and co-workers have pioneered the Pd-catalysed direct arylation of fluoroaromatics 
using aryl halides.
20,39-40
 In the course of their investigations they have also suggested a new 
mechanism, called CMD (concerted metallation deprotonation, which will be discussed in 
more detail in section 1.4) in order to explain the reactivity of electron-deficient substrates 
towards C–H bond cleavage. These types of substrates were known to be unreactive in 
reactions proceeding via an SEAr (electrophilic aromatic substitution) mechanism, which 
usually involves nucleophilic aromatic rings.
14,41
 Direct arylation of electron-deficient arenes 
has since been extensively investigated, substituting aryl halides with boronic acids,
42
 
tosylates,
43
 diaryliodonium salts
44
 or simple arenes,
45
 as well as using different metals, such 
as Cu.
46
 
In 2006 Fagnou and co-workers performed a number of competition experiments 
toward different polyfluoroarenes in direct arylation reactions and discovered that C–H 
functionalisation was favoured for fluorinated aromatics, and moreover that for substrates 
bearing two or more different C–H bonds, the activation occurred preferentially ortho to the 
fluorine atom, this being the most acidic position (Scheme 12).
20
 The regioselectivity and 
reactivity of these functionalisation reactions correlated with the acidity of the functionalised 
fluoroaromatic. 
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Scheme 12: Regioselective intermolecular C–H functionalisation reaction at Pd of fluorinated 
aromatics (Fagnou et al.). 
In 2014, Doucet and co-workers investigated the effect of other substituents on the reactivity 
of monofluorobenzenes towards C–H functionalisation catalysed by Pd, showing that the 
introduction of another functional group meta to fluorine can modify the reactivity of the 
substrate as well as altering the regioselectivity (Scheme 13). Using electron-withdrawing 
groups a complete regioselectivity ortho to fluorine was observed while in the case of 
electron-donating groups, such as methoxy group, a mixture of isomers was noted.
47
 
 
Scheme 13: Regioselective C–H functionalisation of monofluoroarenes at Pd (Doucet et al.). 
Using a Gorelsky rationalisation of the factors influencing the reactivity and regioselectivity 
of direct arylation reactions catalysed by Pd it is possible to understand the difference in 
behaviour.
14
 The two main factors that play a role are the interaction energies of the 
substrate with the metal, and the arene distortion energy due to the group on the ring. 
Despite the C–H bond of fluorobenzene being more acidic than the C–H bond of 1-fluoro-3-
methoxybenzene, the latter is more reactive due to its more favourable arene distortion 
energy, which favours C–H bond functionalisation.47 
The same authors subsequently reported an investigation into the reactivity of para-
substituted fluorobenzenes in direct arylation reactions at Pd using aryl bromides (Scheme 
14) where the use of electron-donating or electron-withdrawing groups does not influence 
the regioselectivity, in all cases reaction occurs ortho to the fluorine atom.
48
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Scheme 14: Direct arylation of para-substituted fluorobenzenes (Doucet et al.). 
These studies all demonstrate that a fluorine atom can act as a powerful directing group in 
C–H activation and functionalisation reactions. However, a number of mechanistic 
investigations show that, in contrast to classical directing groups, a fluorine atom does this 
not by coordinating to the transition metal atom and bringing it in proximity to a particular 
position on the ring, but by making the activation of a particular C–H bond more 
thermodynamically favourable. An ortho fluorine atom has three effects on the adjacent 
position: it makes both the C–H and C–M bonds in that position stronger (higher bond 
dissociation energy) and it also withdraws electrons inductively, which stabilises the partial 
negative charge that forms upon deprotonation and thus increases the ‘acidity’ of the C–H 
bond. A stronger C–M bond makes its formation more thermodynamically favourable but a 
stronger C–H bond opposes this by creating a higher barrier to C–H activation; this is 
counteracted by the increased acidity of the position and C–M bond strength, with the result 
that the overall C–H activation becomes more favourable. 
1.3 Fluoroaromatics: applications and synthesis 
Whilst, as the previous sections have alluded to, fluorine can play an important role 
in the regiochemistry of C–H activation reactions, it can also impart many other useful 
properties on a compound. This raises the possibility of using fluorine as a directing group in 
synthesis, but also retaining it in the final target molecule. Fluorinated compounds are 
increasingly playing an important role both in the development of novel pharmaceutical 
agents and agrochemicals, and in the production of high performance materials. Since the 
discovery that the presence of fluorine in a system can help the introduction of a molecule 
into a cell while bringing metabolic stability, changes in chemical properties and enhancing 
binding interactions,
49
 the production of fluorinated compounds has become very 
important.
50
 
The production of fluoroaromatics is usually carried out using one of two different 
approaches: nucleophilic fluorination or electrophilic fluorination. The driving force in the 
fluorination reaction is the formation of thermodynamically favorable C–F bond (107 
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kcal/mol).
51
 Using the electrophilic approach, the substrate, which usually has a high 
electron-density centre, is treated with a fluorinating agent in which fluorine behaves as an 
electrophile. Because of its high electronegativity, in order to obtain an electrophilic fluorine 
it is necessary to withdraw charge through the inductive effect by putting a good leaving 
group near it, as in N–F compounds, e.g. SelectfluorTM (F-TEDA-BF4) (1.33 in Figure 3); the 
main disadvantages of using this kind of fluorinating agent are its high cost and low atom 
economy.
51
  
 
Figure 3: Electrophilic fluorinating agent Selectfluor. 
If the fluorine is introduced as an anion, using nucleophilic reagents, problems can arise due 
to the fact that it can act as a base as well as a nucleophile. In the unsolvated form it has 
strongly basic behavior but it can also be solvated, decreasing the nucleophilicity necessary 
to fluorinate a substrate, and leading to side reactions.
52
 One alternative to traditional 
fluorination methods would be the use of the cross-coupling reactions of fluorinated 
fragments that proceed via C–H activation reactions. Understanding the mechanism of these 
processes and using fluorine substituents as directing groups (see section 1.2) could lead to 
new and efficient methodologies to obtain fluoroaromatic motifs.
52-56
  
1.4 C–H activation mechanisms 
Many reviews are available concerning the mechanisms and the types of C–H 
activation reactions.
2,4,22,24,41,57-58
 Bercaw and Labinger have attempted to divide these 
reactions into a number of main categories.
59
  
 σ-Bond metathesis: These reactions are typical of electron-poor metal centers,60-61 
such as high-valent early transition metals and usually include the formation of a 
four-membered transition state during which the formal oxidation state of the metal 
does not change.
58
 When the precursors are osmium, iridium, rhenium or ruthenium 
hydrides, the process is better described as σ-CAM (complex-assisted metathesis)62 
due to the stabilisation of the σ-complex by the metal.63  
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Scheme 15: σ-CAM mechanism. 
 Oxidative addition: these reactions usually proceed via a highly unstable 
coordinatively unsaturated intermediate, followed by an increase in the oxidation 
state of the metal; it is typical of low valent, electron-rich transition metals, such as 
Pt, Ir, Ru and Rh. 
 
Scheme 16: Oxidative addition (general scheme). 
 Electrophilic substitution: these reactions typically involve late transition metals, 
such as Pd(II) or Pt(II) in strong acids, such as acetic acid, or in polar solvents, e.g. 
methanol. The term electrophilic derives from the origin of the organometallic 
intermediate [M
x+2
(X)(R)Ln] where the transition metal attacks an electron rich 
carbon followed by a deprotonation step.  
 
    [M
x+2
(X2)Ln] + R–H               [M
x+2
(X)(R)Ln] + H–X             (Eqn.1) 
 
In particular the electrophilic aromatic substitution mechanism (SEAr)
64
 is known for 
C–H activation reactions where the reaction proceeds via a Wheland intermediate, in 
which the aromaticity of the ring is lost, and the bond orders of the C–C bonds of the 
ring are no longer 1.5.
65
 
In addition to these three subtypes, the CMD (concerted metallation deprotonation) 
mechanism, also called AMLA (ambiphilic metal-ligand assisted C–H activation) is 
known.
20,66
 This mechanism was first suggested by Fagnou in 2006 for the intermolecular C–
H activation of perfluoroarenes at Pd to explain the complete inversion in the reactivity of 
electron-deficient substrates compared to electron-rich arenes going via the SEAr mechanism 
as mentioned in section 1.2. The CMD (or AMLA-6) mechanism,
41,57,67
 similar to the one 
proposed by Echavarren and Maseras for Pd-catalysed arylation reactions,
66
 proceeds via an 
agostic C–H interaction followed by six-membered cyclic transition state, generally 
involving an acetate or a carbonate, which is believed to have a multiple role by acting as a 
base, but also enhancing the electrophilicity of the Pd(II) center. Computational study 
revealed that the regioselectivity in the activation was directly dependent on the C–H bond 
acidity, meaning that the ortho fluorine effect can have a strong effect on the regioselectivity 
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of reactions proceeding by this mechanism.
20
 In order to prove the hypothesised mechanism, 
Fagnou and co-workers started their investigation with the highly electron-deficient 
pentafluorobenzene due to its inability to undergo reactions via an SEAr mechanism. 
 
Scheme 17: C–H bond functionalisation of perfluoroarenes at Pd via CMD (Fagnou et al.). 
They then performed competition experiments using different fluoroarenes finding that the 
most electron-deficient arene reacted preferentially, and thus showing the completely 
opposite trend compared to functionalisation reactions proceeding via the SEAr mechanism. 
Measurement of the KIE made clear that the CMD was the rate determining step, so they 
also performed computational calculations demonstrating that the regioselectivity ortho to 
the fluorine atom, in cases where more than one site is available for functionalisation, was 
the result of the C–H acidity and not of the stabilisation of the Pd by the fluorine atom.20 
Perutz and co-workers reported a subsequent computational study on Fagnou’s 
reactions comparing different fluorinated aromatics. In contrast to Fagnou’s own 
calculations, not just the CMD step was taken in account, but also the oxidative addition and 
the reductive elimination steps. They demonstrated that the Pd–C bond energies change the 
energetic barriers in the CMD, but also in the reductive elimination step, and that the 
presence of the fluorine atoms lowers the activation energy of the overall reactions making 
the C–H functionalisation regioselective.68  
These computational and experimental studies were performed on intermolecular  
C–H functionalisation reactions at Pd but intramolecular systems, which would form 
fluorinated metallacycles, have not been studied. Changing the ligand at Pd from a 
phosphine (as in Fagnou’s and Perutz’s calculations) to a different donor atom could change 
the electronic environment on the metal centre and lead to a different behaviour in the 
oxidative addition and in the consequent formation of the M–C bond, possibly also resulting 
in a change in mechanism. Finally the choice of the base could also affect the system making 
a possible transmetallation step the rate determining step. 
A more detailed discussion of intramolecular C–H activation mechanisms is given in 
the next section, and specific substrates are considered in more detail in Chapter 2.  
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1.5 C–H activation in cyclometallation reactions 
Directed C–H bond activation frequently results in the generation of a metallacycle, 
i.e. a ring containing a metal–carbon bond. Metallacycle formation is also the first step of 
many transition metal-catalysed C–H functionalisation processes. This section will give a 
brief historical overview of metallacycles and their synthesis and relevant mechanisms with 
an emphasis on Pd.  
Cyclometallation reactions via C–H activation at various transition metals have been 
known since the 1960s when the groups of Cope
69
 and Kleiman
70
 discovered the formation 
of a new C–M σ-bond between a transition metal and a ligand also containing a donor atom, 
such as N, resulting in a ring containing a metal atom (Figure 4).  
 
Figure 4: First examples of cyclometallation products reported separately by Cope and 
Kleiman. 
This type of metallacycle formation, also known as a cyclometallation reaction,
71
 usually 
occurs in two steps: firstly the metal coordinates to a soft donor atom such as P, N, O or S, 
and secondly, an intramolecular C–X (X = H, F) bond activation closes the n-membered-ring 
(typically n = 5 or 6 depending on the nature of M).
60,72
 The activation of a C–F bond to 
obtain a metallacycle is much rarer than the analogous C–H bond activation and few 
examples are reported.
73-78
 
Since their initial discovery, metallacycles
79
 themselves have come to play an 
important role in organometallic and organic chemistry
80
 being successfully employed as 
precursors, intermediates or catalysts
81-84
 to obtain organic molecules,
85-87
 and also used as 
anticancer agents or for other biological applications in their own right.
88-89
 They have been 
extensively studied and several reviews and books cover different aspects such as their 
synthesis from different transition metals
72,90-91
 and mechanistic investigations.
92-94
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1.5.1 Cyclopalladation reactions 
Almost all the transition metals can form metallacycles, but the most extensively 
studied and used are those derived from palladium, known as palladacycles.
72,82
 They 
contain a Pd–C bond that can be stabilised by one or two neutral donor atoms Y (P, N, S, 
etc.) and they can be defined as four- (CY) or six-electron donor (YCY) palladacycles 
(Figure 5).
90
  
 
Figure 5: Four- (CY) or six- electron (YCY) donor palladacycles. 
The CY type usually exist as acetate- or halogen-bridged dimers, as syn and anti geometrical 
isomers depending on the relative positions of the Pd–C bonds (Figure 6).  
 
Figure 6: syn and anti isomeric forms of palladacycles. 
They can be monomeric,
95
 cationic,
96
 neutral
97
 or anionic
98
 depending on the X ligand(s) on 
the metal. The carbon atom, which forms the bond with the metal, can be sp
2
 or sp
3
 
hybridised.
99
 
The cyclopalladation reactions are also called ortho-palladation reactions, due to the 
activation of the ortho position in the aromatic ligand with respect to the donor atom “arm” 
(e.g. N,N-dimethylbenzylamine, 1.38 in Scheme 18).
69,97,100
 
 
Scheme 18: Cyclopalladation reaction of dmba with PdCl2. 
A series of factors influences the success of cyclopalladation reactions:
60,101
 
 The nature of the donor atom (Y) and its basicity: palladium coordinates with the 
donor atom (Y) in the first step of the process, so the exact nature of it affects the 
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rate and the success of the reaction. Different donor atoms on the same general 
structure of the substrate give different results: for example in the case of certain 
dimethylphosphine and arsine derivatives the cyclopalladation does not occur,
102-103
 
while for the equivalent dimethylamines it is successful.
104
 The donor atom also 
stabilises the Pd–C bond, making the chelate effect an important feature: e.g. the 
intramolecular reaction of azobenzene with PdCl2 is 10
4
 times faster with respect to 
the same reaction with benzene and this is due to the chelation of the azo-group that 
can change the process from an intermolecular to an intramolecular one.
101
  
 
 Ring size of the resulting metallacycle: most known palladacycles contain a five-
membered ring. Taking for example the reaction of tetrachloropalladate salts (Na, Li 
or K) with amines of the type Ph(CH2)nNMe2, with n = 0–3, the cyclic product 
forming is exclusively the one with a five-membered ring (n = 1).
97
 
 
Scheme 19: Reaction of tetrachloropalladate salts with amines of type Ph(CH2)nNMe2, with n = 
0–3. 
The same behaviour has also been observed for similar phosphine ligands.
102,105
 
Six-membered palladacycles have, however, been obtained from different classes of 
ligands containing N, P and O, where the structure does not provide any feasible 
alternative (e.g. 1.43, Figure 7);
106
 
 
Figure 7: An example of a six-membered ring palladacycle. 
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 Steric arrangement around the donor atom and the metal: the ease of 
cyclometallation reactions for saturated carbon atoms decreases from primary to 
tertiary, e.g. compounds with large N-substituents such as 8-alkylquinolines react 
with palladium(II) much faster if there is methyl group on the 8-position than an 
ethyl group (Scheme 20), due to the decrease in the steric shielding of the nitrogen 
atom.
107
 
 
Scheme 20: Cyclopalladation reactions with substituted alkylquinolines. 
The same trend has been observed in P- and S-donor ligands; for example tertiary 
carbons in phosphines cannot be palladated even in the presence of bulky 
substituents.
108
  
Many external factors beyond the features of the substrate are also important in the 
formation of palladacycles, including the solvent, metallating agent, specific reaction 
conditions and presence or absence of an external base. The most commonly used sources of 
palladium are palladium(II) salts such as Pd(OAc)2 or Pd(acac)2, and tetrachloropalladate 
salts of the form M2[PdCl4] (M = Li, Na, K).
101
 The structural features of palladium acetate 
and their effects on its reactivity have been extensively studied.
109-110
 By varying the 
cyclopalladating agent, it is possible to obtain different degrees of metallation for some 
ligands, such as in the reaction of benzylideneazines with Pd(OAc)2 and PdCl2 (Scheme 21), 
where the reaction with palladium chloride produces only dicyclopalladated compounds 
whereas the reaction with palladium acetate gives mono- and di-metallated derivatives 
depending on the reaction conditions.
104,111-112
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Scheme 21: Difference in reactivity of benzylideneazines with Pd(OAc)2 and PdX2. 
Different sources of palladium can also lead to different mechanisms in reactions with the 
same substrate; this important aspect will be further discussed in Chapter 2. 
An alternative source of palladium could also be a pre-formed Pd complex where a 
cyclometallated ligand is exchanged for a different one in a reaction called 
transcyclometallation (Scheme 22).
60,113
 It is a particular type of C–H bond activation 
reaction to form metallacycles where a ligand-exchange process takes place using another 
pre-made metallacycle and involves M–C bond breaking followed by a M–C′ formation. 
 
Scheme 22: Example of transcyclometallation reaction (Pfeffer et al.). 
This kind of reaction has been extensively studied by different research groups and will be 
further discussed in Chapter 3.
99,114-115
 
The choice of the solvent in cyclopalladation reactions is very important and is often 
linked to the palladium source used. The most commonly used solvent is methanol due to its 
ability to dissolve a wide range of palladium salts and the fact that it favours the formation 
of vacant sites of coordination on the palladium atom.
101
 A typical example of this solvent 
effect is the cyclopalladation reaction of azobenzene which does not take place in non-polar 
solvents but occurs after the addition of an alcohol or water to the reaction mixture.
101
 
Sometimes the choice of the solvent can also strongly affect the yield of the reaction (see 
Chapter 2). 
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Cyclopalladation reactions are often linked with the elimination of a proton from the 
starting substrate and if this proton forms a strong acid such as HCl a base is necessary to 
neutralise it. Bases often used for this purpose are sodium acetate,
102,116-118
 NaOH
119-121
 or 
aliphatic amines such as trimethylamine or tributylamine.
97
 If the substrate has basic 
properties (e.g. an amine), it can also be used in excess (see Chapter 2).
122
 
The formation of palladacycles, via C–H activation, can proceed by a number of 
different mechanistic pathways: electrophilic substitution, oxidative addition, σ-bond 
metathesis
59,93
 or concerted metalation deprotonation (CMD or AMLA-6).
20,66
 The 
cyclopalladation of amino-based substrates has been extensively studied
94,123-124
 and the main 
two mechanisms proposed for this process are electrophilic aromatic substitution (SEAr)
64
 
and concerted metalation deprotonation (AMLA-6 or CMD).
20,66
 In the first, the C–H 
activation proceeds via a Wheland intermediate (Figure 8)
65
 and a covalent bond is 
consequently formed between the carbon atom of the arene and the Pd. In these mechanisms 
the palladium acetate is acting as an intramolecular base and is electrophilically activating 
the arene. 
 
Figure 8: Example of the Wheland intermediate in a SEAr mechanism.
124
 
Macgregor and co-workers suggested an AMLA-6 (or CMD) mechanism
41,57,67
 which, as 
previously discussed, proceeds via an agostic C–H interaction followed by six-membered 
cyclic transition state (Scheme 23) involving an acetate, which is acting as a base, but also 
enhancing the electrophilicity of the Pd(II) center. The formation of the agostic species is the 
rate determining step in their calculation, showing a parallel with Fagnou’s intermolecular 
C–H functionalisation reaction. 
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Scheme 23: CMD mechanism suggested by Macgregor et al. 
94
 
A further discussion of these two mechanisms will be given in Chapter 2 where the 
investigation of intramolecular C–H activation of fluorinated benzylamines will be 
described. 
1.6 Project aims and objectives  
1.6.1 Aims 
The aim of this project was the investigation of the effect of fluorine substituents on 
the regioselectivity of intramolecular C–H activation reactions of fluoroaromatics at 
different transition metals. The substrates taken into consideration were a series of partially 
and totally fluorinated N,N-dimethyl-benzylamines and diphenylbenzylphosphines. 
 
1.6.2 Objectives 
I. To investigate intramolecular C–H activation reactions of fluorinated N,N-
dimethyl-benzylamines at Pd(II) to assess if the presence of fluorine atoms on the 
aromatic ring can lead to a regioselective C–H activation, in particular if an ortho 
fluorine effect could be observed (Chapter 2);
122
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II. To investigate the regioselectivity of direct and transmetallation C–H activation 
reactions of fluorinated diphenylbenzylphosphines at Pd(II) (Chapter 3); 
III. To explore the behaviour of fluorinated N,N-dimethylbenzylamines on C–H 
activation reactions at Rh(III), Ir(III) and Ru(III) to assess if regioselective 
transformations could be obtained (Chapter 4); 
IV. To undertake a preliminary investigation of fluorinated N,N-
dimethylbenzylamines and diphenylbenzylphosphines towards stoichiometric C–F 
activation and catalytic C–F functionalisation reactions (Chapter 5). 
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Chapter 2: Fluorinated aminopalladacycles 
2.1 Introduction 
n the synthesis of active pharmaceuticals and the construction of building blocks for the 
total synthesis of natural products, the functionalisation of a C–H bond to form a new C–
Het or C–C bond is one of the most useful processes available, thanks to its inherent atom 
economy and efficiency.
5
 In the past decade the field has expanded to the point where it has 
become a potential replacement for traditional cross-coupling reactions,
6-9
 processes that 
require pre-activation of substrates.
10-13
 Control of regioselectivity however remains one of 
the main challenges for the field, as discussed in Chapter 1, and the use of directing groups 
ortho or meta to the target C–H site,22,33 offers a starting point to develop regioselective 
reactions, despite certain limitations, e.g. requirement for directing groups which are often 
difficult to remove.  
The role of fluorine substituents as directing groups in intramolecular reactions at Ir 
and Rh has been described by Jones and co-workers for C–H activation reactions of 2-
phenylpyridines and phenylimines, and the regioselectivity, mechanism and kinetics of the 
reactions have been investigated (Scheme 24).
116
 
 
Scheme 24: C–H activation reactions at Ir and Rh of substituted phenylimines (Jones et al.). 
Jones and co-workers reported that substrates with electron-withdrawing substituents reacted 
significantly more slowly than those with electron-donating substituents, which suggests an 
electrophilic aromatic substitution mechanism (SEAr).
125
 They also noted that the 
regioselectivity was extremely sensitive to steric effects, but temperature independent for Ir 
and Rh. Finally the authors also found that the regioselectivity was solvent dependent in 
reactions at Ir but solvent independent in reactions at Rh and that an ortho-fluorine effect 
was observed for substrates bearing a meta-F substituent, favoring the activation of the C–H 
bond ortho to the C–F bond.116 
I 
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Fagnou and co-workers, as discussed in Chapter 1, also reported the use of fluorine 
atoms as directing groups in intermolecular reactions catalyzed by Pd, in reactions 
proceeding via concerted metallation deprotonation mechanism (known as CMD
20,66
 or 
AMLA-6
57,94
), promoting C–H functionalisation ortho to the fluorine atoms (Scheme 
25).
14,20
  
 
Scheme 25: Intermolecular C–H functionalisation reaction at Pd of fluorinated aromatics 
(Fagnou et al.). 
In this chapter the effect of fluorine substituents on the regioselectivity of directed 
intramolecular reactions
94
 of fluorobenzylamines at Pd
II
 to form fluorinated palladacycles 
and on the structures of the resulting metallacycles are investigated. The aim was to explore 
whether an ortho fluorine effect could be observed in intramolecular reactions that proceed 
via a concerted metallation deprotonation mechanism
20,66
 (CMD) or an electrophilic 
aromatic substitution (SEAr) mechanism to form fluorinated metallacycles. The same 
mechanisms have been investigated computationally
68
 and experimentally for intermolecular 
reactions at Pd,
20
 Rh and Ir,
116
 where an ortho fluorine effect could be observed, due to the 
acidity increase of the proton ortho to fluorine and strengthening of the Pd–C bond as 
suggested by Perutz and co-workers.
68
 
2.1.1 Model reaction  
The study concerning the regioselectivity of intramolecular C–H activation started with the 
selection of two model reactions:  
 The cyclometallation of the non-fluorinated N,N-dimethylbenzylamine (2.7a) with 
Pd(OAc)2 forming the known palladacycle 2.8a (Scheme 26).
104
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Scheme 26: Synthesis of palladacycle 2.8a taken as model reaction. 
The reaction conditions in Scheme 26 were slightly altered with respect to the 
original procedure reported by Thompson and Heck,
104
 following studies conducted 
in the Fairlamb group, and acetonitrile was used as the solvent instead of 
acetone.
109,122
 These improved conditions afforded a 90% yield of palladacycle 2.8a 
and single crystals of the complex, suitable for X-ray analysis, were obtained by 
slow diffusion of hexane into a saturated solution of the compound in chloroform.  
 The cyclometallation of the non-fluorinated N,N-dimethylbenzylamine with 
Li2PdCl4 forming the known palladacycle 2.9a (Scheme 27). 
 
 
Scheme 27: Synthesis of palladacycle 2.9a taken as model reaction. 
The reaction conditions in Scheme 27 have again been slightly changed from the 
original procedure reported by Cope and co-workers for the synthesis of 
palladacycle 2.9a:
97
 the reaction time was decreased from 20 to 6 hours.
122
 
The model reactions were chosen on the basis of their known and well-studied reaction 
mechanisms. The cyclometallation reaction of N,N-dimethylbenzylamine (2.7a) with 
Pd(OAc)2 has been investigated extensively over the last 30 years. Ryabov and co-workers 
initially proposed that the reaction proceeds via an electrophilic aromatic substitution, where 
the Wheland intermediate (Figure 9) is formed by the intramolecular attack on the C–H bond 
by the electrophilic palladium followed by the coordination of the nitrogen to the metal 
centre.
64
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Figure 9: Resonance forms of Wheland intermediate. 
Ryabov et al. suggested the formation of palladacycle 2.8a via an unsaturated 14 e
−
 complex 
(2.14) formed after the 16 e
−
 complex (2.15) due to the rate constant k1 being smaller than k2 
(Scheme 28). 
 
Scheme 28: Electrophilic aromatic substitution mechanism suggested by Ryabov et al. 
Macgregor and co-workers later studied the mechanism of the same reaction using DFT 
calculations, suggesting that the reaction proceeds via an agostic C–H intermediate and not 
via the arenium intermediate, in an AMLA-6 mechanism,
20,66
 whereby the acetate group 
coordinated to the metal deprotonates the C–H bond whilst the Pd–C bond is forming 
(Scheme 29).
94
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Scheme 29: Computational reaction profile (kcal/mol) and bond lengths (Å) for the 
cyclometallation of Pd(OAc)2(DMBA-H) proceeding via an AMLA-6 mechanism (Macgregor et 
al.). 
The mechanism of the cyclometallation reaction of the non-fluorinated N,N-
dimethylbenzylamine 2.7a with Li2PdCl4 forming the known palladacycle 2.9a is instead 
suggested to be an electrophilic aromatic substitution (SEAr) mechanism (Scheme 30) as 
reported by Jones and co-workers in the C–H activation of phenylimines at Rh and Ir 
discussed previously.
116
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Scheme 30: Proposed electrophilic aromatic substitution mechanism for 2.17a. 
Using the optimised conditions (Scheme 26 andScheme 27), the synthesis of fluorinated 
palladacycles 2.8a–f and 2.9a–f (see X-ray structures in Appendix II) was attempted to 
assess the regioselectivity of cyclometallation reactions of fluorinated benzylamines 2.7a–f.  
2.1.2 Fluorinated N,N-dimethylbenzylamines  
The synthesis of 3-fluoro N,N-dimethylbenzylamine (2.7c) was already reported by 
Liu and Sayre,
126
 whereby a methanolic solution of dimethylamine reacts with 3-
fluorobenzylbromide (2.25) in a nucleophilic substitution reaction to form the desired 
product, which was isolated following an aqueous workup (Scheme 31). 
 
Scheme 31: Synthesis of 2.7c (originally reported by Liu et al.). 
The reaction was taken as a model and used to synthesise all the required pre-ligands (2.7b–
f, Figure 11). Their characterisation is discussed in more detail below. 
2.1.3 Acetate-bridged and chloride-bridged palladacycles 
The metallacycles discussed in this chapter are both acetate-bridged and chloride-
bridged palladacycles 2.8a–f and 2.9a–f, respectively (Figure 10).  
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Figure 10: General structure of fluorinated acetate- and chloride-bridged palladacycles. 
The acetate-bridged palladacycles (2.8a–f) obtained from Pd(OAc)2 possess a “clamshell” 
type structure, non-planar at palladium, similar to that reported for [(2-phenylpyridine)Pd(μ-
OAc)]2 by Bercaw and co-workers,
127
 where the coordination plane containing the palladium 
atom is almost perpendicular to the acetate bridge. Bercaw et al. suggested that this 
geometry is a consequence of the d
8–d8 interaction of the two palladium atoms and a π-
stacking interaction between the aromatic rings.
127-128
 The chloride-bridged palladacycles 
(2.9a–f) show a square-planar geometry with two ligands, bound through an M–N and an 
M–C(sp2) bond, forming two equal five-membered rings, as reported by Mentes for the 
equivalent non-fluorinated palladacycle 2.9a.
129
 The structural analysis of all the 
palladacycles (2.8a–f and 2.9a–f) is discussed in section 2.4 of this chapter. 
Palladacycles in general are widely used as pre-catalysts in Heck, Suzuki
130-131
 and 
Sonogashira reactions,
132
 Stille cross-couplings
84,133-134
 and carbonylation reactions,
135
 and 
recently their anti-cancer activities have been assessed and reviewed.
88
 The addition of a 
fluorine substituent on the benzyl ring of these metallacycles could lead to different catalytic 
activity in cross coupling reactions and further investigation is ongoing. 
2.2 Results 
2.2.1 Fluorinated N,N-dimethylbenzylamines  
The fluorinated substrates chosen for the cyclometallation reactions with Pd(OAc)2 
were mono- and di-fluorinated tertiary benzylamines 2.7b and 2.7d, respectively, presenting 
just one position (C-6 in Figure 11) for the C–H activation reaction, and mono- and di-
fluorinated benzylamines 2.7c and 2.7e offering two possibilities for the reaction at C-2 and 
C-6 (indicated with coloured arrows in Figure 11). Compound 2.7f shows two equivalent 
positions thus offering no choice. 
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Figure 11: Fluorinated N,N-dimethylbenzylamines. 
All of the fluorinated benzylamines (2.7a–f) were fully characterised by NMR (Table 1) and 
IR spectroscopies and ESI mass spectrometry. Taking N,N-dimethyl-2-fluorobenzylamine 
(2.7b) as an example, the 
1
H-NMR spectrum shows two singlets at δ 2.28 and 3.52 for the 
methyl and methylene protons respectively. It also shows two triplets of doublets at δ 7.36    
(J = 7.5, 1.7 Hz) and 7.11 (J = 7.5, 1.2 Hz), a multiplet at δ 7.25 and a doublet of doublets of 
doublets at δ 7.04 (J = 9.6, 8.2, 1.1 Hz) for the four magnetically inequivalent aromatic 
protons (Figure 12).  
 
Figure 12: 1H-NMR of 2.7b at 294.35 K in CDCl3 (400 MHz). 
The 
19
F-NMR spectrum shows a multiplet at δ −118.10 (Figure 13) while the 13C-NMR 
spectrum in CDCl3 shows six doublets at δ 161.6 (J = 246.3 Hz), 131.8 (J = 4.5 Hz), 129.1 
(J = 8.1 Hz), 124.0 (J = 3.6 Hz), 115.4 (J = 22.3 Hz) and 56.6 (J = 1.9 Hz), and a singlet for 
the methyl carbons at δ 45.3. The first doublet corresponds to the carbon bonded directly to 
fluorine with a coupling constant typical for a 
1
JC–F value. 
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Figure 13: 
19
F-NMR of 2.7b at 294.35 K in CDCl3 (376 MHz). 
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Table 1:
 1
H-NMR and 
19
F-NMR spectroscopic signals of N,N-dimethyl-fluorobenzylamines 
2.7b–f. 
Compound δ (1H) / ppm δ (19F) / ppm 
2.7b 
 
7.36 (td, J = 7.5, 1.7 Hz, 1H), 7.25 (m, 1H), 
7.11 (td, J = 7.5, 1.2 Hz, 1H), 7.04 (ddd, J = 
9.6, 8.2, 1.1 Hz, 1H), 3.52 (s, 2H), 2.28 (s, 
6H); 
−118.10 (m) 
2.7c 
 
7.27 (m, 1H), 7.08 (d, J = 7.6 Hz, 1H), 7.10–
7.02 (m, 1H), 6.95 (td, J = 8.3, 1.8 Hz, 1H), 
3.43 (s, 2H), 2.25 (s, 6H); 
−113.70 (m) 
2.7d 
 
7.09 (ddd, J = 8.8, 5.7, 3.2 Hz, 1H), 6.98 (td, J 
= 9.0, 4.5 Hz, 1H), 6.91 (m, 1H), 3.46 (d, J = 
1.2 Hz, 2H), 2.27 (s, 6H) 
−119.46 (m), 
 
−124.33 (dtd, J = 13.7, 
9.1, 4.9 Hz) 
2.7e 
 
7.14 (m, 1H), 7.08 (m, 1H), 7.00 (m, 1H), 3.35 
(s, 2H), 2.22 (s, 6H) 
−138.4 (m),  
 
−140.4 (m) 
2.7f 
 
6.91–6.80 (m, 2H), 6.68 (tt, J = 8.7, 2.2 Hz, 
1H), 3.38 (s, 2H), 2.23 (s, 6H) 
−110.55 (m) 
 
2.2.2 Reaction of fluorinated N,N-dimethylbenzylamines with 
Pd(OAc)2 
Following the identification of the optimised reaction conditions shown in Scheme 
32, palladacycles 2.8a–f were synthesised in good to excellent yields (Table 2).122 
 
Scheme 32: Cyclopalladation reactions of fluorinated tertiary amines with Pd(OAc)2. 
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Table 2: Products from intramolecular C–H activation of fluorinated benzylamines with 
Pd(OAc)2. 
Substrate  Complex  
Combined 
yield / % 
 
 
90 
 
 
85 
 
 
      
76 
 
 
78 
 
 
75 
 58 
 
 
 
 
82 
 
By way of example, a full spectroscopic analysis of complex 2.8b is described below. 
Reaction of N,N-dimethyl-2-fluorobenzylamine (2.7b) with Pd(OAc)2 for 14 h in acetonitrile 
afforded palladacycle 2.8b in 85% yield.  
 
Scheme 33: Synthesis of palladacycle 2.8b. 
The 
1
H-NMR spectrum of 2.8b (Figure 14) is consistent with a dinuclear complex showing 
C2 symmetry, and with the diastereotopic protons in the CH2 group appearing as an AB 
quartet at δ 3.47 (JH–H = 14.2 Hz). An additional coupling could be observed in the low 
frequency component of the AB quartet due to the coupling with the fluorine atom (JH–F = 
1.4 Hz). The carbons and protons of the N-methyls are split into two sets of signals 
corresponding to the axial and equatorial positions of the five-membered ring. While in the 
free substrate (2.7b) the methyl protons resonate at δ 2.28, in palladacycle 2.8b they are 
shifted to high and low frequency into two different signals at δ 2.07 and 2.83. In the 13C-
NMR spectrum the resonances of the two methyl groups also appear as two separate signals, 
shifted to high frequency from δ 45.3 (free substrate) at δ 51.6 and δ 52.9 (Figure 15).  
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Figure 14: 
1
H-NMR of palladacycle 2.8b at 294.15 K in CDCl3 (400 MHz). 
 
Figure 15: 
13
C{
1
H}-NMR of palladacycle 2.8b at 298 K in CDCl3 (126 MHz). 
The 
19
F-NMR spectrum shows a doublet of doublets at δ −115.01 (J = 9.7, 5.5 Hz), similar 
to the free substrate 2.7b. 
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Figure 16: 
19
F-NMR of palladacycle 2.8b at 300 K in CDCl3 (471 MHz). 
The LIFDI method
136
 was used to record mass spectra and the molecular ion with the typical 
isotopic pattern of a dinuclear palladium complex was the only peak observed (m/z = 
636.02) confirming that the dinuclear Pd2 species is present in solution. Palladacycle 2.8b 
was crystallized by slow diffusion of hexane into a concentrated solution of the compound in 
chloroform (Figure 17). 
 
Figure 17: Molecular structure of palladacycle 2.8b. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%.  
All the other palladacycles 2.8a–f were synthesised, characterised and crystallised in the 
same way as 2.8b (see crystallographic analysis in section 2.4).  
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The reaction with 3-fluoro-N,N-dimethylbenzylamine (2.7c) allowed an assessment 
of the effect of the presence of a fluorine atom on the regioselectivity of C–H activation 
reactions due to the two possible options for attack, ortho or para to fluorine (arrows in 
Figure 18).  
A mixture of isomeric forms of palladacycle 2.8c (2.8c2, 2.8c6, and 2.8c2,6 in Figure 
18) was obtained in 76% overall yield, and a single crystal analysed by X-ray gave a 
disordered crystal structure due to the different positions of the fluorine atoms on the ring.
†
 
 
Figure 18: Synthesis of palladacycle 2.8c (mixture of isomeric forms). 
The 
19
F-NMR spectrum of the mixture of isomers 2.8c shows four signals for the four 
magnetically inequivalent fluorine atoms: two doublets of doublets at δ −104.25 (J = 8.8, 5.2 
Hz) and δ −104.47 (J = 8.8, 5.1 Hz) for the fluorines ortho to palladium in 2.8c2 and 2.8c2,6, 
and a multiplet at δ −119.46 – −119.51 corresponding to two overlapping signals for the 
fluorines para to palladium in 2.8c6 and 2.8c2,6 (observed in a 
19
F-COSY-NMR spectrum).  
                                                     
†
 The nomenclature of the complex, e.g., 2.8c6, indicates complex 2.8c formed from substrate 2.7c by C−H  
activation in position 6 (numbering from the benzyl arm). Arrows represent the available sites for C−H 
activation. 
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Figure 19: 
19
F-NMR spectrum of mixture of isomers of palladacycle 2.8c in CDCl3 (471 MHz). 
To determine the ratio between the regioisomers and assess whether the para or the ortho 
isomer was the major species, the mixture of isomers was reacted with pyridine-d5 in order 
to split each palladacycle into two monomers by coordination to the palladium.  
 
Scheme 34: Formation of monomers 2.8cpyr2 and 2.8cpyr6 from 2.8c isomers. 
In the 
1
H-NMR spectrum of the resulting products, the integration of the methylene protons 
of each monomer gives a ratio of 1:0.9 (confirmed by integration of the fluorine signals) 
indicating a lack of any significant regioselectivity in the intramolecular C–H activation 
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reactions with Pd(OAc)2. The two momomers obtained, 2.8cpyr2 and 2.8cpyr6, have two 
different environments in the 
19
F-NMR spectrum (Figure 20): a doublet of doublets at δ 
−100.98 (J = 8.7, 5.4 Hz) for monomer 2.8cpyr2 with the fluorine ortho to palladium and a 
doublet of doublets at δ −119.88 (J = 15.9, 9.6 Hz) for monomer 2.8cpyr6 with the fluorine 
para to palladium. The 
1
H-NMR spectrum (Figure 21) shows a chemical shift for the proton 
a′ (label in Scheme 34) of 6.28 ppm that is upfield due to anisotropic shielding of the 
pyridine ring suggesting that the two nitrogens are trans to each other as reported for similar 
systems.
137
 Moreover the 
1
H-NMR spectrum shows just one doublet for the methylene 
protons and one singlet for the methyl groups bonded to the nitrogen atom.  
 
 
Figure 20: 
19
F-NMR spectrum of palladacycle 2.8cpyr2 and 2.8cpyr6 at 293.45 K in pyr-d5 (376 
MHz). 
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Figure 21: 
1
H-NMR spectrum of palladacycle 2.8cpyr2,6 and 2.8cpyr6 at 293.45 K in pyr-d5 (400 
MHz). 
Table 3:
 1
H-NMR and 
19
F-NMR signals of monomers 2.8cpyr2 and 2.8cpyr6 in pyr-d5 at 293.45 K 
(400 MHz). 
1
H-NMR signals / ppm
 
Assignment (Scheme 34) 
a 6.77 (m, 1H) a' 6.28 (dd, J = 8.4, 6.2 Hz, 1 H) 
b 7.07 (td, J = 7.7, 5.5 Hz, 1 H) b' 6.65 (t, J = 8.4 Hz, 1 H) 
c 6.92–6.88 (m, 1 H) c' 6.92–6.88 (m, 1 H) 
d 3.86 (br s, 2 H) d' 3.93 (br s, 2 H) 
e 2.84 (s, 6H) e' 2.76 (s, 6H) 
f 2.19 (s, 3H) f' 2.19 (s, 3H) 
19
F-NMR signals / ppm 
1 −100.98 (dd, J = 8.7, 5.4 Hz) 2 −119.88 (dd, J = 15.9, 9.6 Hz) 
 
Difluorinated substrate 2.7e behaved in the same manner as 2.7c showing a lack of 
regioselectivity in the cyclometallation reaction with Pd(OAc)2, and giving a mixture of 
isomers 2.8e2, 2.8e6, and 2.8e2,6 (Scheme 35). 
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Scheme 35: Synthesis of palladacycle 2.8e (mixture of isomeric forms). 
NMR characteristics of palladacycles 2.8a, 2.8b and 2.8d synthesised under the same 
reaction conditions as 2.8c, are reported in Table 4. 
Table 4: 
1
H- and 
19
F-NMR signals of palladacycles 2.8a, 2.8b and 2.8d. 
Compound δ (1H) / ppm δ (19F) / ppm 
2.8a 
7.02 (d, J = 7.1 Hz, 2H), 6.97 (t, J = 
7.3 Hz, 2H), 6.89 (t, J = 7.2 Hz, 2H), 6.84 (d, J = 
7.2 Hz, 2H), 3.58 (d, J = 13.7 Hz, 2H, RCH2N), 
3.09 (d, J = 13.7 Hz, 2H, CH2), 2.80 (s, 6H, 
NCH3), 2.06 (s, 6H, NCH3), 2.05 (s, 6H, CH3CO). 
- 
2.8b 
 
6.91 (td, J = 7.8, 5.6 Hz, 2H, H-4), 6.79 (d, J = 7.4 
Hz, 2H, H-5), 6.71 (ddd, J = 9.5, 8.1, 0.9 Hz, 2H, 
H-3), 3.50 (d, J = 14.1 Hz, 2H, CHH′), 3.45 (dd, J 
= 14.3, 1.4 Hz, 2H, CHH′), 2.83 (s, 6H, NCH3), 
2.07 (s, 6H, NCH3), 2.06 (s, 6H, CH3CO). 
−115.01  
(dd, J = 9.7, 5.5 
Hz) 
2.8d 
 
6.67 (td, J = 8.7, 3.7 Hz, 2H, H-3), 6.51 
(td, J = 7.7, 4 Hz, 2H, H-4), 3.76 (dd, J = 14.4, 1.8 
Hz, 2H, CHH′), 3.54 (d, J = 14.4 Hz, 2H, CHH′), 
2.83 (s, 6H, NCH3), 2.23 (s, 6H, NCH3), 2.00 (s, 
6H, CH3CO). 
 −111.12 (ddd, J = 
20.9, 7.6, 3.6 Hz, 
2F), 
 
 −121.08 (m, 2F).  
 
Palladacycle 2.8d was also crystallized by slow diffusion of hexane into a concentrated 
solution of the compound in chloroform (Figure 22). 
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Figure 22: Molecular structure of palladacycle 2.8d. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%.  
2.2.3 Reaction of fluorinated N,N-dimethylbenzylamines with 
Li2PdCl4 
The same fluorinated benzylamines 2.7a–f were reacted with Li2PdCl4 in methanol 
based on the procedure of Cope and co-workers (Scheme 36) to obtain chloride-bridged 
palladacycles 2.9a–f (Table 5).97 
 
Scheme 36: Cyclopalladation reactions of fluorinated tertiary amines with Li2PdCl4.  
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Table 5: Intramolecular C–H activation of fluorinated benzylamines with Li2PdCl4. 
 
Substrate 
2.7a–e 
Complex 
2.9a–e 
Yield / % 
  
70 
  
86 
  
76 
  
67 
  
71 
 
Two equivalents of 2-fluoro-N,N-dimethylbenzylamine (2.7b) were reacted with Li2PdCl4 in 
methanol for 6 h affording palladacycle 2.9b in 86% yield along with the protonated 
substrate 2.10bH
+
 (Scheme 37). In contrast to the acetate-bridged palladacycles (2.8a–f) and 
similar to the reported non-fluorinated example 2.9a,
97
 the chloride-bridged compounds 
appear in solution in two geometrical isomeric forms: syn and anti, depending on the relative 
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position of the Pd–C bonds (Scheme 37), whilst in the solid state only the anti isomer was 
observed (Figure 23).
72
  
 
Scheme 37: Synthesis of palladacycle 2.9b. 
 
Figure 23: Molecular structure of palladacycle 2.9b. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%. 
In the 
1
H-NMR spectrum of palladacycle 2.9b, the methyl groups resonate as two singlets at 
δ 2.86 and 2.88 due to the syn and anti isomeric forms, shifting to high frequency with 
respect to the free substrate 2.7b, which shows a single resonance at δ 2.28. The same can be 
observed for the methylene protons which resonate at δ 4.01 in palladacycle 2.9b and at 3.52 
in the free substrate 2.7b. The 
19
F-NMR spectrum shows a broad multiplet due to the overlap 
of syn and anti isomeric signals at δ −113.97 to high frequency compared to the free 
substrate 2.7b (δ −118.10). 
To investigate the regioselectivity of the cyclopalladation reaction forming chloride-
bridged palladacycles, substrate 2.7c was reacted with Li2PdCl4 in the same way as 2.7b 
(Scheme 36). Substrate 2.7c offers two sites (C-2 or C-6) for the C–H activation reaction 
(arrows in Figure 24).  
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Figure 24: Substrate 2.7c offers two sites (C-2 or C-6) for the C–H activation reaction. 
The reaction contrasts with that of palladium acetate, giving exclusively one regioisomer, 
2.9c6, in 76% yield along with the protonated substrate 2.10cH
+
. Complex 2.9c6 was 
crystallized by slow evaporation of a saturated solution of the complex in chloroform at 
−20 °C (Figure 25) confirming that the cyclopalladation had taken place only para to the 
fluorine atom, in position C-6 (Scheme 38). 
 
Scheme 38: Synthesis of palladacycle 2.9c6 (geometrical isomers syn and anti). 
 
Figure 25: Molecular structure of palladacycle 2.9c6. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%.  
Interestingly, the regioselectivity obtained differs from that ortho to fluorine of 
intermolecular reactions of fluorinated arenes reported by Fagnou et al.
20
 and from the 
intramolecular systems reported by Jones and co-workers.
116
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In the 
1
H-NMR spectrum of palladacycle 2.9c6 (Figure 26) the methylene protons 
resonate as a broad singlet at δ 3.90, while the two methyl groups bound to nitrogen exhibit 
two singlets at δ 2.83 and 2.86. The aromatic protons couple to each other and to fluorine 
and resonate at δ 7.10 (m) and 6.64 (m).  
 
Figure 26: 
1
H-NMR of palladacycle 2.9c6 at 298 K in CDCl3 (500 MHz) (syn and anti isomeric 
forms). 
In the 
19
F-NMR spectrum (Figure 27) two multiplets appear centered at δ −119.01 and 
−119.10, corresponding to the minor and major isomers in the ratio 1:1.2. It is not possible 
to distinguish which is due to syn and which is due to the anti isomer.  
The 
13
C-NMR spectrum also shows two sets of signals for the two geometrical 
isomers syn and anti. The N-methyl groups resonate in each isomer as two singlets at δ 53.1 
and 52.8 while the methylene carbons as two doublets at δ 73.2 and 73.0 (J = 2.6 and 2.9 Hz 
respectively), confirmed by a 
13
C-DEPT-135 NMR experiment. Two singlets appear at         
δ 109.0 and 108.8 for the carbons ipso to the benzyl arm of the two geometrical isomers and 
the aromatic carbons para to the C–F bond resonate as two sets of doublets at δ 112.0         
(J = 9.8 Hz) and 111.9 (J = 9.8 Hz). Two sets of doublets appear at δ 147.6 (J = 6.3 and 6.5 
Hz, respectively) corresponding to the aromatic carbon ortho to the C–F bond in both 
isomers. Finally at δ 161.41 and 161.38 (J = 241.5 and 241.6 Hz respectively) two doublets 
appear corresponding to the carbons bonded to fluorine in the minor and major isomers. 
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Figure 27: 
19
F-NMR of palladacycle 2.9c6 at 298 K in CDCl3 (471 MHz) (syn and anti isomeric 
forms). 
Palladacycles 2.9a–e were synthesised and crystallised following the same 
procedures used for 2.9c (Figure 28); their NMR spectroscopic signals are reported in Table 
6 and a crystallographic analysis is reported in section 2.4.2 of this chapter. 
 
Figure 28: Molecular structure of palladacycle 2.9e6. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%.   
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Table 6:
 1
H-NMR and 
19
F-NMR signals of palladacycles 2.9a–e at 293.45 K (400 and 500 MHz). 
Compound δ (1H) / ppm δ (19F) / ppm 
2.9a
97
  
 
7.17 (dd, J = 19.3, 7.6 Hz, 2H), 
6.99−6.94 (m, 2H), 6.87 (t, J = 6.8 Hz, 
4H), 3.93 (s, 4H), 2.87 (s, 6H), 2.84 (s, 
6H) 
- 
2.9b 
 
6.94 (dd, J = 20.1, 7.7 Hz, 2H), 6.70 (dd, 
J = 13.6, 4.9 Hz, 2H), 6.87 (td, J = 7.9, 
5,6 Hz, 2H), 4.01 (d, J = 2.3 Hz, 4H), 
2.88 (s, 6H), 2.86 (s, 6H). 
−113.97 (m) 
2.9c6 
7.10 (m, 2H), 6.64 (m, 4H), 3.90 (br s, 
4H), 2.86 (s, 6H), 2.83 (s, 6H). 
−119.01 (m, minor isomer), 
 
 −119.10 (m, major isomer). 
2.9d 
 
6.66 (qd, J = 8.5, 3.6 Hz, 2H), 
6.52 (m, 2H), 4.05 (d, J = 4.1 Hz, 4H), 
2.77 (s, 6H), 2.75 (s, 6H). 
δ −102.94 (ddd, J = 20.0, 7.7, 
3.6 Hz), 
  
−105.75 (ddd, J = 20.1, 7.9, 
3.6 Hz),  
 
−120.49 (m), 
 
−120.90 (m). 
2.9e6 
 
6.92 (ddd, J = 19.1, 10.6, 8.6 Hz, 2H), 
6.74 (dd, J = 10.6, 7.6 Hz, 2H), 3.88 (s, 
4H), 2.85 (s, 6H), 2.82 (s, 6H). 
−140.22 (m, major isomer),  
 
−140.55 (m, minor isomer), 
 
−143.50 (m, major isomer), 
 
−143.67 (m, minor isomer). 
 
Substrate 2.7d reacted with Li2PdCl4 under the conditions used for the other fluorinated 
amines giving the non-cyclometallated palladium complex 2.28d, instead of the expected 
chloride-bridged palladacycle 2.9d (Scheme 39). 
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Scheme 39: Formation of palladium complex 2.28d instead of palladacycle 2.9d. 
The 
19
F-NMR spectrum of complex 2.28d shows two multiplets for the two sets of 
chemically inequivalent fluorine atoms at δ −121.52 and −118.22. The 1H-NMR shows two 
singlets for the protons of the methyl groups bound to nitrogen and for the methylene 
protons at δ 2.60 and 3.90 respectively. The aromatic protons resonate as a doublet of 
doublets of doublets centered at δ 8.77 (J = 8.8, 5.5, 3.2 Hz), a multiplet centered at 7.12 and 
a triplet of doublets at 7.06 (J = 9.0, 4.6 Hz). Complex 2.28d was crystallised by slow 
evaporation of a saturated solution of the complex in dichloromethane at 2 °C (Figure 29). 
 
Figure 29: Molecular structure of complex 2.28d. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%.  
Palladacycle 2.9d was obtained reacting substrate 2.7d with Li2PdCl4 with a reaction time of 
one week (Scheme 40) suggesting that complex 2.28d is one of the species at equilibrium in 
the electrophilic aromatic substitution mechanism described in the introduction to this 
chapter (Scheme 30). 
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Scheme 40: Synthesis of palladaycle 2.9d (geometrical isomers syn and anti). 
The cyclopalladation reactions with Li2PdCl4 were also carried out in acetonitrile on the 
same reaction scale and with the same reaction conditions to assess the role of the solvent in 
the regioselectivity obtained for substrate 2.7c and 2.7e. The C–H activation reactions also 
occurred para to the fluorine atom suggesting that the regioselectivity is not solvent 
dependent. 
2.2.4 Bridging halide conversion at Pd(II)  
Chloride-bridged palladacycles 2.9a, 2.9c6 and 2.9e6 were reacted in acetone at 25 
°C with silver acetate (Scheme 41) to give the corresponding acetate-bridged palladacycles 
2.8a, 2.8c6 and 2.8e6 (Table 7).  
 
Scheme 41: Bridging halide conversion from chloride-bridged to acetate-bridged palladacycles. 
In the case of the fluorinated palladacycles 2.9c6 and 2.9e6, only the para isomers were 
formed, giving a new route to obtain fluorinated acetate-bridged palladacycles 
regioselectively. 
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Table 7: Acetate-bridged palladacycle obtained by bridging halide conversion. 
Complex  
   
Yield / % 91 98 95 
 
Complexes 2.8c6 and 2.8e6 were fully characterised and their NMR data are reported in 
Table 8.  
Table 8: 
1
H-NMR (500 MHz) and 
19
F-NMR (471 MHz) signals of monomers 2.8c6 and 2.8e6 in 
CDCl3 at 298 K  
Compound δ (1H) / ppm δ (19F) / ppm 
2.8c6 
 
6.95 (dd, J = 8.3, 6.2 Hz, 2H, H-1), 
6.71−6.61 (m, 4H, H-2, H-4), 3.52 (d, J = 
13.9 Hz, 2H, CHH′), 3.09 (d, J = 13.9 Hz, 
2H, CHH′), 2.79 (s, 6H, NCH3), 2.06 (s, 6H, 
NCH3), 2.05 (s, 6H, CH3CO) 
 −119.31  
(td, J = 9.6, 6.2 Hz) 
2.8e6 
 
6.78−6.72 (m, 4H, H-2, H-5), 3.58 (d, J = 
13.8 
Hz, 2H, CHH′), 3.13 (d, J = 13.8 Hz, 2H, 
CHH′), 2.79 (s, 6H, NCH3), 2.11 (s, 6H, 
NCH3), 2.06 (s, 6H, CH3CO). 
−140.92 (m, 2F),  
 
−143.94 (ddd, J = 19.7, 
10.7, 8.8 Hz, 2F). 
  
Palladacycles 2.8c6 and 2.8e6 were crystallised by slow diffusion of hexane into a 
concentrated solution of the compound in chloroform (Figure 30 andFigure 31). 
 76 
 
 
Figure 30: Molecular structure of palladacycle 2.8c6. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%.  
 
Figure 31: Molecular structure of palladacycle 2.8e6.. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%.  
2.2.5 Chlorinated amino palladacycles 
The chlorinated substrate 3-chloro-N,N-dimethylbenzylamine (2.7g) was 
synthesised following the same procedure used for the synthesis of the fluorinated tertiary 
amines 2.7b–f (Scheme 42) and reacted with Pd(OAc)2 and Li2PdCl4 to obtain chlorine 
substituted chloride- and acetate-bridged palladacycles 2.8g and 2.9g.  
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Scheme 42: Synthesis of chlorinated tertiary amine 2.7g. 
Reaction of N,N-dimethyl-3-chlorobenzylamine (2.7g) with Li2PdCl4 allowed an assessment 
of the effect the chlorine atom on the regioselectivity of C–H activation reaction due to the 
two possible options for attack, ortho or para to chlorine. The reaction, as for the fluorinated 
substrates, gave one regioisomer, 2.8g6, where the C–H activation occurs para to the 
chlorine atom (Scheme 43). 
 
Scheme 43: Regioselective synthesis of palladacycle 2.8g6. 
The 
1
H-NMR spectrum two multiplets at δ 7.08 and 6.90–6.85 for the aromatic protons 
while the methylene protons resonate as a singlet at δ 3.89. The two inequivalent methyl 
groups bound to the nitrogen resonate at δ 2.85 and 2.82. A single crystal, suitable for the X-
ray analysis, was grown by slow evaporation of a saturated solution of the compound in 
chloroform and confirmed the regioselectivity para to the chlorine atom (Figure 32). 
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Figure 32: Molecular structure of palladacycle 2.8g6. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%. 
The same chlorinated tertiary amine, 2.7g, was also reacted in acetonitrile for 14 h with 
Pd(OAc)2 affording only palladacycle 2.9g6 in 87% yield (Scheme 44) and showing 
complete regioselectivity para to chlorine.  
 
Scheme 44: Synthesis of chlorinated acetate-bridged palladacycle 2.9g6. 
The 
1
H-NMR spectrum (Figure 33) shows two multiplets at δ 6.97–6.87 and 6.74 for the six 
aromatic protons and only two doublets at δ 3.55 (J = 13.9 Hz) and 3.10 (J = 13.9 Hz) for 
the diastereotopic methylene protons of the palladacycle 2.9g6 showing the formation of just 
one isomer. The inequivalent methyl groups bound to the nitrogen and the methyl group of 
the acetate bridge resonate as three singlets at δ 2.78, 2.08 and 2.05, respectively. 
Due to the difficulty in obtaining a single crystal suitable for X-ray analysis of 
palladacycle 2.9g6, the compound was synthesised via a different route in order to confirm 
the position of attack of the C–H activation reaction. As reported in section 2.2.3 the 
conversion of chloride- to acetate-bridged palladacycles can be carried out straightforwardly 
whilst maintaining the regioselectivity of the starting materials. 
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Figure 33: 
1
H-NMR spectrum of palladacycle 2.9g6 at 293.45 K in in CDCl3 (400 MHz). 
Palladacycle 2.8g6 was thus reacted with silver acetate in acetone (Scheme 45) and the 
1
H-
NMR spectrum of the resulting acetate-bridged palladacycle, 2.9g6, was compared with the 
one of an authentic sample of 2.9g6. It was found to be consistent, confirming the 
hypothesised para substitution (Figure 34). 
 
Scheme 45: Bridge-conversion reaction of 2.8g6 to 2.9g6. 
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Figure 34: Comparison of 
1
H-NMR of palladacycle 2.9g6 obtained via two different routes. 
2.3 Discussion 
In this study a fluorinated benzylamine 2.7c that undergoes cyclometallation in a system 
where a choice is presented in the position of C–H activation (ortho or para to the fluorine 
atom) does not show any regioselectivity, forming a mixture of isomers (2.8c2, 2.8c6, and 
2.8c2,6). It is feasible that the lack of regioselectivity is the result of two opposing effects: 
while the activation in the ortho position (isomer 2.8c2 in Figure 35) is favoured due to the 
ortho fluorine effect as for the intermolecular reactions, proceeding via a CMD mechanism, 
of fluorinated substrates,
20
 the same position is disfavoured by the electronic repulsion 
between the lone pair of the oxygen in the acetate bridge pointing towards the aromatic ring 
and the fluorine lone pair (Figure 35).  
 
Figure 35: Representation of the electronic repulsion in palladacycle 2.8c2.  
Such steric and electronic effects could manifest themselves if C–H activation occurred 
through a dinuclear Pd complex. Future kinetic studies would be necessary to confirm this 
Bridge-conversion reaction from Cl to OAc 
Direct C–H activation reaction with Pd(OAc)2 
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proposal. To explore the steric and electronic effect theory the cyclometallation reaction of 
the same substrate 2.7c, was investigated using a different source of palladium (Li2PdCl4) 
which is reported to undergo cyclometallation via a different mechanism (SEAr).
97
 The 
resulting cyclometallation reaction gave just isomer 2.9c6 regioselectively, where the C–H 
activation occurs para to the fluorine atom. It is proposed that the formation of isomer 2.9c2 
is prevented by electronic repulsion between the chlorine and the fluorine lone pairs, which 
cannot be avoided due to the structural features of the chloride-bridged palladacycle (see 
below).  
 
Figure 36: Representation of the electronic repulsion in palladacycle 2.9c2. 
Comparing the two X-ray crystal structures in Figure 37 and Figure 38, it is possible to 
observe a key difference between the geometries of the two complexes. While the acetate-
bridged palladacycle 2.8c6 (obtained as a single isomer via reaction in Scheme 41) has a 
clam-shell structure that is able to twist (see crystallographic analysis in section 2.4), the 
chloride-bridged palladacycle 2.9c6 has a planar structure where the aromatic ring cannot 
twist away and the repulsion cannot be avoided. 
 
Figure 37: Molecular structure of palladacycle 2.8c6. 
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Figure 38: Molecular structure of palladacycle 2.9c6. 
An additional experiment with difluorinated amine 2.7e was performed to confirm this 
effect: the amine was reacted with Pd(TFA)2 to give a trifluoroacetate-bridged palladacycle 
2.30. Although the NMR spectra were complex and the ratio between the ortho and para 
isomers could not be determined, an X-ray crystal structure was obtained showing disorder 
in the position of the fluorine (Figure 39), which is consistent with the explanation given 
above. 
 
Figure 39: Molecular structure of palladacycle 2.30. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%.  
This theory is also supported by the experiment with the chlorinated substrate 2.7g (Scheme 
43) that gives, regioselectively, the para chloride-bridged palladacycle 2.8g6 for the same 
steric and electronic repulsion mentioned above and also gives regioselectivity in the 
formation of the acetate-bridged palladacycle 2.9g6, where the C–H activation ortho to 
chlorine is disfavoured by repulsions but in contrast to the fluorinated substrates the 
influence of the ortho fluorine effect is missing. 
The regioselectivity of these examples of cyclometallation reactions seems to be 
associated with a particular mechanism (CMD for the acetate-bridged and SEAr for the 
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chloride-bridged palladacycles) in addition to important electronic factors and the structural 
features of the palladacycles themselves. Interestingly Jones and co-workers have found an 
ortho fluorine effect in fluorinated imines, which react with Ir and Rh via an electrophilic 
aromatic substitution reaction as mentioned in section 2.1.
116
 The difference between the 
systems reported here and that reported by Jones et al. may be associated with a change in 
the rate determining step and also with differences in ligand conformation and identity. 
Furthermore as mentioned above, the amino-system is dimeric while the imino-system is 
monomeric and the regioselectivity could be different due to the C–H activation happening 
via a dinuclear Pd complex. 
The observed regioselectivity raises the question of thermodynamic or kinetic control in 
the step where the Pd–C bond is formed. Looking at the mechanism (Scheme 29) studied by 
Macgregor et al. and at the proposed mechanism for the SEAr (Scheme 30), in order to have 
thermodynamic control of the reaction in the acetate-bridged system, the second and third 
steps need to be reversible (to have the aromatic ring flipped vertically) while in the 
chloride-bridged system the last three need to be reversible. To assess whether the reactions 
were reversible, several experiments were performed to test: 
 Changes in isomeric distribution at higher temperature than the standard reaction: 
for the acetate system the isomer 2.8c6 was reacted with acetic acid at 75 °C and the 
reaction was monitored over 16 h, but no conversion to the ortho isomer 2.8c2 was 
observed; for the chloride-system the standard reaction was carried out in methanol 
at reflux resulting in the formation of the para isomer 2.9c6 only, suggesting that 
these reactions are under kinetic control.  
 Exchange reaction between non-fluorinated palladacycle 2.8a in the presence of 
fluorinated substrate 2.7c and acetic acid: the reaction performed in toluene, at 
reflux, for 24 h showed formation of a mixture of fluorinated isomers 2.8c2–2.8c6 
(conversion 33%) showing a lack of regioselectivity; the same reaction for the 
chloride-bridged palladacycle 2.9a in the presence of 2.7cH
+
Cl
−
 in deuterated 
acetonitrile gave selectively just the para isomer 2.9c6, again suggesting kinetic 
control (Scheme 46).  
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Scheme 46: Exchange reaction between palladacycle 2.8a in the presence of 2.7cH
+
. 
2.4 Crystallographic analysis  
2.4.1 Molecular structure of acetate-bridged palladacycles 
As mentioned in Section 2.1.3, all the acetate-bridged palladacycles 2.8a–f show a 
typical “clamshell” structure, non-planar at palladium, where the coordination plane 
containing the palladium atom is almost perpendicular to the acetate bridge, similar to that 
reported by Bercaw and co-workers.
127
  
 
Figure 40: Molecular structure of palladacycle 2.8a. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%.  
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Detailed crystallographic data can be found in Appendix II, but the most interesting 
differences between the structures are described by the following three parameters, listed in 
Table 9: 
 Pd···Pd distance; 
 interplane angle: angle between plane C (aromatic metallacycle)–C(ipso)–Pd(1) and 
the corresponding plane at Pd(2); 
 torsion angle N′–Pd′–Pd–N. 
Table 9: Selected distances and angles of acetate-bridged palladacycles 2.8a–f. 
Compound 
Pd···Pd distance 
(Å) 
Interplane angle 
(°) 
Torsion angle 
N′–Pd′–Pd–N 
(°) 
2.8a 
2.9324(6) 
2.9279(7) 
19.5(3) 
19.3(3) 
−104.3(3) 
−104.4(3) 
2.8b 2.9600(2) 9.45(16) 71.94(9) 
2.8c 3.0185(7) 37.22(13) −98.18(12) 
2.8d 3.0974(8) 85.66(15) −84.03(11) 
2.8e 3.0369(7) 37.88(13) −99.83(9) 
2.8f 3.0285(5) 86.30(11) −77.81(13) 
 
Analysing the data, a correlation between the Pd···Pd distance and the number of the 
fluorine atoms in the aromatic ring can be observed, potentially due to the withdrawal of 
electron density by the fluorine atoms that decreases the d
8–d8 interactions. C–F bond 
lengths (Table 10) show that there is almost no variation across the series, and all of them 
are slightly larger than 1.30 Å, corresponding to the sum of the covalent radii (Csp
2
: 0.73 Å, 
F: 0.57 Å).  
In Figure 41 is shown a graphical representation of the interplane angle for 
palladacycle 2.8b with the C (aromatic metallacycle), C(ipso) and Pd(1)  highlighted in 
yellow. 
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Figure 41: Interplane angle in palladacycle 2.8b. 
Across the series the interplane angle values increase from 9.45(16)° for the fluorinated 
palladacycle 2.8b, 19.5(3)° for the non-fluorinated compound 2.8a to 37.22(13)° and 
37.88(13)° for palladacycles 2.8c and 2.8e (mono- and di-fluorinated palladacycles 
respectively) and to 86.30(11)° for the difluorinated palladacycle 2.8d. It is possible to 
observe that as well as the number of fluorine atoms, the position of the fluorine has an 
effect on these values; in fact the highest value is for the palladacycle 2.8d where the 
fluorine atom occupies the position ortho to the Pd–C bond. It also possible to observe 
corresponding increases in the angle (hereafter called γ) between the two benzene ring 
planes, represented in Figure 42. 
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Figure 42: Angle between benzene planes (γ) in palladacycle 2.8b. 
The twisting of the benzene ring with respect to the coordination plane at palladium, 
(especially in structure 2.8d) is due to the electronic repulsion between the oxygen of the 
acetate bridge and the fluorine on the aromatic ring (distance (F(1)···O(2) is 2.886(2) Å in 
2.8d, compared to the sum of the van der Waals radii of 2.99 Å, a reduction of only 3%).
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The structural comparison in Figure 43 shows the different level of twisting and the opening 
of the clam shell as the fluorine substituents are introduced.  
 
Figure 43: Structural comparison between molecular structures showing the different level of 
twisting (clockwise from top left 2.8a, 2.8b, 2.8c, 2.8d, 2.8e, 2.8f). 
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Table 10: Selected bond lengths of palladacycles 2.8a–f. 
Bond  
length (Å) 
2.8a 2.8b 2.8c6 2.8d 2.8e6 2.8f 
C(1)−Pd(1) 1.963(7) 1.952(3) 1.958(2) 1.966(2) 1.9525(19) 1.974(2) 
O(1)−Pd(1) 2.145(5) 2.135(2) 2.1426916) 2.0996(17) 2.1383(14) 2.0363(17) 
O(n)−Pd(1) O(3) 
2.040(5) 
O(3) 
2.05010(19) 
O(2) 
2.0358(16) 
O(2) 
2.0276(17) 
O(2) 
2.0328(13) 
O(2) 
2.1192(17) 
C(n)−F(n) - C(5)−F(1) 
1.368(3) 
C(4)−F(1) 
1.363(3) 
C(2)−F(1) 
1.371(3) 
C(5)−F(2) 
1.357(3) 
C(3)−F(1) 
1.363(2) 
C(4)−F(2) 
1.348(2) 
C(2)−F(1) 
1.366(3) 
C(4)−F(2) 
1.363(3) 
N(1)−Pd(1) 2.064(6) 2.070(2) 2.0608(18) 2.0500(19) 2.0639(16) 2.057(2) 
 
Table 11: Selected bond angles of palladacycles 2.8a–f. 
Bond angle (°) 2.8a 2.8b 2.8c6 2.8d 2.8e6 2.8f 
C(1)−Pd(1)−O(n) O(3) 
92.5(3) 
O(3) 
92.36(10) 
O(1) 
91.51(8) 
O(2) 
95.10(8) 
O(2) 
91.42(7) 
O(1) 
93.58(8) 
C(1)−Pd(1)−N(1) 82.2(3) 82.06(10) 82.58(8) 81.72(8) 82.26(7) 81.25(9) 
N(1)−Pd(1)−O(n) O(1) 
93.3(2) 
O(1) 
95.60(8) 
O(1) 
93.70(7) 
O(1) 
94.30(7) 
O(1) 
94.15(6) 
O(2) 
93.70(7) 
O(n)−Pd(1)−O(1) O(3) 
91.8(2) 
O(3) 
90.04(8) 
O(2) 
91.36(7) 
O(2) 
87.48(8) 
O(2) 
91.41(5) 
O(2) 
90.24(7) 
 
2.4.2 Molecular structure of chloride-bridged palladacycles 
As mentioned above all the X-ray crystal structures of the chloride-bridged 
palladacycles (2.9a–f) show a square-planar geometry with two ligands, bound through an 
M–N bond and an M–C(sp2), forming two equal five-membered rings, as reported by 
Mentes for the equivalent non-fluorinated palladacycle (see structure of palladacycle 2.9b in 
Figure 44).
129
 Principal bond lengths and angles are given in Table 13 below. 
 89 
 
 
Figure 44: Molecular structure of palladacycle 2.9b. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%.  
In the solid-state all the complexes adopt the anti isomeric form while in solution it is 
possible to observe both isomeric forms. The effective symmetry of these complexes in 
solution is expected to be C2h for the anti isomer and C2v for the syn assuming that the five-
membered ring inverts rapidly. In contrast to the acetate-bridged structures, there is no 
folding at the bridging atom. A survey of the Cambridge Structural Database shows that this 
behaviour is characteristic of similar complexes with the majority having the Pd2C2 unit 
planar or very close to it. The Pd–Cl bonds in each structure are not the same due to the 
trans influence of the nitrogen and the aromatic carbon. Palladacycle 2.9d (Figure 45) is the 
only complex with the potential for repulsion between the fluorine and the chlorine atom, 
and in fact the Cl···F(1) distance is 2.9264(1) Å, smaller (9%) than the sum of the van der 
Waals radii of 3.22 Å.
138
 The complex shows a twist in the five-membered ring plane with 
respect to the plane containing both chlorine and palladium atoms. 
 
Figure 45: Molecular structure of palladacycle 2.9d. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%.  
′ 
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A similar twist was observed by Smith and co-workers for the complex methoxy-substituted 
di-μ-chlorobis(dialkylbenzylamine-2-C,N)-dipalladium(II).139 
The geometries of the planar structures are also defined by the same angles reported 
above for the acetate-bridged palladacycles in section 2.4.1. All the crystallographic data are 
reported in Appendix II, the main bond angles are repeated here in Table 13. There are no 
significant changes in the geometries of these palladacycles according to substitution. 
Table 12: Selected bond lengths of palladacycles 2.9a–f. 
Bond length 
(Å) 
2.9b 2.9c6 2.9d 2.9e 
C(1)−Pd(1) 1.967(4) 1.975(2) 1.997(3) 1.972(4) 
Cl(1)−Pd(1) 2.4565(11) 2.4658(6) 2.4379(7) 2.4336(11) 
Cl(1′)−Pd(1) 2.3264(10) 2.3352(6) 2.3277(7) 2.3415(10) 
C(n)−F(n) 
C(5)−F(1) 
1.363(5) 
C(4)−F(1) 
1.365(2) 
C(2)−F(1) 
1.366(3) 
C(5)−F(2) 
1.369(3) 
 
C(3)−F(1) 
1.361(5) 
C(4)−F(2) 
1.353(5) 
N(1)−Pd(1) 2.073(3) 2.0820(19) 2.079(2) 2.080(3) 
 
Table 13: Selected bond angles of palladacycles 2.9a–f. 
Bond angle (°) 2.9b 2.9c6 2.9d 2.9e 
C(1)−Pd(1)−Cl(1′) 94.51(12) 95.16(7) 98.22(8) 94.89911) 
C(1)−Pd(1)−N(1) 82.69(14) 81.96(8) 82.18(10) 81.99(15) 
N(1)−Pd(1)−Cl(1) 96.85(9) 97.49(5) 95.25(7) 97.73(10) 
Cl(1′)−Pd(1)−Cl(1) 85.92(4) 85.42(2) 84.36(3) 85.38(4) 
2.5 Biological evaluation of novel palladacycles  
Over the past decade it has been demonstrated that palladacycles show potent 
anticancer activity towards several cancer cell lines, as described by Kapdi and Fairlamb 
recently.
88
 In particular Karami et al.
140-141
 reported a study on palladacycles similar to those 
described in this chapter. The palladaycles synthesised here are fluorinated and due to the 
extensive studies on fluoroaromatics as pharmaceutical drugs
50,142-143
 a number of them (see 
2.9c6 and 2.9e6 in Figure 46) were tested against ovarian cancer cells (A2780) provided by 
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the European Collection of Authenticated Cell Cultures (ECACC). All other compounds of 
interest, shown in Figure 46, could not be examined due to insolubility in the aqueous 
medium used to grow the cancer cells. 
 
Figure 46: Mono and di-fluorinated palladacycles tested against ovarian cancer cells A2780. 
2.5.1 Results and discussion 
Palladacycle 2.9c6 was dissolved in DMSO and the medium used to grow the cancer 
cells was added. The solution was sterilised through a filter and diluted as reported in the 
experimental Chapter 7. An aliquot of the prepared solution was added to each well of the 
plate (Figure 47). On the plate two controls were set up (one positive and one negative) and 
it was then left incubating for three days. An MTT assay was performed dissolving MTT (3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) in phosphate-buffered saline, 
filtered through sterilising filters and the solution was added to each well. The plate was left 
incubating for 2 hours then it was centrifuged. An aliquot of medium was removed from 
each well and DMSO was added to dissolve the formazan (precipitate formed after 
metabolism, see colour of the wells in Figure 47).  
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Figure 47: Plate containing 96 wells: each column contains a different concentration of 
compound from 0 μM to 260 μM. 
The wells coloured in purple contain ovarian cancer cells which are still alive and 
correspond to the wells where the concentration of palladacycle is low. Absorbance was 
recorded at 540 nm using the plate reader and cell viability plotting as percentage from 
negative to positive controls. Figure 48 shows the curve used to calculate the IC50 value. 
 
Figure 48: IC50 calculation for compound 2.9c6 on ovarian cancer cells A2780. 
The same experiment was performed with palladacycle 2.9e6 and the curve used to calculate 
the IC50 is shown in Figure 49. 
2.9c6 
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Figure 49: IC50 calculation for compound 2.9e6 on ovarian cancer cells A2780. 
Palladacycles 2.9c6 and 2.9e6 show IC50 values of 11.99 and 14.01 μM respectively, similar 
to those reported by Karami and co-workers (12–14 μM).88  
The study needs to be expanded to better explore the activity, in particular the 
palladacycles should be tested for a smaller and more detailed range of concentrations (e.g. 
between 11 and 15 μM) to obtain an exact IC50 value. Moreover the test should be performed 
on three different batches of the same palladacycle to assess the reproducibility of the 
results. The error bars on the experimental results are typical for this kind of experiment due 
to the natural variations in living organisms. 
2.6 Conclusions 
This chapter has described the synthesis and full characterisation of novel 
fluorinated acetate- and chloride-bridged palladacycles (2.8a–f and 2.9a–f, respectively) 
obtained from fluorinated N,N-dimethylbenzylamines 2.7a–f. 
The aim of this study was to assess the effect of fluorine substituents on the 
regioselectivity of intramolecular C–H activation reactions at palladium. The fluorinated 
N,N-dimethylbenzylamines 2.7a–f  were reacted with two different sources of palladium 
(Pd(OAc)2 and Li2PdCl4) to study the regioselectivity in two different reaction mechanisms 
(CMD and SEAr, respectively).  
2.9e6 
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The study showed that when fluorinated benzylamines 2.7c and 2.7e react with 
Pd(OAc)2 the products do not exhibit any regioselectivity for the C–H activation reaction, 
while the same substrates react with Li2PdCl4 to give selectively palladacycles 2.9c6 and 
2.9e6 where the C–H activation occurs para to fluorine. The same palladacycles can then be 
converted to the relevant acetate-bridged palladacycles 2.8c6 and 2.8e6 by reaction with 
silver acetate, maintaining the regioselectivity. 
The lack of regioselectivity in the acetate-bridged palladacycle system, which 
proceeds via a CMD mechanism, contrasts with the behaviour of fluorinated substrates in 
intermolecular reactions at palladium that give ortho selectivity.
20
 Also the para selectivity 
obtained in the chloride-bridged palladacycle system, which proceed via an SEAr 
mechanism, diverges completely from the previously reported intramolecular reaction of 
fluorinated imines at rhodium proceeding via the same mechanism.
116
 
The presence of fluorine substituents has a distinct effect on the clamshell shape of 
the acetate-bridged palladacycle. Depending on the number and position of the fluorine 
atoms on the aromatic ring, the shape of the palladacycle changes, e.g. the difluorinated 
palladacycle 2.8d has a more open clam shell structure than the non-fluorinated palladacycle 
2.8a, consistent with the weaker d
8–d8 interaction between the palladium atoms. Also 
palladacycle 2.8d shows a big twisting of the aromatic ring to relieve the repulsion between 
the oxygen and fluorine lone pairs. By contrast the chloride-bridged palladacycles 2.9a–f 
have rigid planar structures that do not allow great structural variation. The impossibility of 
this important twist of the aromatic ring disfavours the formation of the ortho isomer in the 
C–H activation reaction of substrates, such as 2.7c and 2.7e, where there is a choice for the 
C–H activation, resulting in the formation of the para isomer only. In the case of 2.7d where 
there is no choice, the fluorine has to occupy the ortho position and a slight twist is observed 
along with a very slow reaction. More general conclusions are given in Chapter 6. 
Part of the work described in this chapter has been published and a full copy of the 
paper can be found in Appendix I.
122
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Chapter 3. Fluorinated benzylphosphines and 
relevant palladacycles 
3.1 Introduction 
hosphapalladacycles are an important class of compounds in catalytic processes at 
palladium, due to the important role phosphine ligands play in many reaction 
mechanisms involving transition metals.
133,144-145
 Their investigation and scope has 
developed enormously in recent decades following the early synthesis of Herrmann’s 
catalyst (3.1, Figure 50) used in the Heck cross-coupling reactions of chloro- and 
bromoarenes.
146
  
 
Figure 50: Herrmann’s catalyst. 
Phosphapalladacyles possess different properties to the aminopalladacycles described in 
Chapter 2, due to the lower basicity and the larger atomic radius of the phosphorus atom.
147
 
In contrast to the nitrogen atom,
148
 phosphorus can also acts as a π-acceptor, binding more 
strongly to some transition metals. A traditional description of the electronic interaction of a 
phosphorus–transition metal bond (M–P) involves two components:  
 The σ component consists of donation of electrons from the phosphine ligand lone 
pair to an empty orbital, of σ pseudosymmetry, on the metal, M; 
 The π component describes the back-donation from the filled orbitals on the metal, 
into empty orbitals, of a π pseudosymmetry, belonging to the phosphine ligand.148 
Ab initio molecular orbital calculations have been performed by Marynick and co-workers 
on simple phosphines (PR3 with R = H, F, CH3) to assess the nature of the LUMOs of 
phosphine ligands. They showed that the π-acceptor orbitals on the phosphorus consist of a 
doubly degenerate pair of orbitals of π symmetry, where not just the d orbitals of the 
phosphorus, but also the antibonding orbitals P–R σ* are involved.149 The σ* orbitals mix 
into the phosphorus 3d orbitals generating the π-acceptor orbital as illustrated in Figure 
51.
148
 
P 
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Figure 51: Mixing of P–R σ* (phosphine) and P 3d orbitals resulting in the π-acceptor LUMOs 
on phosphorus. 
A more electron withdrawing substituent R therefore increases the 3p character in the σ* 
orbital, lowering its energy. A scale of π-acidity can be written as PF3 > P(OAr3) > P(OR)3 > 
PAr3 > PR3 where R is an alkyl group.
150
 
In this chapter the synthesis of fluorinated diphenylbenzylphosphines 3.2–3.5 and 
their relevant chloride-bridged and acetate-bridged phospha-palladacycles will be taken into 
consideration (Figure 52). 
 
Figure 52: Fluorinated acetate-bridged and chloride-bridged palladacycles. 
3.1.1 Synthesis of fluorinated phosphapalladacycles 
As discussed in Chapter 1 there are several methods to synthesise palladacycles; 
hereafter only direct cyclometallation reactions and transmetallacyclisation reactions of 
tertiary phosphines at Pd will be discussed. 
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3.1.1.1 Direct reactions 
The synthesis of acetate-bridged phosphapalladacycle 3.9 from 
diphenylbenzylphosphine 3.8, was first reported by Hiraki and co-workers
100
 via the direct 
reaction of the tertiary phosphine with Pd(OAc)2. Due to the difficulties of purification of 
palladacycle 3.9, they converted the impure product via a metathesis reaction to the chloride-
bridged palladacycle 3.10, and after a recrystallisation with chloroform, they convert the 
bridge back to the acetate yielding only 21% of the product 3.9 (Scheme 47). 
 
Scheme 47: Synthesis of palladacycles 3.9 and 3.10 (Hiraki et al.). 
Later Shaw and co-workers reported an extensive study on the cyclometallation at platinum 
and palladium of tertiary benzylphosphines, noting the difficulty of employing phosphines 
that do not contain bulky groups on the phosphorus atom, such as the 
diphenylbenzylphosphine 3.8.
151-152
 They also showed that the inclusion of tert-butyl groups 
on tertiary phosphines promotes the internal metal–carbon bond formation.105 Although the 
mechanism of this kind of reaction is not fully understood,
153
 the authors made some 
observations concerning the factors that could have an effect on the cyclometallation at 
transition metals of these substrates, based on their experimental results: 
 Steric hindrance: the promotion of cyclometallation by bulky pre-ligands on the 
phosphorus atom can be explained using thermodynamic arguments. From a 
thermodynamic point of view, bulky ligands are not strongly bound to the metal in 
the phosphine–metal complex such as complex 3.10 (Scheme 47) due to their 
interactions with the other ligands in the cis-position (e.g. the Cl atoms in 3.10). 
When the ligand cyclometallates, the cis ligand is eliminated, resulting in a stronger 
interaction between the phosphorus and the metal. From an entropic point of view 
the metallation is favoured by bulky ligands because only a small amount of 
rotational entropy is lost on cyclometallation due to the already restricted rotation 
around the P–M bond, while if the ligand is less hindered the loss of entropy is large 
and the P–M bond strength decreases. 
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 Ring size: while for an amino ligand the cyclometallation reaction occurs only if a 
five-membered ring is formed,
154
 tertiary phosphines are able to undergo 
cyclometallation to form five-, four- or even three-membered rings.
155
 
These observations were confirmed by the same researchers a few years later in a report 
concerning the entropic effects on formation of large macrocycles and cyclometallation 
reactions
156
 and the influence of the Thorpe–Ingold effect, also called “gem-dimethyl 
effect”, in the synthesis of smaller rings.157 Soon after, they also showed that while di(tert-
butyl)benzylphosphine is readily metallated, the same is not true for di(tert-butyl)(o-tolyl)- 
and (tert-butyl)-di(o-tolyl)phosphine. This suggests that the difference is due to electronic 
rather than steric effects, considering that all three systems have similar steric bulk, and 
should cyclometallate, forming a 5-membered ring.
102
 Later they managed to synthesise 
complex 3.12 (Scheme 48)
158
 starting from complex 3.11 in 2-methoxyethanol and using 
sodium acetate, known as an agent to promote cyclometallation.
159
 
 
Scheme 48: Synthesis of palladacycle 3.8 (Shaw et al.). 
Leung and co-workers have reported the synthesis of a similar palladacycle (3.15)
160
 reacting 
the racemic phosphine 3.14 directly with Pd(OAc)2 followed by chloride metathesis with 
LiCl (Scheme 49). 
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Scheme 49: Synthesis of palladacycle 3.15 (Leung et al.). 
It is clear that electronic effects play a role in the cyclopalladation reactions of these two 
phosphines. In internal metallation at iridium it has already been shown that electron-
donating groups on the aromatic ring of analogues of triphenylphosphine, affect the rate of 
ortho-metallation, e.g. for complexes such as [IrCl{P(C6H4X)3}3] the rate of 
cyclometallation increases in the order X = F < H < OMe < Me.
160
  
Vrieze and co-workers reported that bulky fluorinated tertiary phosphines 
(cyclohexyl and t-butyl groups on the phosphorus) could activate the C–H ortho to the 
fluorine atom in cyclometallation reactions at Ir and Rh and the one para to fluorine for 
reactions of the same substrates at Pd.
153
 The authors attributed the difference in 
regioselectivity to a difference in mechanism, suggesting a nucleophilic mechanism for 
reaction at Ir(I) and Rh(I) and an electrophilic one for reaction at Pd(II). The regiochemistry 
of the C–H activation reactions was determined by 1D 19F-NMR spectroscopy, which for 
these kind of compounds is not very explanatory, as shown in Chapter 2 for amino-type 
palladacycles. Also the mechanisms have not been validated with further experiments and 
they only rely on the electrophilic or nucleophilic behaviour of the metal. (Scheme 50).
153
  
 
Scheme 50: Synthesis of fluorinated palladacyle 3.17. 
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3.1.1.2 Transmetallation reactions 
Due to the aforementioned issues with the direct reaction of diphenyl-
benzylphosphines to form the acetate- and chloride-bridged phosphapalladacycle, the 
procedure reported by Ryabov and co-workers using a ligand-exchange reaction from the 
chloride-bridged palladacycle 3.10, with the tertiary phosphine 3.8, was taken into 
consideration as possible alternative.
161
 
 
Scheme 51: Synthesis of palladacycle 3.10 by ligand-exchange reaction. 
Ryabov and co-workers reported that exchange could be achieved between a nitrogen and a 
phosphorus ligand, as shown in Scheme 51, or between two different nitrogen ligands or two 
different phosphorus ligands.
64,114
 Later they studied the kinetics, thermodynamics and 
mechanism of these reactions
64
 and concluded that the exchange between ligands takes place 
due to acidolysis of the starting palladacycle. The mechanism was described as a two-step 
dissociative process in which the Pd–N bond is cleaved in the first step followed by Pd–C 
bond cleavage. The reaction can be viewed as an equilibrium that is shifted towards the 
formation of a complex with the ligand containing the strongest electron donating group. 
Pfeffer and co-workers improved the yield of this transmetallacyclisation reaction 
using trifluoroacetic acid in toluene instead of acetic acid in methanol (Scheme 52)
115
 
obtaining palladacycle 3.10 as the main product along with the protonated amine 2.10aH
+
. 
 
Scheme 52: Improved synthesis of palladacycle 3.10 by ligand-exchange reaction. 
Finally Smoliakova and co-workers reported the synthesis of non-fluorinated 
phosphapalladacycle 3.10 from diphenylbenzylphosphine (3.8) in a solvent-free system 
using silica gel as a support.
162
 They also confirmed the structure of the compound 3.10 via 
full characterisation data and crystallographic analysis that had not been previously reported. 
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Scheme 53: Synthesis of palladacycle 3.10 in a solvent-free system. 
In this chapter an investigation into the effects of fluorine substituents in the regioselectivity 
of intramolecular C–H activation reactions of fluorinated benzylphosphines at palladium is 
described. The resulting fluorinated phosphine-derived palladacycles are, in fact, closer 
systems to those calculated theoretically by Perutz and co-workers on intermolecular 
arylation reactions of fluoroaromatics described earlier (see Chapter 2).
68
  
The aim was to explore whether an ortho fluorine effect could be observed in 
intramolecular C–H activation reactions of fluorinated diphenylbenzylphosphines at Pd as 
reported experimentally by Vrieze and co-workers for similar substrates (Scheme 50).
153
  
3.1.2 Fluorinated benzylphosphines 
Tertiary phosphines are a versatile class of compounds used as ligands in the 
synthesis of transition metal complexes and as reagents in organic transformations.
163
 
General synthetic methodologies for the synthesis of tertiary phosphines include reactions of 
halo-phosphines with organometallic reagents such as Grignards or organolithiums,
164-165
 or 
reactions of phosphides with aryl halides catalysed by transition metals.
166
 Both of these 
methods are widely used for the synthesis of aromatic phosphines, but the synthesis of 
benzylic phosphines has not been extensively studied and in particular, only a limited 
number of fluorinated tertiary phosphines with diphenyl groups on the phosphorus atom are 
reported, and those that are are not fully characterised.
153,167
 The syntheses of all fluorinated 
benzylphosphines 3.2–3.5 reported in this chapter were based on the synthesis of  
diphenylbenzylphosphine 3.8 reported by Freitag and co-workers (Scheme 54)
168
 using 
slightly different conditions for each substrate.  
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Scheme 54: Synthesis of fluorinated diphenylbenzylphosphines. 
3.2 Results 
3.2.1 Syntheses of fluorinated benzylphosphines 
Four different systems were chosen to study (3.2–3.5 in Figure 53): 3.2 and 3.5 are 
monofluorinated and difluorinated benzylphosphines respectively, presenting just one 
possibility for the C–H activation (C-6 in 3.2 and equivalent positions C-2 and C-6 for 3.5), 
while 3.3 and 3.4 are monofluorinated and difluorinated benzylphosphines respectively, 
offering two possibilities for the attack at C-2 and C-6. 
 
Figure 53: Fluorinated benzylphosphines synthesised and used in this study. 
Substrates 3.3
153
 and 3.5
167
 were already used in the literature as ligands but no 
characterisation data or synthetic procedures were reported. All these fluorinated 
benzyldiphenylphosphines (3.2–3.5) were synthesised as reported in Scheme 54. 
The reaction of lithium diphenylphosphide, 3.22, with the appropriate benzyl bromides is 
expected to proceed via an SN2 mechanism (Scheme 55). 
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Scheme 55: SN2 mechanism for the synthesis of fluorinated tertiary phosphines. 
The deprotonation of the colourless diphenylphosphine (3.19) with 
n
BuLi, in THF at −78 °C, 
produced a bright red/orange solution corresponding to the lithium phosphide (3.22), which 
reacts with the relevant fluorobenzylbromide giving LiBr and the corresponding product 
(3.20). All of the benzylphosphines were handled as air sensitive compounds. 
The spectroscopic data for 2-fluoro-diphenylbenzylphosphine (3.2) are taken as 
representative of this series of substrates and discussed in detail below. The 
1
H-NMR 
spectrum (Figure 54) run in C6D6, shows two multiplets at δ 7.40–7.33 and 7.06–7.01 
corresponding to the aromatic protons of the two equivalent phenyl rings. It also shows two 
multiplets centered at δ 6.91 and 6.76 and one triplet of doublets at δ 6.66 (J = 7.5, 1.6 Hz) 
belonging to the four aromatic protons in the fluorinated benzyl ring coupled to the fluorine 
atom. The methylene protons resonate at δ 3.34 as a singlet, not showing a coupling with the 
phosphorus atom as observed for the non-fluorinated diphenylbenzylphosphine 3.8.
168
 
  
Figure 54: 
1
H-NMR spectrum of 3.2 in C6D6 at 294 K (400 MHz). 
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The 
31
P-NMR spectrum (Figure 55) shows a doublet due to the coupling with the 
fluorine (
4
JP–F = 13.2 Hz) at δ −10.91, again in a range consistent with literature value for 
diphenylbenzylphosphine 3.8.  
 
Figure 55: 
31
P-NMR spectrum of 3.2 in C6D6 at 294 K (162 MHz). 
 
Figure 56: 
19
F-NMR spectrum of 3.2 in C6D6 at 294 K (376MHz). 
The fluorine atom on the benzyl ring resonates as a multiplet centered at δ −116.84 
in the 
19
F-NMR spectrum of 3.2 (Figure 56) due to the coupling with the aromatic protons 
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and with the phosphorus. The 
13
C-NMR spectrum (Figure 57) was run in CDCl3, to avoid the 
overlap of the residual benzene signal with the aromatic protons of the two equivalent 
phenyl groups, which resonate as two doublets at δ 133.1 (J = 18.8 Hz) and 128.5 (J = 6.6 
Hz), a doublet at δ 115.4 (J = 22.2, 1.4 Hz) and as a singlet at δ 129.1. The spectrum also 
shows a doublet of doublets at δ 161.0 for the carbon bonded to the fluorine (J = 245.4, 4.3 
Hz) and four doublets of doublets at δ 131.4 (J = 7.8, 4.3 Hz), 127.8 (J = 8.1, 2.6 Hz), 124.8 
(J = 15.3, 8.3 Hz) and 123.9 (J = 3.5, 1.7 Hz) respectively for the non-equivalent ortho- and 
meta-carbons and a doublet at δ 138.1 (J = 15.0 Hz) for the quaternary carbon ortho to F. 
High resolution ESI mass spectrometry confirmed the identity of compound 3.2 as the m/z 
value found for [M+H]
+
 was 295.1053 (calculated for C19H17FP 295.1046 [M–H]
+, Δ = −0.6 
mDa).  
  
 
Figure 57: 
13
C-NMR spectrum of 3.2 in CDCl3 at 298 K (126 MHz). 
Procedures for the synthesis and characterisation of the other fluorinated phosphines 
were similar to those of 3.2 and their spectroscopic data are reported in Table 14 and Table 
15.  
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Table 14: NMR Data (δ (J/Hz)) for tertiary diphenylbenzylphosphines 3.8 and 3.3–3.5. 
Compound 
δ (31P{1H}) / 
ppm 
δ (1H) / ppm δ (19F) / ppm 
3.8
a
 CDCl3 −10.00 (s) 7.12–7.47 (m, 15H), 3.33 (s, 2H) - 
3.3 
CDCl3 
−9.94 (s) 
7.43–7.36 (m, 4H), 7.15–7.11 (m, 6H), 
6.91–6.81 (m, 2H), 6.78 (m, 1H), 6.73 
(ddd, J = 9.7, 2.4, 1.2 Hz, 1H), 3.20 (s, 
2H) 
−113.47 (m) 
3.4 
C6D6 
−10.0 (s) 
7.27 (m, 4H), 7.05 (m, 6H), 6.64 (ddt, 
J = 11.2, 7.6, 1.7 Hz, 1H), 6.55 (dt, 
J = 10.2, 8.4 Hz, 1H), 6.41 (ddd, J = 
5.9, 3.7, 1.7 Hz, 1H), 2.99 (s, 2H) 
−138.09 – 
−138.18 
 
−141.63 – 
−141.73 
3.5 
C6D6 
−9.16 (s) 
7.24 (m, 4H), 7.02 (m, 6H), 6.42 (m, 
2H), 6.32 (m, 1H), 2.94 (s, 2H) 
−110.30– 
−110.40 
a
reference 
168
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Table 15: 
13
C-NMR Data (δ (J/Hz)) in CDCl3 for the tertiary diphenylbenzylphosphines 3.2–3.5 
Compound δ (13C) / ppm 
3.2 
161.0 (dd, J = 245.4, 4.3 Hz), 138.1 (d, J = 15.0 Hz), 133.1 (d, J = 18.8 
Hz), 131.4 (dd, J = 7.8, 4.3 Hz), 129.0 (s), 128.5 (d, J = 6.6 Hz), 127.8 
(dd, J = 8.1, 2.6 Hz), 124.8 (dd, J = 15.3, 8.3Hz), 123.9 (dd, J = 3.5, 1.7 
Hz), 115.4 (dd, J = 22.2, 1.4 Hz), 28.6 (d, J = 16.2 Hz) 
3.3 
163.2 (dd, J = 245.2, 1.9 Hz), 140.7 (dd, J = 8.4, 7.7Hz), 138.7 (d, J = 
16.3 Hz), 133.3 (d, J = 18.8 Hz), 129.9 (dd, J = 8.4, 1.6 Hz), 129.0 (s), 
128.7 (d, J = 6.4 Hz), 125.3 (dd, J = 6.8, 2.8 Hz), 116.6 (dd, J = 21.4, 6.6 
Hz), 113.1 (dd, J = 21.0, 2.6 Hz), 36.1 (dd, J = 17.2, 1.9 Hz) 
3.4 
150.4 (ddd, J = 247.3, 12.7, 1.8 Hz), 149.1 (ddd, J = 245.9, 12.7, 3.0 
Hz), 138.4 (d, J = 16.0 Hz), 135.0 (ddd, J = 9.0, 5.8, 3.9 Hz), 133.2 (d, J 
= 18.7 Hz), 129.1 (s), 128.7 (d, J = 6.5 Hz), 125.5 (td, J = 6.3, 3.5 Hz), 
118.3 (dd, J = 17.2, 6.6 Hz), 117.0 (d, J = 17.6 Hz), 35.34 (dd, J = 17.2, 
1.0 Hz) 
3.5 
162.9 (ddd, J = 247.7, 13.2, 1.6 Hz), 137.5 (d, J = 14.8 Hz), 134.5 (t, J = 
12.9 Hz), 133.0 (d, J = 18.7 Hz), 129.2 (s), 128.7 (d, J = 6.6 Hz), 112.2 
(m), 101.6 (td, J = 25.3, 2.2 Hz), 36.2 (d, J = 17.1 Hz) 
  
Compounds 3.3 and 3.5 were crystallised in air by slow evaporation of a saturated solution 
of the compound in MeOH at 2 °C. Compound 3.3 crystallised as the phosphine (Figure 58), 
whilst 3.5 crystallised as its phosphine oxide (Figure 59). 
 
Figure 58: Molecular structure of compound 3.3. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%. 
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Figure 59: Molecular structure of compound 3.5 in the oxide form. Hydrogen atoms were 
omitted for clarity; thermal ellipsoids shown with probability of 50%. 
Table 16: Selected distances (Å) and angles (°) in fluorinated phosphines 3.3 and 3.5 oxide. 
Bond Length / Å 3.3 3.5 
C(1)–P(1) 1.8603(19) 1.8117(18) 
C(8)–P(1) 1.838(2) 1.8061(18) 
C(14)–P(1) 1.8352(19) 1.8045(19) 
C(n)–F(n) 
C(4)–F(1) 
1.364(2) 
C(4)–F(1) 
1.362(2) 
C(6)–F(2) 
1.358(2) 
P(1)–O(1) - 1.4905(13) 
Bond Angle / ° 3.3 3.5 
C(n)–P(n)–C(n) 
C(8)–P(1)–C(1) 
99.33(9) 
C(14)–P(1)–C(1) 
103.26(9) 
C(8)–P(1)–C(1) 
106.41(8) 
C(14)–P(1)–C(1) 
106.45(8) 
C(2)–C(1)–P(1) 108.05(13) 112.20(12) 
O(1)–P(1)–C(1) - 114.01(8) 
O(1)–P(1)–C(8) - 111.64(8) 
O(1)–P(1)–C(14) - 111.81(8) 
 
3.2.2 Synthesis of fluorinated palladacycles 
The study of the fluorinated phospha-palladacycles started with the selection of a 
model reaction, the synthesis of the acetate-bridged phosphapalladacycle 3.9 from 
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diphenylbenzylphosphine 3.8 reported by Hiraki and co-workers
100
 via direct reaction of the 
tertiary phosphine with Pd(OAc)2 (model reaction with fluorinated substrates in Scheme 56). 
In our hands the reaction performed first in methanol as in the Hiraki procedure and then in 
acetonitrile, according to the study by Fairlamb and co-workers,
109,122
 gave a mixture of 
products that were not possible to separate by flash chromatography (30:70, hexane/ethyl 
acetate). 
Due to the difficulty in obtaining the acetate-bridged product using a direct reaction, 
the synthesis of chloride-bridged palladacycles using Li2PdCl4, followed by the conversion 
to acetate-bridged palladacycles by reaction with silver acetate was considered as a viable 
alternative (Scheme 10).
100
  
 
Scheme 56: Synthesis of palladacycles 3.6 and 3.7 (based on Hiraki et al. method). 
The methodology was tested directly with fluorinated substrate 3.2 to form the 
fluorinated chloride-bridged palladacyle 3.23 (Scheme 57) using Li2PdCl4 as source of 
palladium. 
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Scheme 57: Failed synthesis of palladacycle 3.23 along with the unexpected product 3.24. 
The product was not the expected palladacycle 3.23, but the monomeric complex 3.24, that 
was crystallised by slow diffusion of a saturated solution of the compound in CDCl3 (Figure 
60). 
 
 
Figure 60: Molecular structure of complex 3.24. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%. 
The monomeric complex 3.24 was reacted with caesium carbonate in refluxing methanol to 
attempt the cyclometallation reaction, but the dimeric non-cyclometallated compound 3.25 
was the only product obtained (Scheme 58).  
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Scheme 58: Attempted at cyclometallation reaction from monomer 3.24. 
The dimeric complex 3.25 shows a broad singlet at δ 29.74 in the 31P-NMR spectrum shifted 
to high frequency with respect to the monomeric complex 3.24 (δ 20.91) and a multiplet at δ 
−113.03 in the 19F-NMR spectrum with a chemical shift almost identical to the monomeric 
compound 3.24 (δ −113.07). LIFDI mass spectrometry confirmed the formation of the 
dimeric product 3.25 giving the molecular ion (minus two molecules of HCl) as the only 
peak with a characteristic isotope pattern of a dinuclear palladium compound (m/z = 869.90).  
As previously discussed Shaw and co-workers reported an extensive study of direct 
cyclometallation reactions with non-bulky phosphines and in particular they managed to 
synthesise palladacycle 3.12 (Figure 61)
158
 in 2-methoxyethanol using sodium acetate 
starting from the monomeric complex 3.11.
159
 
  
Figure 61: Palladacycle 3.12 synthesised by Shaw et al.  
The same reaction conditions were used with fluorinated complex 3.24, but the expected 
cyclometallated product (3.23) was not obtained (Scheme 59). The only species detected by 
NMR spectroscopy was complex 3.25 along with the starting material. 
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Scheme 59: Attempted synthesis of palladacycle 3.23 using the procedure of Shaw et al. 
The next attempt was to use the procedure of Smoliakova and co-workers (see section 3.1), 
which employs silica gel in a solvent-free system.
162
 This reaction was attempted using 2-
fluoro-diphenylbenzylphosphine (3.2) once again (Scheme 60). The use of different types of 
silica (200–425 and 100–230 mesh) and both sodium and lithium tetrachloropalladate were 
tested; in all the attempts the monomeric complex 3.24 and the dimeric complex 3.25 (the 
same obtained from the reaction in Scheme 58) were the only products and no 
cyclometallation was observed.  
 
Scheme 60: Attempted synthesis of palladacycle 3.23 using the method of Smoliakova et al. 
The reaction with the non-fluorinated diphenylbenzylphosphine 3.8 was also attempted to 
validate their method (Scheme 61) but no cyclometallation product (3.10) was obtained 
using both different types of silica (200–425 and 100–230 mesh).  
 
Scheme 61: Failed synthesis of palladacycle 3.10 (Smoliakova et al.). 
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Due to the difficulties in obtaining the fluorinated palladacycles 3.23 by direct 
reactions, the transcyclometallation method from the aminopalladacycles studied by Ryabov 
and co-workers was considered as an alternative.
161
 
 
Scheme 62: Synthesis of palladacycle 3.10 reported by Ryabov et al. 
The amino-type chloride-bridged palladacycle (2.9a) was synthesised as reported in Chapter 
2. The presence of acetic acid in the ligand exchange reaction (Scheme 62) led to the 
formation of a mixture of acetate- and chloride-bridged palladacycles so it was changed to 
hydrochloric acid (1 M in diethyl ether). The reaction was monitored by TLC (50:50 
EtOAc/petrol) and after 24 hours all the starting material was consumed. However, the 
product of the reaction was not the expected phospha-palladacycle 3.10, but a mixture of 
two products: the heteropalladacycle 3.26 where the amino ligand was still cyclometallated 
and the phosphine substrate coordinated to the metal, and the monomeric dichloro-
diphenylbenzylphosphine palladium complex 3.27 (Scheme 63).  
 
Scheme 63: Transmetallation reaction following the procedure of Ryabov et al. 
The mixture was separated by flash chromatography, allowing isolation and characterisation 
of the pure compounds 3.26 and 3.27. In the 
31
P-NMR spectrum, the heterocomplex 3.26 
(Scheme 63) in CDCl3 showed a broad signal at δ 38.33 due to the small coupling with the 
methylene protons. The 
1
H-NMR spectrum showed three signals at δ 7.58 (m), 7.30 (td, J = 
7.8, 2.0 Hz) and 7.09 (m) for the aromatic protons of the coordinated phosphine, and three 
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sets at δ 7.41 (td, J = 7.4, 1.7 Hz), 6.92 (d, J = 6.4 Hz) and 6.77 (td, J = 7.3, 0.9 Hz) for the 
aromatic protons of the cyclometallated amine. The methylene protons of the amino-ligand 
resonate as a doublet at δ 4.03 (J = 11.9 Hz; overlap of two doublets) while the methylene 
protons of the phosphine ligand resonate at δ 3.98 and show a small splitting (d, J = 1.92 Hz) 
due to a coupling with the phosphorus. Two singlets at δ 1.85 correspond to the two methyl 
groups of the amino-ligand. Mass spectra were recorded by the LIFDI method
136
 resulting in 
the molecular ion with a characteristic isotope pattern for a monomeric Pd species (m/z = 
551.07). A single crystal of the heterocomplex 3.26 was grown by slow diffusion of hexane 
into a solution of the compound in chloroform (Figure 62). 
 
Figure 62: Molecular structure of complex 3.26. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%. 
 
The monomeric dichloro-diphenylbenzylphosphine palladium complex 3.27 (Scheme 63) 
showed two multiplets at δ 7.51 and 7.08 in the 1H-NMR spectrum for the ortho and meta 
aromatic protons on the two phenyl rings and a doublet of doublets at δ 7.17 (J = 9.2, 4.1 
Hz) for the para hydrogen. The benzyl aromatic protons resonate at δ 7.43 (t, J = 7.4 Hz) 
and 7.33 (t, J = 7.5 Hz), while the methylene protons at 3.95 (t, J = 4.1 Hz). LIFDI mass 
spectrometry
136
 used to analysed the complex, showed the molecular ion with characteristic 
isotope pattern for a monomeric Pd species (m/z = 728.05). A single crystal suitable for X-
ray analysis of the monomer 3.27 was grown by slow diffusion of hexane into a solution of 
the compound in chloroform (Figure 63). 
 115 
 
 
Figure 63: Molecular structure of complex 3.27. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%. 
 
Table 17: Selected distances (Å) and angles (°) complexes 3.26 and 3.27 
Bond Length / Å 3.26 3.27 
C(1)–Pd(1) 2.004(3) - 
Cl(1)–Pd(1) 2.4234(7) 2.2946(4) 
Cl(2)–Pd(1) - 2.2967(4) 
P(1)–Pd(1) 2.2506(7) 2.3154(4) 
P(2)–Pd(1) - 2.3273(4) 
N(1)–Pd(1) 2.143(2) - 
Bond Angle 3.26 3.27 
C(1)–Pd(1)–P(1) 94.88(8) 119.92(6) 
Cl(1)–Pd(1)–C(1) 166.14(7) - 
P(1)–Pd(1)–Cl(1) 92.65(3) 87.518(15) 
Cl(1)–Pd(1)–P(2) - 90.626(15) 
Cl(2)–Pd(1)–P(1) - 91.081(15) 
N(1)–Pd(1)–Cl(1) 91.07(6) - 
C(1)– Pd(1)–N(1) 81.83(10) - 
 
Since palladacycle 3.10 could not be obtained using the modified Ryabov method, an 
alternative was sought in the literature. Pfeffer and co-workers have reported an 
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improvement in the yield of this reaction by using trifluoroacetic acid in toluene (Scheme 
64).
115
  
 
Scheme 64: Synthesis of palladacycle 3.10 by Pfeffer et al.  
Following the reaction conditions reported in the paper, it was possible to observe complete 
consumption of starting material after two hours by TLC. However, the isolated product was 
not the palladacycle 3.10 but the monomer 3.26 (Scheme 65), which is thought to be a 
possible intermediate in the overall formation of the palladacycle 3.10. 
 
Scheme 65: Formation of monomer 3.26 instead of palladacycle 3.10. 
The monomer 3.26 was reacted with PdCl2 in toluene at reflux in an attempt to obtain the 
phosphapalladacycle 3.10 (Scheme 66).  
 
Scheme 66: Synthesis of palladacycle 3.10 from monomer 3.26 
After work-up the crude reaction mixture was analyzed by LIFDI mass spectrometry and 
31
P- and 
1
H-NMR spectroscopies. The LIFDI mass spectrum showed the presence of several 
Pd-containing compounds (m/z = 553.98, 692.95, 835.94, 871.95). This was confirmed by 
the 
31
P NMR spectrum, which showed three signals at δ 29.12, 31.81 and 56.70. All of the 
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species in the mass spectrum possessed the typical isotope pattern of Pd2 (the signal at 
692.94 showed the exact isotope pattern hypothesised for 3.10 confirming that 3.26 is in fact 
a reaction intermediate).  
In an attempt to obtain the palladacycle 3.10 as the only product, the reaction 
between the chloride-bridged palladacycle 2.9a and diphenylbenzylphosphine (3.8) was 
extended to 24 hours (Scheme 67), which led to full conversion to the expected product. 
 
Scheme 67: Synthesis of palladacycle 3.10 
After isolation of the product 3.10, the 
31
P-NMR spectrum recorded in CDCl3, showed two 
singlets at δ 55.71 and 56.08 in ratio 2:3, while Smoliakova et al. and co-workers reported 
one singlet at δ 55.95.162 The µ2-Cl-bridged-palladacycles can exist in two possible 
geometrical isomers, syn and anti, depending on the relative positions of the Pd–C bonds,169   
giving an explanation for the two signals detected in the 
31
P-NMR spectrum. The LIFDI 
mass spectrum showed the correct isotope pattern for the hypothesized product 
C38H32Cl2P2Pd2 (3.10) at m/z = 833.94, and despite the 
1
H-NMR signals differing slightly 
from the reported values
162
 they are consistent with the hypothesised structure (Table 18 and 
6).   
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Table 18: 
1
H-NMR signals of palladacycle 3.10 (500 MHz in CDCl3 at 300 K). 
 δ (1H) / ppm 
Assignment 
(Scheme 67) 
Experimental 500 
MHz, (J / Hz) 
Literature values
162
 
500 MHz, (J / Hz) 
a 
aromatic 
phenyl rings 
7.77 (m) 
7.46 (m) 
7.74 (br. s) 
7.64 (br. s) 
7.56 (br. s) 
7.35 (m) 
7.26 (d, 
3
JH–H = 7.9 Hz) 
7.01 (d, 
3
JH–H = 7.9 Hz) 
 
b 
aromatic 
benzyl ring 
6.96 (m) 6.90 (br. s) 
c 
methylene 
protons 
3.82 (d, J = 12.3, 2H) 3.81 (d, J = 15, 2H) 
 
Table 19: 
31
P-NMR signals of palladacycle 3.10 (202 MHz in CDCl3 at 300 K) 
δ (31P) / ppm 
Experimental 202 MHz, (J / Hz) 
Literature values
162
 
202 MHz, (J / Hz) 
55.71 (s) 
56.08 (s) 
55.95 
 
3.2.2.1 Fluorinated chloride-bridged phosphapalladacycles 
The aim of the synthesis of fluorinated phosphapalladacycles was to assess the 
regioselectivity of the intramolecular C–H activation reactions and compare it with that for 
tertiary fluorinated benzylamines (Chapter 2). All the fluorinated phosphapalladacycles were 
synthesised using the optimised conditions of the exchange reaction (Scheme 68) (also 
referred to as a transcyclometallation reaction) reported by Pfeffer and co-workers.
115
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Scheme 68: Synthesis of fluorinated palladacycles (general scheme). 
The reaction between complex 2.9a and 2-fluoro-diphenylbenzylphosphine 3.2, in toluene at 
reflux for 24 hours, gave palladacycle 3.23 in 43% yield along with the protonated substrate 
2.10aH
+
 (Scheme 69).  
 
Scheme 69: Synthesis of palladacycle 3.23. 
Whereas the free phosphine 3.2 shows a single resonance in the 
1
H-NMR spectrum at δ 3.34 
for the methylene protons, 3.23 exhibits two doublets at δ 3.83 and 3.84 (J = 11.8 Hz) 
representing the syn and anti isomeric forms. The aromatic protons of the benzylic group 
resonate as a multiplet at δ 6.77–6.67 and as three doublets of doublets at δ 6.87 (J = 13.8, 
7.8 Hz), 6.99 (J = 12.7, 7.8 Hz) and 7.66 (J = 7.8, 4.5 Hz). The phenyl protons of the 
phosphino-ligand resonate at δ 7.39–7.32 (m), 7.52–7.40 (m), 7.70 (dd, J = 12.0, 7.7 Hz)  
and 7.82 (dd, J = 11.8, 7.7 Hz), values consistent with the reported data for the non-
fluorinated palladacycle 3.10.
162
 It is also possible to observe the two isomeric forms (syn 
and anti) in the 
31
P-NMR spectrum, which shows two sets of singlets at δ 58.8 and 58.4 
(ratio 1.4:1 by integration) and in the 
19
F-NMR spectrum where the two isomers resonate as 
two multiplets at δ −110.58 and −110.70.  
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Figure 64: 
1
H-NMR spectrum of palladacycle 3.23 in CDCl3 at 298 K (500 MHz). 
 
 
Figure 65: 
31
P-NMR spectrum of palladacycle 3.23 in CDCl3 at 298 K (202 MHz). 
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Figure 66: 
19
F-NMR spectrum of palladacycle 3.23 in CDCl3 at 298 K (471 MHz). 
A single crystal of palladacycle 3.23 was obtained by slow evaporation of a saturated 
solution of the complex in toluene. 
 
Figure 67: Molecular structure of palladacycle 3.23 Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%. 
The reaction of 2.9a with 3-fluoro-diphenylbenzylphosphine 3.3 (Scheme 70) allowed an 
examination of the regioselectivity of the cyclopalladation reaction since the substrate 3.3 
offers a choice between the C-2 position or C-6 position (Scheme 70) for C–H activation. 
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Scheme 70: Synthesis of palladacyle 3.28 (regioselectivity para to F). 
Two different products 3.28p and 3.28o in Figure 68 could have been formed due to the two 
sites available (blue and purple bonds) for the C–H activation. 
 
Figure 68: Possible isomers of palladacycle 3.28 (Scheme 70). 
From the NMR spectroscopic data it was possible to deduce that the reaction gave 
exclusively palladacycle 3.28p in 84% and the protonated substrate 2.10H
+
, meaning that the 
cyclometallation occurs only in the position para to the fluorine atom (C-6).
 
The 
19
F-NMR 
spectrum exhibits two multiplets at −118.6 and −118.5 ppm in ratio 1:1.5 and the 31P-NMR 
spectrum shows two singlets at 55.0 and 54.6 ppm for the two geometrical isomers. 
A 
1
H-
1
H-COSY NMR spectrum (Figure 69) of palladacycle 3.28p clarified the 
correlation between the six benzyl protons and allowed assignment of the correct signals to 
the two species, indicated in Figure 69 with the green circles and the purple triangles. 
Unfortunately it was not possible to ascertain which signals correspond to the syn isomer 
and which the anti, but it is possible to observe in the expansion of the aromatic region that 
the patterns of the multiplets form similar pairs of resonances and in one case (6.83 ppm) the 
multiplets overlap perfectly to form one signal. 
A 
1
H-
31
P-HSQC NMR experiment was performed making it possible to correlate the 
two singlets in the 
31
P-NMR (55.0 ppm and 54.5 ppm) with the two methylene protons at 
3.79 and 3.78, respectively. 
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A proton-decoupled proton (
1
H{
1
H})-NMR experiment
170
 of palladacycle 3.28 
(Figure 71) was run on a 700 MHz NMR instrument, in an attempt to get additional 
information by removing the coupling between aromatic protons and clarify the coupling 
with fluorine and phosphorus atoms. This experiment uses the method of slice-selective 
excitation developed by Zangger and co-workers.
170-171
 When a linear gradient is applied, 
different parts of an NMR sample show different magnetic field strengths so when a 
combination of different 180° pulses is then applied, the signals become either off-resonance 
or on-resonance. By collecting a series of data it is possible to suppress the homonuclear 
coupling in the region of interest. In this study the aromatic region between 6.5–6.9 ppm was 
analysed and the spectrum shows only the coupling between proton and fluorine atoms. The 
coupling constants observed were both 9 Hz for the doublets at 6.61 ppm and 6.83 ppm, 
which both correspond to the same geometrical isomer. As reported for fluorobenzenes
172-174
 
and for parafluorotoluene,
175
 the coupling constant ortho-JH–F is ~9 Hz, the meta- JH–F is 
around 5 Hz and the para- JH–F close to 0. 
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Figure 69: Expansion of aromatic region in 
1
H-
1
H-COSY NMR spectrum of palladacycle 3.28 at 
298 K (500 MHz) in CDCl3. 
From the data obtained two protons showed coupling constants of 9 Hz and the only 
possibility is that there are two protons ortho to the fluorine atom, which corresponds to the 
geometry of the para isomer 3.28p shown in Figure 70. 
 
Figure 70: para isomer (palladacycle 3.28p). 
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Figure 71: 
1
H{
1
H}-NMR (700 MHz) spectrum (above) and 
1
H-NMR spectrum (below) of 
palladacycle 3.28p at 298 K (700 MHz) in CDCl3. 
A single crystal of the palladacycle 3.28p was grown by slow evaporation of the complex in 
toluene, confirming the para-selectivity (Figure 72). 
 
Figure 72: Molecular structure of palladacycle 3.28p. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%. 
Palladacycle 3.29 was synthesised in an identical fashion, and crystallised by slow 
evaporation of a saturated solution of the complex in chloroform, while 3.30 was synthesised 
and crystallised following the same procedures used for 3.23 (Figure 74 andFigure 75). 
Their NMR signals are reported in Table 20 and a crystallographic analysis is given in 
section 3.4.  
1
H{
1
H}-NMR 
1
H-NMR 
 126 
 
 
Table 20: NMR spectroscopic data for complexes 3.10, 3.23 and 3.28–3.30. 
Compound 
δ (31P{1H}) 
/ ppm 
δ (1H) / ppm δ (19F) / ppm 
3.10
a
 55.95 
7.74 (br s, 4H), 7.64 (br s, 4H), 7.56 (br s, 
1H), 7.35 (m, 5H), 7.26 (d, J = 7.9 Hz, 1H), 
7.01 (d, J = 7.9 Hz, 1H), 6.90 (br s, 2H), 
3.81 (d, J = 15 Hz, 2H) 
- 
3.23  
58.81 
58.37 
7.82 (dd, J = 11.8, 7.7 Hz, 5H, Ph), 7.70 
(dd, J = 12.0 Hz, 3H, Ph), 7.66 (dd, J = 7.8, 
4.5 Hz, 1H, benzyl), 7.52–7.40 (m, 8H, Ph), 
7.39–7.32 (m, 4H, Ph),  6.99 (dd, J = 12.7, 
7.8 Hz, 1H, benzyl), 6.87 (dd, J = 13.8, 7.8 
Hz, 1H, benzyl), 6.77–6.67  (m, 2H 
benzyl), 3.84 (d, J = 11.8 Hz, 2H, major 
isomer ), 3.83 (d, J = 11.8 Hz, 2H, minor 
isomer) 
−110.58 (m, 
minor isomer) 
 
 −110.70 (m, 
major isomer) 
3.28p 
54.99 
54.59 
7.85 (m, 1H, benzyl), 7.81 (m, 4H, Ph), 
7.73–7.65 (m, 3H, Ph), 7.56 (m, 1H, 
benzyl), 7.52–7.39 (m, 10H, Ph), 7.39–7.31 
(m, 5H, Ph), 6.84 (dd, J = 9.6, 2.8 Hz, 2H, 
benzyl), 6.74 (td, J = 8.9, 2.8 Hz, 1H, 
benzyl), 6.62 (td, J = 9.0, 2.7 Hz, 1H, 
benzyl), 3.79 (d, J = 12.1 Hz, 2H, CH2, 
major isomer), 3.78 (d, J = 12.4 Hz, 2H, 
CH2, minor isomer) 
−118.65 (m, 
minor isomer) 
−118.54 (m, 
major isomer) 
3.29 
56.28 
53.89 
7.50 (m, 10H, Ph), 6.50 (m, 2H, benzyl), 
3.85 (d, J = 12.64 Hz, major isomer, CH2); 
3.49 (d, J = 12.6 Hz, minor isomer, CH2) 
−116.10  
(m, minor and 
major isomer) 
3.30p 
54.54 
54.07 
7.90–7.61 (m, 6 H), 7.60–7.33 (m, 14H), 
7.23–7.16 (m, 2H, minor and major 
isomers), 6.99–6.89 (m, 2H, minor and 
major isomers), 3.76 (d, J = 12.2 Hz, 4H, 
minor and major isomers, CH2). 
−140.66, 
−142.52 (m, 
minor isomer), 
 
−141.24, 
 −142.72 (m, 
major isomer). 
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Figure 73: Palladacycles 3.29 and 3.30p. 
 
Figure 74: Molecular structure of palladacycle 3.29 along with a molecule of toluene in the unit 
cell. Hydrogen atoms were omitted for clarity; thermal ellipsoids shown with probability of 
50%.  
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Figure 75: Molecular structure of palladacycle 3.30p along with disordered molecule of 
chloroform. Hydrogen atoms were omitted for clarity; thermal ellipsoids shown with 
probability of 50%.  
3.2.2.2 Fluorinated acetate-bridged phosphapalladacycles 
Chloride-bridged palladacycle 3.28 was reacted in acetone at 25 °C with silver 
acetate (Scheme 41) to give the relevant acetate-bridged palladacycle 3.31, showing a 
possible new route for the formation of acetate-bridged palladacycles, as observed for the 
amino-palladacycle systems.
122
 
 
Scheme 71: Bridge halide conversion reaction from 3.28 to 3.31. 
The structure was confirmed by the X-ray diffraction analysis of a single crystal obtained by 
slow evaporation of a saturated solution of the complex in chloroform (Figure 76). 
Palladacycle 3.31 shows in the 
31
P-NMR spectrum a broad singlet at δ 53.71 and in the 19F-
NMR spectrum a multiplet centered at δ −112.50 due to the presence in solution of the 
geometrical isomer trans only. As for the amino-palladacycles, presented in Chapter 2, 
acetate-bridged palladacycles of tertiary amines or phosphines show no formation of the cis 
isomer, due to the steric hindrance of the phenyl groups bound to the phosphorus. 
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Figure 76: Molecular structure of palladacycle 3.31. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%. 
 
The 
1
H-NMR spectrum shows three multiplets (δ 7.54–7.39, 7.36–7.21, 7.21–7.07) for the 
phenyl protons and a doublets of doublets of doublets (δ 6.77, J = 7.5, 4.3, 1.0 Hz) and a 
multiplet at δ 6.68–6.52 for the benzylic protons; the methylene protons resonate as a triplet 
at δ 3.21 (J = 15.3 Hz) and a doublet of doublets at 2.83 (J = 15.3, 9.7 Hz). The equivalent 
methyl groups of the acetate bridge resonate as a singlet at 1.96. LIFDI mass spectrometry 
also confirmed the formation of palladacycle 3.31 with the molecular ion being the only 
peak (m/z = 918.0127).  
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Figure 77: 
31
P-NMR spectrum of palladacycle 3.31 in CDCl3 at 294K (162 MHz). 
 
Figure 78: 
19
F-NMR spectrum of palladacycle 3.31 in CDCl3 at 294K (471 MHz). 
3.3 Discussion 
In this chapter several different cyclometallation reactions at palladium have been 
investigated and, as reported by Shaw and co-workers, tertiary phosphines that do not 
contain bulky groups on the phosphorus atom do not cyclometallate in direct reactions.
152
 
The only method that has been found to successfully obtain fluorinated phospha-
palladacycles from fluorinated diphenylbenzylphosphines (3.2–3.5) is the 
transcyclometallation reaction between an amino chloride-bridged palladacycle (2.9a) and 
the relevant fluorinated phosphine in the presence of trifluoroacetic acid. This study shows 
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that a fluorinated substrate (3.3) with the possibility of cyclometallating via C–H activation 
with Pd ortho to F (position C-2, Scheme 70) or para to F (position C-6, Scheme 70) shows 
complete regioselectivity toward the para position. The regioselectivity, as observed for 
fluorinated benzylamines in Chapter 2, derives from the structural features of the product 
obtained. The formation of isomers 3.28o and 3.30o (from attack on position C-2) is 
disfavoured presumably by electronic and steric repulsion between the lone pair of the 
fluorine atom and the lone pair of the chlorine atom; due to the planar structure (confirmed 
by X-ray crystallography), the fluorinated ring cannot twist and the electronic repulsion 
dominates the regioselectivity. 
 
Figure 79: Representation of the electronic repulsion in palladacycle 3.30o. 
The mechanisms of intramolecular C–H activation reactions of tertiary phosphines have not 
been well studied in the past several decades, but investigations at different transition metals 
has divided their reactions into electrophilic and nucleophilic mechanisms.
176
 Vrieze and co-
workers investigated the reaction of metal halides (Ir, Rh, Pd and Pt) with tertiary 
benzylphosphines and discovered that the reactivity increases in the order Pt(II) ~ Pd(II) << 
Rh(I) < Ir(I). They also assessed the differences in regioselectivity and in reaction 
mechanism of the different transition metals by reacting the metal halides with two 
fluorinated phosphines 3.32 and 3.33 (Figure 80) presenting two choices for the C–H 
activation reactions. 
 
Figure 80: Fluorinated tertiary phosphines 3.32 and 3.33 used by Vrieze et al. to assess the 
regioselectivity of C–H activation at different transition metals. 
They hypothesised that for iridium and rhodium the mechanism was nucleophilic due to the 
formation of 80% of the ortho isomer (C–H activation at position 2), the metal atom is the 
negative center and is oxidized from M
n+
 to M
(n+2)+
. They also investigated the behaviour of 
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Pd toward the same cyclometallation reaction suggesting that in this case the mechanism 
was electrophilic,
177
 due to the formation of 100% of para isomer (C–H activation in 
position 6),
153
 such that the metal attacks the aromatic ring acting as an electrophilic center. 
As mentioned previously, Vrieze and co-workers’ paper lacks mechanistic 
investigation and despite the fact that the experimental results are consistent with their 
explanation, it is not possible to confirm an electrophilic mechanism without further 
investigations. Our observations are, however, consistent with their hypothesis since we also 
observe complete para selectivity, and although the Pd source differs, since in this case the 
phosphapalladacycle formation is via a transcyclometallation reaction, it would suggest that 
an electrophilic mechanism is also operating here. 
3.4. Crystallographic analysis of chloride-bridged 
phosphapalladacycles 
As reported by Smoliakova et al. for the non-fluorinated phosphapalladacycle 3.10
162
 the X-
ray crystal structures of all the fluorinated palladacycles exhibit a square planar geometry 
with an anti configuration where the two phosphorus atoms are trans to each other. The 
same geometry was observed in the analogous amino-palladacycles (Chapter 2) and in 
chloride-bridged dimers with chiral phosphines.
160
 The main bond lengths reported in Table 
21 are all similar to those reported for the non-fluorinated palladacycle 3.10.
162
  
 133 
 
Table 21: Selected distances (Å) and angles (°) in chloride-bridged palladium dimer structures 
Bond length 
/ Å 
3.10
a
 3.23 3.28p  3.29 3.30 
C(1)–Pd(1) 2.009(2) 2.0071(17) 2.006(3) 2.027(7) 1.998(2) 
Cl(1)–Pd(1) 2.4393(5) 2.4457(4) 2.4499(6) 2.4233(15) 2.4135(5) 
Cl(n)–Pd(1) 2.4267(5) 2.4368(4) 2.4457(6) 2.4148(16) 2.4149(5) 
P(1)–CH2 1.832(2) 1.8263(17) 1.827(3) 1.812(7) 1.810(2) 
P(1)–Pd(1) 2.1953(5) 2.1949(4) 2.1867(7) 2.1937(17) 2.1854(6) 
C(n)–F(n) - 
C5–F1 
1.355(2) 
C4–F1 
1.359(3) 
C2–F1 
1.362(8) 
C4–F2 
1.364(8) 
C4–F1 
1.351(3) 
C3–F2 
1.346(3) 
Bond Angle 
/ ° 
3.10
 a
 3.23 (B-144) 3.28p  3.29 3.30 
C(1)–
Pd(1)–P(1) 
82.04(6) 82.40(5) 82.59(8) 79.62(19) 82.44(7) 
Cl(n)–
Pd(1)–Cl(1) 
97.75(6) 85.946(13) 85.69(2) 85.65(5) 85.402(59) 
P(1)–Pd(1)–
Cl(n) 
178.283(18) 
95.104919) 
178.211(16) 
94.591(15) 
176.77(3) 
94.53(2) 
174.05(7) 
95.19(6) 
179.36(2) 
94.89(2) 
a 
as reported in ref 
162
 
The bond angles between Cl(n)–Pd(1)–Cl(1) are smaller in the fluorinated palladacycles 
(average 85°) compared to the non-fluorinated one (97°). 
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3.5 Summary 
This chapter describes the synthesis and full characterisation of fluorinated diphenyl-
benzylphosphines 3.2–3.5 and their respective fluorinated chloride-bridged 
phosphapalladacycles 3.23 and 3.28–3.30. 
Due to various electronic and steric factors the direct reactions of these fluorinated 
phosphines to obtain phospha-palladacycles either with Pd(OAc)2 or Li2PdCl4 did not give 
the cyclometallated products. The only method found to obtain these products was the 
transcyclometallation reaction from the amino-chloride-bridged palladacycle 2.19a and the 
relevant phosphine in the presence of trifluoroacetic acid.  
The effect of fluorine substituents on the regioselectivity of intramolecular C–H 
activation reactions was studied. For substrates such as 3.3 and 3.4, where two possible C–H 
bonds could be activated, the cyclopalladation reactions occur regioselectively para to the 
fluorine atom. The resulting products were analysed in detail by NMR spectroscopy, mass 
spectrometry and X-ray crystallography. The crystallographic analysis showed that the 
position of the fluorine substituents on the ring does not have a marked effect on the 
geometry of the palladacycles, behaviour similar to that observed for chloride-bridged 
palladacycle with amino-ligands (Chapter 2). However, it does have an effect on the 
regioselectivity, disfavouring the formation of the ortho isomer, feasibly due to the repulsion 
between the lone pair of the fluorine atom and of the chlorine atom, resulting in the 
exclusive formation of the para isomer. More general conclusions are given in Chapter 6.
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Chapter 4: C–H activation reactions of 
benzylamines at Ir, Rh and Ru 
4.1 Introduction 
Despite the success of palladium catalysis in organic synthesis and its application in 
the pharmaceutical and agrochemical industries, there is considerable scope and potential for 
the development of catalysis using other kinds of metallacycles such those containing 
cobalt,
178-179
 ruthenium
180-181
 and rhodium.
182-183
 The synthesis of such complexes has 
historically required forcing conditions, such as strong bases and acids or mercury reagents, 
to provide a driving force for the C–H activation process.116,184-185 
Pfeffer and co-workers reported in 2001 the synthesis of metallacycles at Ir, Ru and 
Rh using tertiary, secondary and primary amines as substrates (4.2 in Scheme 72), along 
with NaOH as a base and acetonitrile as the solvent of the reaction (Scheme 72 andScheme 
73).
119-120,186
 
 
Scheme 72: General cyclometallation reaction of amines at Ir and Rh (Pfeffer et al.). 
 
 
Scheme 73: General cyclometallation reaction of amines ar Ru (Pfeffer et al.). 
The mechanism of the reaction was not investigated by the authors, but they 
hypothesised that the reaction proceeds via an electrophilic aromatic substitution (SEAr) 
mechanism. This is consistent with the fact that the more electrophilic cationic Ru or Rh 
complexes could only be cyclometallated in the presence of a strong base such as NaOH.
117
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Davies and co-workers later reported a new and efficient method to promote C–H 
activation at Ir using NaOAc, which acts as both a base and co-ligand (Scheme 74).
117
 
 
Scheme 74: Cyclometallation reaction at Ir of amine 2.17a (Davies et al.). 
The same reaction attempted at Rh and Ru however did not afford the desired metallacycles 
and the only product obtained, at Rh, was the complex [Rh(OH2)(
1
-O2CMe)2Cp*] with no 
coordination of the nitrogen ligand (2.7a) observed. The higher reactivity of IrCp* than Rh 
toward C–H activation has already been observed for benzoate complexes.187  
The two possible reaction mechanisms proposed for the C–H activation reaction to 
form the metallacycle at Ir(III) were oxidative addition of the aryl C–H bond to give an 
Ir(IV) cation, followed by reductive elimination of HX (X = Cl or OAc), or electrophilic 
aromatic substitution (SEAr). The two mechanisms would of course require different sources 
of metal: electrophilic mechanisms are favoured by electron-poor metal centres whilst the 
opposite is true for oxidative addition mechanisms. The failure of the cyclometallation 
reactions at Rh and Ru is therefore more consistent with an electrophilic mechanism, due to 
the good σ-donor, but poor π-acceptor properties of these metals. Later Davies and co-
workers reported computational and experimental studies of the C–H activation reaction at Ir 
of N,N-dimethylbenzylamine (2.7a) to validate their first hypothesis, but unexpectedly they 
showed that a completely different mechanism was involved, and that the reaction in fact 
proceeds via an AMLA mechanism, as for cyclometallation of the same ligand at 
palladium.
94
 They proposed a two-step process involving the initial displacement of the 
acetate (κ2–κ1) followed by C–H bond cleavage. Performing synthetic studies in parallel 
with the computational ones, no simple correlation between reactivity and computed C–H 
activation barriers was observed, suggesting that the C–H bond cleavage is not the rate 
determining step.
67
 
 Due to the limited substrate scope of Davies’ method (activation of amines, imines 
and oxazolines only), Jones and co-workers decided to investigate the reactivity and scope 
of functionalised imines (4.5) and phenylpyridines at Ir and Rh to assess how electronic 
factors could affect the C–H activation processes.116 
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Scheme 75: Cyclometallation reaction of phenylimines at Ir and Rh (Jones et al.). 
They reported that reactions with the same substrate at Ir were 2–4 times faster than at Rh 
and that those with electron-donating groups on the aromatic ring were faster than those with 
electron-withdrawing substituents, further supporting an electrophilic activation mechanism 
(SEAr). They also investigated the regioselectivity of these reactions, reacting Ir and Rh 
complexes with meta-substituted phenylimines (Scheme 75). The regioselectivity was 
particularly sensitive to steric effects, giving preference to the isomer with the R group in the 
para position, 4.6p. In the case of R = F the major isomer formed was the one with the 
fluorine atom ortho to the metal, 4.6o (2.3:1 for Ir and 8.5:1 for Rh), an effect which can be 
attributed to the ortho fluorine effect already discussed in intermolecular reactions at 
palladium (Chapter 2).  
 In this chapter an investigation into the effects of fluorine substituents on the 
regioselectivity of intramolecular C–H activation reactions of fluorinated benzylamines at 
iridium, rhodium and ruthenium is described.  
The aim was to explore whether an ortho fluorine effect could be observed in 
intramolecular C–H activation reactions of fluorinated dimethylbenzylamines at Rh, Ru and 
Ir, as reported experimentally by Jones for fluorinated imines at Rh and Ir,
116
 and to assess 
whether a change in reaction conditions, using the Pfeffer (NaOH and KPF6)
11-13
 and Davies 
(NaOAc) methods,
117
 would lead to a change in regioselectivity resulting from the reactions 
proceeding via different mechanisms. 
4.2 Results and discussion 
4.2.1 Reactions at Ir 
The study of intramolecular C–H activation reactions of fluorinated benzylamines began 
with the reaction of the 2-fluoro-N,N-dimethylbenzylamine (2.7b) with the iridium complex 
[Cp*IrCl2]2 at 25 °C in dichloromethane. The reaction conditions used were the same as 
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those developed by Davies and co-workers
117
 for the non-fluorinated ligand 2.7a (Scheme 
76), using NaOAc as a base, and metallacycle 4.7 was obtained in 68% isolated yield. 
 
Scheme 76: Cyclometallation reaction at Ir of 2.7b following Davies’ method. 
The 
1
H- and 
19
F-NMR spectra of 4.7 are consistent with those reported for the non-
fluorinated Ir metallacycle 4.4.
117
 The 
1
H-NMR spectrum run in CDCl3 shows three different 
signals for the three aromatic protons at δ 7.35 (d, J = 7.5 Hz), 6.99 (dd, J = 13.9, 7.6 Hz) 
and 6.55 (m) and two coupled doublets for the diastereotopic CH2 protons at δ 4.27 (d, J = 
13.3 Hz) and 3.54 (dd, J = 13.3, 1.1 Hz) where the low frequency doublet shows an 
additional splitting due to the coupling with the fluorine atom. The two methyl groups 
resonate as two singlets at δ 3.07 and 2.90 while the methyl groups of the Cp* are at δ 1.63. 
The 
19
F-NMR spectrum of 4.7 shows a doublet of doublets at δ −117.48 (J = 9.7, 6.0 Hz), 
slightly changed from that of the free amine 2.7b (δ −118.6), but with a substantial reduction 
in the 
3
JH–F of 6.0 Hz (15.9 Hz in the free substrate 2.7b). 
 
Figure 81: 
1
H-NMR of 4.7 in CDCl3 at 298 K (400 MHz). 
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Figure 82: 
19
F-NMR of 4.7 in CDCl3 at 298 K (376 MHz). 
The effect of the fluorine on the regioselectivity of C–H activation at Ir was tested with the 
key substrate 2.7c, which presents two possibilities for attack at C-2 and C-6 (red and blue 
arrows respectively in Scheme 77) such that the C–H activation can occur ortho or para to 
the fluorine atom, respectively. 
 
Scheme 77: Cyclometallation reaction at Ir of 2.7c following Davies’ method. 
The reaction yielded a mixture of isomers 4.8o and 4.8p (49% overall yield) in the ratio 
ortho/para of 1.7 : 1.0. The 
19
F-NMR spectrum of the product mixture shows two signals for 
the para and ortho isomers at δ −123.78 (td, J = 9.7, 6.3 Hz) and −94.21 (m) respectively 
while the 
1
H-NMR spectrum shows two sets of signals for the two isomers (Table 22). It is 
possible to assign to the minor isomer as the para (4.8p) due to the low field doublet of 
doublets in the 
1
H-NMR spectrum at δ 7.49 which corresponds to the proton at C-2 (see 
integration in the 
1
H-NMR spectrum in Figure 83).  
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Table 22: 
1
H-NMR signals of the two isomeric forms ortho and para of 4.8. 
δ (1H) / ppm 
ortho isomer para isomer 
- 7.49 (dd, J = 8.3, 6.3 Hz) 
6.87–6.77 (m) 6.87–6.77 (m) 
6.77–6.67 (m) 6.77–6.67 (m) 
4.08 (d, J = 12.8 Hz) 4.38 (d, J = 13.0 Hz) 
3.52 (d, J = 12.9 Hz) 3.20 (d, J = 12.4 Hz) 
3.02 (s) 3.04 (s) 
2.77 (s) 2.87 (s) 
1.65 (d, J = 0.7 Hz) 1.62 (s) 
 
The results indicate a preference for the ortho isomer, 4.8o, and, due to the mechanism 
presumably being an AMLA as proposed by Davies and co-workers,
67
 there is a similarity in 
behaviour to the intermolecular C–H functionalisation reactions at Pd studied by Fagnou et 
al. experimentally
20
 and by Perutz et al. computationally.
68
 Interestingly the same substrate 
in intramolecular reaction at Pd showed no selectivity for the ortho isomer (ortho/para = 
1:1) due to electronic and steric factors (Chapter 2),
122
 effects which are not relevant in the 
iridium system due to the completely different geometry of the metallacycle 4.8. 
 
Figure 83: 
1
H-NMR spectrum of mixture of isomers 4.8 in CDCl3 at 298 K (400 MHz). 
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Figure 84: 
19
F-NMR spectrum of mixture of isomers 4.8 in CDCl3 at 298 K (376 MHz). 
The structures of the iridium metallacycles have been reported by Jones et al.
116
 for 
phenylpyridines and by Pfeffer et al. for primary benzylamines.
120
 While they both show the 
Cp* in a pseudo-axial position, all the other features (bond angles and bond lengths) differ 
depending on the substrate, so a common analysis cannot be conducted. 
 To assess if the regioselectivity with the same substrate 2.7c could be different in 
reactions proceeding via a different mechanisms, the Pfeffer method, using NaOH as base 
instead of NaOAc, was used to synthesise the positively charged Ir metallacycle 4.13, which 
could then be converted to Ir metallacycle, 4.11, by a metathesis reaction (Scheme 81). The 
method was first employed with substrate 2.7b (Scheme 78).  
 
Scheme 78: Cyclometallation reaction at Ir of 2.7b following the Pfeffer method. 
The iridium complex obtained, 4.9, is a half sandwich Ir(III) complex, positively charged 
with PF6
−
 as a counter anion. The iridium has a pseudo-tetrahedral geometry, is coordinated 
to the nitrogen atom of the fluorinated benzylamine and has an acetonitrile ligand that in 
CD3CN at room temperature shows a fluxional exchange. A 
1
H-NMR spectrum of the crude 
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reaction mixture was run to confirm the formation of the product 4.9, which was then 
converted, without being isolated, to metallacycle 4.7 by reaction with KCl in MeOH 
(Scheme 79), showing matching data with the same metallacycle 4.7 obtained by Davies’ 
method.  
 
Scheme 79: Conversion of metallacycle 4.9 to metallacycle 4.7 with KCl. 
Pfeffer and co-workers reported this conversion reaction under nitrogen,
186
 but metallacycle 
4.9 is not air-sensitive either in solution or in solid state. The only significant observation 
was the slow conversion of metallacycle 4.7 back to metallacycle 4.9 in CD3CN after 48 
hours as observed by 
1
H-NMR spectroscopy. Once tested with substrate 2.7b, the method 
was applied to the key substrate 2.7c to assess the regioselectivity in the intramolecular C–H 
activation reaction (Scheme 80 Scheme 81). 
 
Scheme 80: Cyclometallation reaction at Ir of 2.7c following Pfeffer method. 
 
Scheme 81: Conversion of metallacycle 4.10 to metallacycle 4.8 with KCl. 
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The 
1
H- and 
19
F-NMR spectra of the product in CD3CN showed that the reaction produced 
metallacycle 4.8 along with some by-products, but the interesting detail is the different ratio 
between ortho and para isomers being 3.3:1.0 (calculated by integration of the protons in the 
CH2 group), considerably different from the one obtained using Davies’ method (sample run 
in CDCl3, ratio 1.7:1.0) (Figure 85). 
 
Figure 85: Comparison 
19
F-NMR spectra of metallacycle 4.8 obtained via different syntheses. 
The difference in ratio could feasibly be attributed to a presumed difference in 
mechanism, AMLA in the Davies’ method versus SEAr in the Pfeffer’s method, but further 
investigation is needed to confirm this hypothesis. On the C–H activation at Ir using NaOH, 
the base is not coordinated to the metal and an electrophilic mechanism where the Wheland 
intermediate is formed is possible. It is also true, as reported by Davies and co-workers by 
density functional calculation of the electrophilic C–H activation at Ir, that other possible 
mechanisms are feasible depending upon the ligand present on the metal. Poorly orientated 
ligands, which cannot act as proton acceptors, undergo C–H activation at Ir via an oxidative 
addition mechanism while heteroatoms co-ligands, having lone pairs, undergo σ-bond 
metathesis, because the electronic participation of the metal on the four-centered mechanism 
is less required.
118
 A computational investigation should be performed on the system where 
NaOH is used, to better understand the type of mechanism and in the case of an electrophilic 
one, if the C–H activation is the rate determining step.  
 
Davies et al. method 
Pfeffer et al. method 
Ratio o : p =1.7: 1.0 
Ratio o : p =3.3: 1.0 
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4.2.2 Reactions at Ru 
The only method reported to synthesise Ru metallacycles with benzylamines is that 
of Pfeffer and co-workers discussed previously for Ir, using NaOH as a base, and is 
suggested to proceed via an electrophilic aromatic substitution mechanism.
119
 As already 
shown by Davies et al.
117
 C–H activation at Ru with NaOAc gives the complex 
[RuCl(O2CMe)(p-cymene)], but not cyclometallation products. Substrate 2.7b was therefore 
reacted with [(C6H6)RuCl2]2 in acetonitrile at 45 °C for 50 hours, in the presence of NaOH, 
to obtain metallacycle 4.11 in 74% isolated yield. 
 
Scheme 82: Synthesis of metallacycle 4.11 by the Pfeffer’s method. 
The 
1
H-NMR spectrum of 4.11 (Figure 86) run in CD3CN shows for the three aromatic 
protons a doublet at δ 7.72 (J = 7.5 Hz), a triplet of doublets at δ 7.11 (J = 7.8, 5.6 Hz) and a 
multiplet at δ 6.70. It also shows a singlet at δ 5.67 for the 6-benzene ring and two doublets 
for the diastereotopic CH2 protons at δ 3.62 (J = 14.0 Hz) and δ 3.54 (J = 14.0, 1.4 Hz), 
where the high field doublet shows an additional splitting due to the coupling with the 
fluorine atom. The two methyl groups resonate at δ 3.03 and 2.86 as two singlets. The 19F-
NMR spectrum shows a mutiplet centered at −117.34, slightly different from the free 
substrate 2.7b (δ −118.10). 
Complex 4.11 was then converted to metallacycle 4.12 in 55% isolated yield using 
the same method as that used for the iridium complexes. 
 
Scheme 83: Conversion of metallacycle 4.11 to metallacycle 4.12 with KCl. 
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Figure 86: 
1
H-NMR spectrum of 4.11 in CD3CN at 298 K (500 MHz). 
To assess the regioselectivity of the C–H activation reaction at Ru, substrate 2.7c was 
reacted with [(C6H6)RuCl2]2 following the same method described above and metallacycle 
4.13 was obtained in 63% isolated yield (Scheme 84). As in the case of the equivalent 
iridium metallacycle 4.8, two regioisomers, 4.13o and 4.13p, were formed, this time in the 
ratio ortho : para = 10 : 1.0.  
 
Scheme 84: Synthesis of metallacycle 4.13 by Pfeffer et al. method. 
The mixture of isomers of 4.13 was then converted to metallacycles 4.14o and 4.14p 
(Scheme 85), which showed retention of the ratio between the regioisomers observed 
previously (Figure 87). 
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Scheme 85: Conversion of metallacycle 4.13 to metallacycle 4.14 with KCl. 
 
Figure 87: 
1
H-NMR spectrum of 4.14 in CD3CN at 298 K (500 MHz). 
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Figure 88: 
19
F-NMR spectrum of 4.14 in CD3CN at 298 K (471 MHz). 
As reported by Pfeffer and co-workers the role of NaOH is not fully understood but is 
necessary to obtain the cyclometallated product. Interestingly the source of Ru can change 
the outcome of the reaction, the p-cymene complex is not in fact able to cyclometallate 
tertiary amines and this could be consistent with an electrophilic mechanism being the p-
cymene ligand less electrophilic than the benzene-ligand on the Ru centre.
121
 
4.2.3 Reactions at Rh 
The only method reported to synthesise Rh metallacycles with benzylamines is that 
of Pfeffer and co-workers.
120
 As already shown by Davies et al.
117
 and confirmed by Jones et 
al.,
116
 C–H activation at Rh with NaOAc is substrate specific and does not work for tertiary 
benzylamines. The synthesis with fluorinated substrates was attempted, but the desired 
products could not be obtained by this method. Therefore, as for the synthesis of iridium 
complexes, the substrate 2.7b was reacted with [Cp*RhCl2]2 in acetonitrile at 45 °C for 50 
hours in the presence of NaOH and protected from light to obtain metallacycle 4.15 in a 69% 
isolated yield. 
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Scheme 86: Synthesis of metallacycle 4.15 by Pfeffer et al method. 
The 
1
H-NMR spectrum of 4.15 (Figure 89) run in CDCl3 shows a doublet at δ 7.35 (J = 7.5 
Hz), a doublet of doublets at δ 7.05 (J = 13.5, 7.6 Hz), a triplet at δ 6.59 (J = 9.0 Hz) for the 
three aromatic protons and the characteristic two doublets for the diastereotopic CH2 protons 
at δ 4.02 (J = 13.4 Hz) and δ 3.49 (J = 13.3 Hz). The two methyl groups resonate at δ 2.75 
and 2.76 as two singlets and the methyl groups of the Cp* resonate as a singlet at δ 1.59. 
The same reaction was attempted with substrate 2.7c to assess the regioselectivity, 
but the reaction gave a complex mixture of products from which the isomeric ratio could not 
be determined, and the attempted purification of the products failed. Further experiments 
need to be performed. 
 
 
Figure 89: 
1
H-NMR spectrum of 4.15 in CDCl3 at 298 K (400 MHz). 
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4.3 Summary 
This chapter describes the synthesis and characterisation of Ir, Ru and Rh metallacycles 
(4.7–4.14) with fluorinated benzylamines 2.7b and 2.7c via intramolecular C–H activation 
reactions. 
Two different methods were used in the synthesis of Ir metallacycles, and for 
substrate 2.7c, offering two possibilities for the C–H activation reaction, the regioselectivity 
observed, ortho to fluorine, seems to be dependent from the method used (ortho/para ratio 
of 1.7 : 1.0. using NaOAc as a base versus 3.3:1.0 using NaOH). 
Jones and co-workers, having used NaOAc in the reactions at Ir and Rh of 
phenylimines (4.5) suggested that the mechanism was an SEAr while Davies et al. reported 
computational and experimental studies of N,N-dimethylbenzylamine (2.7a) suggesting an 
AMLA mechanism. Pfeffer et al. did not report any mechanistic investigation for their 
method, but the different results obtained would be consistent with an electrophilic aromatic 
substitution (SEAr) mechanism. This could explain the different ortho/para ratios obtained 
and the fact that reactions with Rh proceed with the Pfeffer method (as for the Jones system) 
using a strong base, but not with the Davies procedure using the weaker base NaOAc. 
In the case of Ru and Rh a comparison between methods could not be carried out 
due to the difficulty in synthesising Ru and Rh metallacycles using NaOAc, as reported by 
Davies and co-workers and confirmed by Jones et al.
116
  
The Ru metallacycle with substrate 2.7c gave a preference for the ortho isomer, the 
(ratio ortho/para of 10:1.0) which was determined by 
1
H-NMR spectroscopy, but a crystal 
structure analysis would help to confirm that the major isomer is the one with the metal 
ortho to the fluorine atom.  
More general conclusions are given in Chapter 6.
 150 
 
Chapter 5: C–F activation experiments at Ni(0), 
Pd(0) and Pt(0)  
5.1 Catalytic C–F functionalisation at Pd(0) 
5.1.1 Introduction 
The introduction of partially fluorinated aromatic fragments via selective C–F 
activation at transition metals holds much potential for the synthesis of pharmaceutical and 
agrochemical building blocks.
188
 The abundance of relatively cheap polyfluoroarenes make 
them attractive alternatives to using heavier halogens or preactivated organometallic 
substrates.
189
 Despite the progress in stoichiometric C–F activation reactions there are few 
examples of C–C bond formation via catalytic C–F activation, presumably due to the 
difficulty of breaking the C–F bond with its very high bond dissociation energy.190  
Kumada and co-workers reported the first example of a catalytic C–C bond 
formation in 1973, using a Ni(II) phosphine complex as a catalyst in the presence of a 
Grignard reagent to functionalise a monofluorobenzene, forming the desired 
isopropylbenzene (5.2), but also noting that isomerization reactions were taking place (e.g. 
the formation of 5.3 in Scheme 87).
188,190-191
 
 
Scheme 87: First example of catalytic C–C bond formation using Ni(II) complex (Kumada et 
al.). 
The first catalytic C–C bond formation with a polyfluoroarene was then reported by Jones 
and co-workers in 1999, using a Zr complex as the catalyst (Scheme 88).
192
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Scheme 88: First catalytic C–C bond formation with a polyfluoroarene (Jones et al.). 
Group 10 transition metal catalysts (Ni, Pd and Pt) are the most frequently used in the 
development of catalytic cross coupling reactions of fluoroaromatics. The Herrmann group 
reported a Ni-catalysed Kumada reaction of functionalised monofluoroarenes using an N-
heterocyclic carbene (Scheme 89),
193
 and a few years later Ackermann reported a similar 
reaction using the cheaper Ni(acac)2 supported with an unusual phosphine oxide ligand, to 
functionalise aryl and alkyl Grignard reagents (Scheme 90).
194
  
 
Scheme 89: Functionalisation of monofluoroarene with Ni(II) and N-heterocyclic carbene ligand 
(Herrmann et al.). 
 
Scheme 90: Functionalisation of monofluoroarene with Ni(II) with phosphine oxide ligand 
(Ackermann et al.).  
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Perutz and co-workers, after extensive studies on stoichiometric C–F activation reactions at 
Ni(0),
195-196
 developed the first Ni(II) cross-coupling reaction of a polyfluoroarene (Scheme 
91).
197
 
 
Scheme 91: Stoichiometric C–F activation reactions at Ni(0) of perfluropyridine (Perutz et al.). 
The Ni fluoride complex used was able to catalyse the regioselective C–F functionalisation 
ortho to the nitrogen atom of a pentafluoropyridine (5.8) in the presence of a vinyl tin 
reagent. Interestingly, in a similar manner, Braun and co-workers later reported the first 
example of selective C–F functionalisation in the presence of a weaker chlorine–carbon 
bond (Scheme 92).
198
  
 
Scheme 92: Selective C–F functionalisation in the presence of a weaker chlorine–carbon bond 
(Braun et al.). 
The first example of a Ni(0) Suzuki cross-coupling reaction was reported in 2006 by Radius 
and co-workers on perfluoroarenes, using a Ni(0) carbene complex previously used by the 
same group in stoichiometric C–F activation reactions of hexafluorobenzene (Scheme 93).199 
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Scheme 93: First example of a Ni(0) Suzuki cross-coupling reaction (Radius et al.). 
Despite the extensive use of Pd in catalysis, few examples of Pd-catalysed cross coupling 
reactions via C–F activation are reported.190 Ogoshi and co-workers reported the first 
example of a Pd(0) catalysed functionalisation of hexafluorobenzene in the presence of 
diarylzinc compounds (generated in situ from zinc dichloride and an arylmagnesium 
bromide) to obtain pentafluorophenyl derivatives (Scheme 94).
200
 
 
Scheme 94: Pd(0)-catalysed functionalisation of hexafluorobenzene (Ogoshi et al.). 
The presence of LiI in the reaction mixture helps the abstraction of the fluorine atom by 
forming the thermodynamically favourable LiF as a by-product, along with the 
functionalised fluoroaromatic. The substrate scope of the reaction includes electron-donating 
and electron-withdrawing substituents on the aryl group and different fluoroaromatics 
including pentafluoropyridine and perfluoronaphthalene. The mechanism (Scheme 95) 
proposed by Ogoshi et al. starts with the oxidative addition of hexafluorobenzene (5.4) to 
the Pd(PCy3)2 (5.17) with the dissociation of one PCy3 ligand (5.19) and the exchange at Pd 
of a fluorine for an iodine atom. The transmetallation step with the diaryl zinc generated in 
situ (5.23) leads to the final step where the reductive elimination of the product (5.15) 
regenerates the catalyst (5.17). 
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Scheme 95: Ogoshi’s proposed mechanism for catalytic C–F activation of hexafluorobenzene. 
The aim of the study reported hereafter, performed in collaboration with Stefanie Federle 
(Erasmus student from Heidelberg University) was to assess if the method developed by 
Ogoshi et al. could be applied to functionalise fluorinated N,N-dimethylbenzylamines via C–
F bond activation, and if this kind of activation could be obtained regioselectively. 
5.1.2 Results and discussion 
The substrates considered for the catalytic C–F activation at Pd(0) were 2,6-difluoro-N,N-
dimethylbenzylamine (5.25), 3,4-difluoro-N,N-dimethylbenzylamine (2.7e) and 2,3,4,5,6-
pentafluoro-N,N-dimethylbenzylamine (5.26), shown in Figure 90. 
 
Figure 90: Fluorinated substrates considered for the catalytic C–F activation at Pd(0). 
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Substrates 5.25 and 2.7e were synthesised as described in Chapter 2, following the 
procedure developed by Liu and co-workers.
126
 The synthesis of substrate 5.26, following 
the same reaction conditions, gave predominantly the by-product 5.28 due to a second 
nucleophilic substitution, para to the benzylic arm, from the excess of dimethylamine 
(Scheme 96). 
 
Scheme 96: Formation of expected product 5.26 along with byproduct 5.28.  
Following this result, the reaction conditions were altered: a temperature of 25 °C was used 
instead of 65 °C and the reaction time was decreased from 24 to 4 hours; this led to the 
successful isolation of 5.26 in 82% yield. Compound 5.26 was a suitable candidate for 
testing the method used by Ogoshi et al. due to the similarity of the substrates (5.26 and 
hexafluorobenzene, 5.4) both having a perfluorinated aromatic ring. The reaction was 
performed using the same stoichiometry used in their report (see Scheme 97), but after 6 
hours the presence of the starting material 5.26 was still evident along with the formation of 
biphenyl 5.30 as by-product. 
 
Scheme 97: Cross coupling reaction of 5.26 using Ogoshi’s conditions. 
After a brief preliminary catalytic screening, the amount of PhMgBr/ZnCl2 was increased 
from 0.6 to 1 eq, the amount of Pd complex 5.17 from 5 to 7 mol% and the amount of LiI 
from 2.4 to 4 mol%. After 6 hours at 60 °C, using these ratios of reagents, the product 5.30 
was obtained in 28% isolated yield as a yellow solid along with biphenyl 5.31 (56% yield 
w.r.t PhMgBr) following purification by flash chromatography (CH2Cl2:methanol, 100:1). 
The 
19
F-NMR spectrum of 5.30, in CDCl3, shows only two signals at δ −144.52 (dd, J = 
23.0, 13.1 Hz) and −142.93 (dd, J = 23.0, 13.1 Hz) validating the hypothesis that the C–F 
functionalisation is regioselective para to the benzylic arm. The regioselectivity was also 
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confirmed by X-ray crystallography of a single crystal obtained by slow evaporation of a 
saturated solution of the product 5.30 in CDCl3 (Figure 91).  
 
Figure 91: Molecular structure of palladacycle 5.30. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%. Selected bond lengths(Å): C(5)–F(1): 1.350(3), 
C(6)–F(2): 1.353(3), C(8)–F(3): 1.346(3), C(9)–F(4): 1.346(3), C(7)–C(10): 1482(4); selected bond 
angles (°): C(15)-C(10)-C(7): 119.6(2), C(11)-C(10)-C(7): 121.1(2), F(4)-C(9)-C(4): 119.8(2), F(1)-
C(5)-C(4): 119.7(2). 
The reaction was also carried out in the absence of ZnCl2, using only the Grignard reagent to 
test the transmetallation step; after 6 hours under these conditions only 25% of the starting 
material was converted to 5.30 (vs. full consumption of starting material in presence of 
ZnCl2, as measured by integration of 
19
F-NMR signals of starting material and product), 
indicating that the transmetallation step is faster in the presence of Zn. The reaction was also 
carried out without the Pd complex (5.17) and in this case after 24 hours no product was 
observed. 
Since the functionalisation occurred para to the benzylic arm, it is possible to 
exclude the coordination of the Pd to the nitrogen atom in the first step of the catalytic cycle, 
as this would lead to an ortho functionalisation. The para position is presumably favoured 
by the nucleophilic palladium atom, being the least electron-rich position in the ring.  
Following the regioselective C–F functionalisation obtained with the 
perfluorobenzylamine 5.26, the reaction was attempted with the difluorinated substrate 2.7e 
having one of the fluorines para to the benzyl arm; this substrate would also allow the 
catalytic process to be tested for C–H versus C–F activation.  
 157 
 
 
Scheme 98: Attempted C–F functionalisation reaction of 2.7e following the Ogoshi method. 
The reaction with substrate 2.7e under the same conditions used previously (Scheme 98) did 
not take place even after 24 hours, and only the starting material 2.7e along with the 
biphenyl 5.31 was recovered, with no C–H or C–F activation products detected. The reaction 
with substrate 5.25 was then attempted (Scheme 99) to check if a regioselective C–H 
functionalisation reaction para to the benzylic arm could be obtained. Similarly for substrate 
2.7e, no cross-coupling products were detected.  
 
Scheme 99: Attempted C–H functionalisation reaction of 5.25 following the Ogoshi method. 
It is possible that the two difluorinated substrates (5.25 and 2.7e) did not react under the 
Ogoshi conditions due to the higher electron density of the aromatic ring; the nucleophilic 
palladium is less inclined to attack these aromatic carbons, which are much less electrophilic 
compared to those in the perfluorinated substrates used by Ogoshi.  
The method was then tested on a different amine, 4-N,N-dimethylamino-2,3,5,6-
tetrafluoro-pyridine 5.34, synthesised by reaction of N,N-dimethylamine with 
pentafluropyridine, 5.8, at 0 °C.
201
 
 
Scheme 100: C–F functionalisation reaction of 5.34 following Ogoshi method. 
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In Ogoshi’s paper, the reaction with pentafluoropyridine, 5.8, gave two products, with the 
C–F activation occurring ortho and para to nitrogen with a ratio of the two isomeric 
products of 1: 3.8 respectively.
200
 The experiment with substrate 5.34 was performed to test 
if a complete ortho selectivity could be obtained by blocking the para position with the 
dimethylamine group. 
The desired product was indeed obtained, but in a low yield (Figure 92, blue stars 
indicate the product against starting material in the 
19
F-NMR spectrum) and even after 24 
hours the conversion was just 10% (as calculated from the 
19
F-NMR spectrum, using C6F6 as 
internal standard). This could again be due to the electron-donating character of the 
dimethylamine which makes the aromatic ring more electron-rich and disfavours the C–F 
functionalisation by the nucleophilic palladium. 
 
Figure 92: 
19
F-NMR spectrum of reaction in Scheme 100. Blue stars indicate signals arising 
from compound 5.35 while green stars indicate the starting material 5.34. 
This brief study has shown that it is possible to expand the substrate scope of Ogoshi’s C–F 
activation reaction to substrates containing tertiary amine groups, and to obtain the products 
regioselectively. However, the failure of reactions with substrates 2.7e and 5.25 and slow 
reaction with compound 5.34 suggests that the electron-deficiency of the aromatic ring is 
crucial for efficient reaction and thus reducing the number of fluorine atoms or adding 
electron-donating groups to the ring hinders the reaction dramatically. 
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5.2 Stoichiometric C–F activation attempts of fluorinated 
benzylamines and benzylphosphines at Ni(0) and Pt(0)  
5.2.1 Introduction 
Stoichiometric transition metal C–F activation reactions have been extensively 
studied and reviewed.
188,190,202-203
 Fahey and Mahan reported in 1977, the first example of a 
stoichiometric C–F activation reaction at Ni(0) of hexafluorobenzene 5.4 (Scheme 101) to 
obtain the Ni(II) complex 5.36, however they were only able to characterise their product 
using IR spectroscopy and elemental analysis, as paramagnetic impurities made NMR 
experiments impossible. The yield was also very low (7%) and the reaction time long (2–3 
days).
204
 
 
Scheme 101: First example of a stoichiometric C–F activation reaction at Ni(0) of 
hexafluorobenzene (Fahey and Mahan). 
Perutz and Braun subsequently reported the C–F activation reactions at Ni(0) of fluorinated 
heterocycles obtaining chemospecific C–F activation over C–H activation, in substrates such 
as tetrafluoropyridine and regioselective activation ortho to the nitrogen atom of the pyridine 
ring (5.8 in Scheme 102). They were able to isolate the product 5.37 and fully characterise it 
by NMR spectroscopy and X-ray crystallography.
195-196,205-206
 
 
Scheme 102: C–F activation reactions at Ni(0) of fluorinated heterocycles (Perutz and Braun). 
In the Perutz group, selective C–H over C–F functionalisation of fluoroaromatics has also 
been studied at Pd(0) and Pt(0).
34,207
 Interestingly the regioselectivity obtained for 
pentafluoropyridine 5.8 was different from that observed for Ni(0) reactions. The substrate 
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was activated in the para position to the nitrogen atom for Pd(0) reactions (5.40 in Scheme 
103) and in the case of Pt(0) reactions  an additional P–C bond activation reaction took place 
(forming 5.41 in Scheme 104). This difference in reactivity is believed to derive from a 
nucleophilic substitution process similar to that exhibited by Rh(I) complexes.
208
 
 
Scheme 103: C–F activation reactions at Pd(0) of fluorinated pyridine (Perutz et al.). 
 
 
Scheme 104: C–F activation reactions at Pt(0) of fluorinated pyridine (Perutz et al.). 
The aim of the preliminary study described in this section was the investigation of C–F 
activation reactions of fluorinated N,N-dimethylbenzylamines and fluorinated 
benzylphosphines with two different metals, Ni(0) and Pt(0).  
 
Scheme 105: General scheme of C–F activation reactions of fluorinated substrates M(0). 
 
5.2.2 Results and discussion 
5.2.2.1 Reaction of fluorinated N,N-dimethylbenzylamines at Ni(0) 
The behaviour of this type of substrate towards C–H and C–F functionalization at 
Ni(0) has not been investigated to date. To begin with, the two substrates 5.26 and 5.25 
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(Figure 93) were chosen following the results obtained with the catalytic process at Pd(0) 
discussed above.  
 
Figure 93: Substrates 5.25 and 5.26 used in the attempted C–F activation reactions at Ni(0). 
Both substrates were reacted with Ni(1,5-COD)2 and PEt3 in hexane at room temperature, as 
reported by Perutz and co-workers for the fluorinated pyridines.
209
 Substrate 5.26 can only 
undergo C–F functionalisation, while 5.25 can undergo either C–F or C–H functionalisation. 
Substrate 5.26 was reacted with Ni(1,5-COD)2 and PEt3 in a ratio of 2:2:1 but the 
main product observed was the complex Ni(1,5-COD)(PEt3)2, 5.44, which crystallised from 
benzene/hexane (Figure 94). The molecular structure was thus determined by X-ray 
crystallography. 
 
Figure 94: X Molecular structure of palladacycle 5.44. Hydrogen atoms were omitted for 
clarity; thermal ellipsoids shown with probability of 50%.  Selected bond lengths (Å): Ni(1)–P(1): 
2.1717(7), Ni(1)–P(2): 2.1786(7), Ni(1)–C(1): 2.095(2), Ni(1)–C(2): 2.092(2), Ni(1)–C(5), Ni(1)–
C(6): 2.096(2); selected bond angles (°): Ni(1)-P(1)-P(2): 103.26(3), C(2)-N(1)-P(2): 95.43(7), C(6)-
N(1)-P(1): 95.62(6), N(1)-P(2)-C(17): 114.18(8), N(1)-P(1)-C(9): 116.84(8). 
A signal at δ −371.0 in the 19F-NMR spectrum indicated the formation of a small quantity of 
metal fluoride complex, presumably 5.45 or 5.46 in Scheme 106. This value is in fact 
consistent with that one reported for the C–F functionalization of hexafluorobenzene at 
Ni(0) (δ −390.33 in C6D6)
195
 but despite a change in reaction conditions (time, temperature) 
it was not possible to isolate or to increase the conversion to the desired product. Changing 
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the ratio between substrate, PEt3 and Ni to 1.2 : 2.2 : 1, did not lead to the detection of the 
characteristic signal of an Ni–F species. 
 
Scheme 106: Reaction of Ni(0) with fluorinated benzylamine 5.26. 
The reaction attempted with substrate 5.25 did not proceed and the starting material was 
fully recovered along with Ni(COD)(PEt3)2, 5.44. 
 
Scheme 107: Reaction of Ni(0) with fluorinated benzylamine 5.25. 
The lack of reactivity of fluorinated N,N-dimethylbenzylamines 5.25 and 5.26 at Ni(0) could 
be attributed to the lower energy of the lone pair on the nitrogen atom of the tertiary amine 
compared to the phosphorus atom. Ni(1,5-COD)2 in fact reacts rapidly with two PEt3 
ligands, forming the Ni(0) complex Ni(PEt3)2 and the fluorinated benzylamines are then 
presumably not able to displace the phosphine ligands to form complex 5.47. This study 
needs further expansion and the reaction of Ni(1,5-COD)2 directly with the tertiary amines 
could be attempted to circumvent this problem. 
5.2.2.2 Reactions of fluorinated benzylphosphines at Pt(0) 
Due to the lack of reactivity of fluorinated benzylamines at Ni(0), a phosphine 
analogue of 2,3,4,5,6-pentafluoro-benzylamine 5.26 was prepared to attempt the 
cyclometallation reaction at Ni(0) via C–F activation (Scheme 108).  
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Scheme 108: Desired reaction of Ni(0) with fluorinated benzylphophine 5.48. 
Due to the electronic properties of the substrate (diphenyl-
pentafluorobenzylphosphine, 5.48) the procedure used for the synthesis of the other 
fluorinated phosphines described in Chapter 3 could not be used (Scheme 109) and resulted 
in unwanted aromatic substitution reactions on the fluorinated ring. 
 
Scheme 109: Attempted synthesis of 5.48 via nucleophilic substitution using 
n
BuLi as a base. 
The next attempt was based on a procedure used by Honaker
210
 and co-workers
 
for the 
synthesis of tertiary phosphines using CsOH as a base to deprotonate the diphenylphosphine 
5.50 followed by reaction with the relevant halide 5.27 (Scheme 110).  
 
Scheme 110: Attempted synthesis of 5.48 via nucleophilic substitution using CsOH as a base. 
This method looked promising since it was used by Ahn and co-workers
167
 for the synthesis 
of 3,5-difluoro-diphenylbenzylphosphine, 3.5, although no experimental data were reported 
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for this compound. When the experiment was attempted for the same substrate and for 
substrate 5.48, both reactions were unsuccessful.  
The synthesis of aromatic phosphines is frequently performed using Grignard 
reagents,
164
 and so in a similar manner, diphenyl-chlorophosphine (5.51) was reacted in THF 
at 0 °C with the in situ generated pentafluorobenzyl Grignard reagent 5.49. The attempt was 
unsuccessful probably due to the non-formation of the Grignard itself owing to the highly 
electron-deficient benzylic ring. 
 
Scheme 111: Attempted synthesis of 5.48 using Grignard reagent. 
Another method attempted was the Ni-catalysed cross coupling reaction for the synthesis of 
tertiary phosphines developed by Ager and co-workers.
211
 The reaction, between 
chlorodiphenylphosphine 5.51 and pentafluorobenzylbromide 5.27 is reported to take place 
in the presence of zinc, which acts as transmetallating agent forming Ph2PZnCl, and also 
reduces the Ni(II) to Ni(0) (Scheme 112). However in this case the main product of the 
reaction was the result of the homocoupling of the chlorodiphenylphosphine 5.53, and the 
fluorinated phosphine 5.48 was formed only in a very small quantity. 
 
Scheme 112: Attempted synthesis of 5.48 using Ni-catalysed cross coupling reaction. 
Drury and co-workers reported the synthesis of several chiral N, P aromatic ligands by the 
reaction  between diphenymethylphosphine borane (5.55)
212
 and the relevant nucleophile 
(Scheme 113).
213
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Scheme 113: Synthesis of pyridyl phosphine 5.56.  
The synthesis could potentially be a good method for the synthesis of pentafluoro-
diphenylphosphine (5.48) using hexafluorobenzene, 5.4, as the electrophile. The 
diphenylmethylphosphine borane 5.57, synthesised as reported by Wagner and co-
workers,
212
 was treated with 
s
BuLi·TMEDA complex, followed by reaction with 
hexafluorobenzene at −78 °C (Scheme 114). 
 
Scheme 114: Attempted synthesis of 5.59 following Drury et al. method. 
The borane group was found to be labile under the reaction conditions and the result was a 
mixture of boron-containing and non-boron-containing species. This instability could be due 
to the highly electron withdrawing properties of the fluorinated benzylic group. Moreover, 
due to the high acidity of the benzylic protons of 5.48, the major product of the reaction, 
after the removal of the remaining borane, was the di-substituted 
diphenyl([dipentafluorophenyl]methyl)phosphine 5.60 (Figure 95), due to further 
deprotonation of the product (5.48) present in the same vessel as the lithiated species (5.58). 
 
Figure 95: Byproduct 5.60 of reaction in Scheme 114. 
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Despite the formation of the by-product 5.60, the reaction successfully gave the target 
product 5.48, so the reaction conditions were modified in order to obtain only the 
monobenzylic perfluorinated phosphine (5.48). The synthesis was carried out directly from 
methyldiphenylphosphine (5.61) without forming the intermediate borane species, and the 
lithiated species 5.62 was transferred by cannula into the THF solution of hexafluorobenzene 
(5.4) to avoid the formation of the byproduct 5.60.  
 
Scheme 115: Successful synthesis of 5.47, also called Jess-phos. 
The reaction successfully gave the monosubstituted phosphine (5.48) with some impurities 
that were removed by precipitation of the reaction mixture with hexane followed by 
sublimation under vacuum at room temperature. The 
31
P{
1
H}-NMR spectrum (Figure 96) of 
the product 5.48 shows a triplet of doublets at δ −10.6 ppm with a 4JP–F of 21 Hz. The triplet 
shows another small splitting corresponding to the coupling with the fluorine para to the 
benzylic arm   (
6
JP–F = 4.6 Hz).  
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Figure 96: 
31
P{
1
H}-NMR spectrum of 5.48 in C6D6 at 298 K (202 MHz). 
The 
19
F-NMR spectrum (Figure 97) shows three signals for the three different fluorine 
environments around the aromatic ring at δ −141.9, −157.8 and −163.5, two of them 
showing second order couplings. The integration between the three fluorine signals is 2:2:1 
indicating that the signal at δ −157.8 is the fluorine in para to the benzylic group, confirmed 
by its splitting being a triplet of doublets with a 
3
J F–F = 21.4 Hz with the fluorine in ortho 
and a 
6
JP–F = 4.6 Hz with the phosphorus atom. 
4
J F–F couplings in perfluoroaromatics are 
known to be very small.
214
  
The 
1
H-NMR spectrum (Figure 98) shows a broad singlet at δ 3.08 for the benzylic 
protons and two multiplets for the aromatic protons of the phenyl rings. The 
13
C{
1
H}-NMR 
spectrum shows the characteristic signals of the fluorinated ring at δ 145.2 (dtt 1JC–F = 247 
Hz, 
2
JC–F = 11.7 Hz, 
3
JC–F = 3.8 Hz), 139.7 (dm, 
1
JC–F = 254 Hz) and 137.7 (dm, 
1
JC–F = 248 
Hz) and the typical signals of the phenyl rings bonded to phosphorus at δ 137.4 (d, 1JC–P = 
16.3 Hz), 133.1 (d, 
2
JC–P = 19.7 Hz), 129.5 (s), 128.8 (d, 
3
JC–P = 6.8 Hz), 112.3 (tdd , 
2
JC–F = 
18 Hz, 
3
JC–F = 3.3 Hz , 
3
JC–P = 9 Hz, Cipso), while the CH2 group resonates at δ 23.1 (d, 
1
JC–P 
= 20.9 Hz). 
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Figure 97: 
19
F-NMR spectrum of 5.48 in C6D6 at 298 K (471 MHz). 
 
 
Figure 98: 
1
H-NMR spectrum of 5.48 in C6D6 at 298 K (500 MHz). 
A single crystal of the oxide form of 5.48 was obtained by slow evaporation of a solution of 
the substrate in benzene (Figure 99). 
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Figure 99: Molecular structure of phoshine 5.48 in the oxide form. Hydrogen atoms were 
omitted for clarity; thermal ellipsoids shown with probability of 50%. Selected bond lengths (Å): 
C(3)–F(1): 1.3346(15), C(4)–F(2): 1.3361(15), C(5)–F(3): 1.3393(15), C(6)–F(4): 1.3388(16), C(7)–
F(5): 1.3399(15), C(1)–P(1): 1.8263(13), O(1)–P(1): 1.4836(9); selected bond angles (°): C(2)-C(1)-
P(1): 108.63(9), F(1)-C(3)-C(2): 120.23(11), F(5)-C(7)-C(2): 119.95 (11).  
5.2.2.3 Reaction of phosphine 5.48 at Pt(0) 
The diphenylpentafluorobenzylphosphine (5.48) was reacted in an NMR tube with a source 
of platinum(0), Pt(PCy3)2 (5.63)
215
 (ratio 1.5:1) at room temperature, and the reaction 
mixture analysed by 
31
P{
1
H}-, 
19
F- and 
195
Pt{
1
H}-NMR spectroscopy. The major product of 
the reaction was characterised as the Pt(0) complex 5.64 shown in Scheme 116.  
 
Scheme 116: Synthesis of complex 5.64. 
The 
195
Pt{
1
H}-NMR spectrum was run as a 2D experiment (
195
Pt-
1
H-HSQC-NMR 
spectroscopy in Figure 101) and shows a quartet in the Pt spectrum with correlation to the 
benzylic protons of the substrate 5.48 coordinated to the Pt (δ −4458.4 correlates with δ 3.5). 
The quartet has a coupling constant of 
1
JP–Pt of 4406 Hz matching with the coupling constant 
between the triplet at δ 61.36 (corresponding to the coordinated 
pentafluorobenzylphosphine) and its Pt satellites in the 
31
P{
1
H}-NMR spectrum (shown in 
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Figure 102). There are another three signals in the 
31
P{
1
H}-NMR spectrum, two belonging 
to the non-coordinated fluorinated phosphine 5.48 (δ −10.61), non-coordinated 
tricyclohexylphosphine 5.19 (δ 9.67) and a doublet at δ 43.55 corresponding to 
tricyclohexylphosphine coordinated to the Pt in compound 5.63 (starting material). The ratio 
calculated by integration of the 
31
P{
1
H}-NMR spectrum shows a ratio of 1 : 2.5 : 1.4. 
There is also a minor species detected by 
195
Pt-
1
H-HSQC-NMR spectroscopy where 
another quartet at δ −4479.1 correlates with a signal in the 1H-NMR spectrum at δ 3.3. Due 
to the multiplicity it must be bonded to three phosphines, and the likely possibility is the 
complex 5.65 in Figure 100.  
 
Figure 100: Presumed structure of the minor complex (5.65) obtained from the reaction in 
Scheme 116. 
 
Figure 101: 
195
Pt-
1
H- HSQC-NMR spectrum of reaction in Scheme 116 at 298 K in C6D6 
(107/500 MHz). 
1
H decoupled in 
195
Pt dimension (y-axis). 
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Figure 102: 
31
P{
1
H}-NMR spectrum of the products resulting from the reaction in Scheme 116 
at 298 K in C6D6 (202 MHz). 
The 
19
F-NMR spectrum shows two sets of signals corresponding respectively to the fluorine 
of the free pentafluorobenzylphosphine (5.48) (δ −142.36, −159.05, −164.25) and to the 
substrate coordinated to the Pt in complex 5.64 (δ −139.46, −160.01, −164.70). 
The behaviour of substrate 5.48 toward C–F activation at Pt(0) suggests that the 
fluorinated phosphine coordinates less strongly to Pt than the PCy3 and hence it is not able to 
displace the latter phosphine from the metal centre. This is not surprising given the strongly 
electron withdrawing nature of the perfluorinated benzyl ring, which will both lower the 
energy of the phosphorus lone pair, and increase the π-acceptor ability of the vacant orbitals 
on the phosphine (see section 3.1). 
The 14-electron complex Pt(PCy3)2 is very reactive toward C–F oxidative addition 
of fluorinated species as reported by Stone et al.
216
 and  Perutz and co-workers
207,215
 and due 
to the labile PCy3 ligands, can easily react with silanes
217
 and borane sources.
218
 However, as 
far as the author is aware, no direct reactions with tertiary phosphines have been reported. 
Further investigation is needed and a possible experiment to promote the cyclometallation 
reaction could be the reaction of substrate 5.48 directly with the source of Pt(0) in 
conjunction with the increase the temperature and of the reaction time to assess a possible 
C–F activation. The addition of LiI as reported in catalytic C–F activation reactions at Pd in 
section 5.1.2 to promote C–F activation could similarly be an interesting further experiment. 
The source of platinum could also be changed, for instance trying the reaction 
between [Pt(1,5-COD)2], 5.66,
216
 directly with phosphine 5.48 to form the 14-electron 
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complex 5.67. A similar reaction  was reported by Stone and co-workers for the synthesis of 
5.63 and [Pt(PMe(t-Bu)2)2])], which can be heated to promote cyclometallation or further 
reacted with borane or silane sources to obtain novel Pt complexes.
216
 
 
Scheme 117: Proposed synthesis of Pt complex 5.67. 
The study could also be extended to the other fluorinated phosphines (described in 
Chapter 3) to investigate C–H versus C–F activation reactions at Pt(0). 
5.3 Conclusions 
The first part of this Chapter (section 5.1) described the cross-coupling reaction via 
C–F functionalisation of fluorinated N,N-dimethylbenzylamines 2.7e, 5.25, 5.26 and 4-N,N-
dimethyl-2,3,5,6-tetrafluoro-pyridine 5.34 using the Pd(0) precursor Pd(PCy3)2 (5.17) as a 
catalyst in the presence of a Grignard reagent and ZnCl2. Whilst the perfluorinated substrate 
5.26 undergoes C–F functionalisation, the reaction with difluorinated substrates 5.25 and 
2.7e do not proceed, potentially due to the aromatic rings being too electron-rich to react 
with the nucleophilic palladium source. In the case of 2,3,4,5,6-pentafluoro-N,N-
dimethylbenzylamine (5.26) the C–F activation occurs regioselectively para to the benzylic 
arm, presumably due to the lower electron density of the C-4 carbon atom in the aromatic 
perfluorinated ring, preferred by the nucleophilic palladium. The reaction with 4-N,N-
dimethylamino-2,3,5,6-tetrafluoro-pyridine (5.34) proceeds slowly ortho to the ring nitrogen 
due to the additional steric bulk in the para position. The slow reaction and low conversion 
observed is presumably due to the additional electron density in the aromatic ring from the 
nitrogen atom. 
The study could be further extended by testing a trifluorinated substrate or changing 
the substrate from fluorinated amines to fluorinated phosphine oxides, due to their different 
electronic behaviour towards the metal. 
The second part of this chapter (section 5.2) described a preliminary study of C–F 
activation reactions of fluorinated N,N-dimethylbenzylamines (5.25 and 5.26) at Ni(0), 
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followed by the synthesis of 2,3,4,5,6-pentafluorodiphenylbenzylphosphine  (5.48, Jess-
Phos) and its reaction  with a source of Pt(0). 
The reaction at Ni(0) of fluorinated benzylamines 5.25 and 5.26 did not give any C–
H or C–F activation product, potentially due to the poor coordinating properties of the 
nitrogen atom compared to the phosphorus atoms of the two PEt3 ligands bound to the metal 
centre. The system reaction conditions need to be improved and the phosphine ligands 
replaced by some which are less strongly coordinating. 
The reaction at Pt(0) of substrate 5.48 did not give any C–F or P–C activation 
product, with the substrate in fact simply binding to the metal centre without displacing the 
PCy3 phosphine ligands coordinated to the metal. Further investigation is needed to fully 
understand the behaviour of these novel and interesting substrate towards C–F activation. 
More general conclusions are given in Chapter 6. 
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Chapter 6: Conclusions and Future Work 
6.1 Conclusions 
The work described in this thesis has explored the effects of fluorine substituents on the 
regioselectivity of intramolecular C–H activation reactions of fluorinated substrates at 
transition metals.  
 Fluorinated benzylamines 2.7a–f were reacted with two different sources of 
palladium, Pd(OAc)2 and Li2PdCl4, to give fluorinated acetate- and chloride-bridged 
palladacycles (2.8a–f and 2.9a–f, respectively), which were fully characterised using a range 
of techniques. Substrates 2.7c and 2.7e do not exhibit any regioselectivity for the C–H 
activation reactions when reacted with Pd(OAc)2 via a proposed CMD mechanism, while 
they exhibit complete regioselectivity para to fluorine when reacted with Li2PdCl4 to give 
palladacycles 2.9c6 and 2.9e6 as the only products via a hypothesised SEAr mechanism 
(Scheme 118).  
 
Scheme 118: Reactivity of substrate 2.7c towards C–H bond activation at Pd(OAc)2 and 
Li2PdCl4. 
The two chloride-bridged para isomers, 2.9c6 and 2.9e6, could then be converted to acetate-
bridged palladacycles 2.8c6 and 2.8e6 by reaction with silver acetate with complete retention 
of regioselectivity.  
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Scheme 119: Bridge conversion reaction to acetate-bridged palladacycle with retention of 
regioselectivity. 
Fluorinated substrates in intermolecular reactions at Pd are known to give ortho selective  
C–H functionalisation reactions when proceeding via a CMD mechanism,20 so the lack of 
regioselectivity in the acetate-bridged palladacycle formation (reported in this study) 
indicates that an additional effect is involved in controlling the regioselectivity. This 
phenomenon could be linked to steric and electronic repulsion between the fluorine and 
oxygen lone pairs. A detailed crystallographic analysis revealed that the geometry of the 
clamshell shape of the acetate-bridged palladacycles is in fact affected by the position and 
the number of fluorine atoms on the ring; for example palladacycle 2.8d, where activation 
must occur ortho to fluorine, shows a large twist of the aromatic ring due to the repulsion 
between the oxygen and fluorine lone pairs. It is this repulsion that could be responsible for 
the lack of regioselectivity in the other palladacycles, by opposing the ortho fluorine effect.  
In the case of chloride-bridged palladacycles, where the mechanism is presumed to 
be an SEAr process, and regioselectivity para to fluorine is observed, the rigidity of the 
planar structure does not permit the same twist that is observed for acetate-bridged 
palladacycles. Electronic and steric repulsions therefore dominate the regioselectivity, 
disfavouring the formation of the ortho isomer and leading to exclusive formation of the 
para isomer. 
 
Figure 103: Comparison between the molecular geometries of the molecular structures of clam 
shell palladacycle 2.8e6 and planar 2.9e6. 
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Although this behaviour diverges from similar C–H activation reactions, which proceed via 
an SEAr mechanism at Rh reported by Jones et al.,
116
 it is possible that the differences in 
substrate and metal could lead to a different mechanism or to a different rate determining 
step of the same mechanism. The hypothesis of steric and electronic repulsions was also 
supported by reacting the chlorinated 3-chloro-N,N-dimethylbenzylamine, 2.7g, with the 
same two sources of palladium and observing in both cases 100% regioselectivity para to 
chlorine, even in the case of the acetate-bridged palladacycle, 2.8g, due to the chlorine atom 
being larger than fluorine and the absence of any ortho fluorine effect.  
 The effect of fluorine substituents on C–H activation reactions of fluorinated 
diphenylbenzylphospines 3.2–3.5 has also been investigated. Fluorinated phosphines were 
synthesised in-house and due to their lack of reactivity toward the direct reactions at Pd, 
assumed to be partly due to the lack of a significant Thorpe–Ingold effect, the C–H 
activation reactions were studied via transcyclometallation reactions (selected example in 
Scheme 120).  
 
Scheme 120: Transcyclometallation reaction example of substrate 3.3 gives regioselectively para 
isomer 3.28p. 
For substrates 3.3 and 3.4 the cyclopalladation reactions to form chloride-bridged 
palladacycles 3.28 and 3.30 occur regioselectively para to fluorine similarly to the chloride-
bridged amino system. The structures of these palladacycles are also rigid, without the 
possibility of twisting to minimise steric interactions (Figure 104). Therefore in substrates 
3.3 and 3.4, where two possible C–H bonds could be activated, the ortho isomers, where the 
fluorine atoms are pointing toward the chlorine atom of the bridge, are disfavoured. 
 177 
 
 
Figure 104: Molecular structure of palladacycle 3.28p (planar structure). 
The effect of fluorine atoms on the regioselectivity of intramolecular reactions at Ir, Rh and 
Ru was also investigated for fluorinated benzylamines 2.7b and 2.7c. Two different methods 
were used in the metalation reactions at Ir to form the same metallacycle 4.4 and a difference 
in regioselectivity was observed. The ratio between ortho and para isomers was 3.3 : 1.0 
using NaOH as a base while it was 1.7 : 1 when using NaOAc. 
 
Scheme 121: Comparison between the two methods to obtain Ir metallacycle 4.4.  
This difference in regioselectivity could potentially be due to the operation of two different 
proposed mechanisms, SEAr and CMD. This could also explain why just one of the two 
methods is successful with Rh and Ru. All three metals show a preference for the formation 
of the ortho isomer, where the metal is ortho to the fluorine atom, in cyclometallation 
reactions with substrate such as 2.7c, where two positions are available for the C–H 
activation. This is in contrast to the reactions with Pd, but can be explained in part by the 
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completely different geometries of the complexes, with the Ir, Rh and Ru compounds being 
pseudotetrahedral around the metal, leading to minimal steric interaction between the ortho 
fluorine and the other ligands. Crystal structure determination of these complexes would be 
useful to confirm the favoured regioselectivity beyond doubt. 
 Preliminary results were obtained in catalytic C–F functionalisation reactions at 
Pd(0) of benzylamines 2.7e, 5.25 and 5.26 and fluoropyridine 5.34 conducted in the 
presence of a Grignard reagent and ZnCl2. C–F activation could be obtained only with 
perfluorinated substrates (5.26 and 5.34) and does not proceed for difluorinated ones (2.7e 
and 5.25). In the case of 5.26 the functionalisation is regioselective para to the benzyl arm, 
presumably due to the lower electron density of the para position in the ring, attacked by the 
nucleophilic source of palladium. In the case of 5.34 where the para position was blocked by 
the dimethylamine group, the C–F functionalisation occurs ortho to the nitrogen atom but 
only in poor yield. 
 
Scheme 122: Cross-coupling reaction via catalytic C–F activation reaction at Pd(0). 
Preliminary studies were also performed towards stoichiometric C–F activation 
reactions of fluorinated benzylamines at Ni(0). These were found to only give trace amounts 
of the expected fluoride complexes, and this is proposed to be due to the poor coordinating 
properties of these ligands, which are not able to displace the triethylphosphine ligands of 
the complex Ni(PEt3)2 and thus unable to coordinate to the metal. 
 
Scheme 123: Attempted stoichiometric C–F activation reaction of 5.26 at Ni(0). 
 Stoichiometric C–F activation reactions at Pt(0) were also attempted using the 
novel ligand pentafluoro-diphenylbenzylphosphine, 5.48, but the only product observed was 
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the Pt complex 5.64, where substrate 5.48 coordinates to the metal centre, without displacing 
the other two PCy3 ligands.  
 
Scheme 124: Stochiometric attempted C–F activation reaction of 5.48 at Pt(0). 
6.2 Future work 
6.2.1 Biological tests on fluorinated palladacycles  
After the preliminary biological tests performed on palladacycles 2.9c and 2.9e it would be 
interesting to expand the study to the remaining fluorinated amino- and phospha- 
palladacycles to observe if the presence of the fluorine can improve their anti-cancer 
activity, in line with the extensive studies on fluoroaromatics as pharmaceutical drugs.
50,142-
143
 Moreover an investigation into the difference in anticancer properties between acetate- 
(2.8b–f) and chloride-bridged (2.9b–f) palladacycles could be performed. Similar studies 
have been reported with fluorinated aromatic amino acids
219
 and with non-fluorinated 
monomers obtained from palladacycles with non-fluorinated benzylamine 2.7a reacting with 
triphenylphosphine or pyridine.
141
 
6.2.2 Investigation of catalytic activity of fluorinated phospha- 
and amino-palladacycles 
Due to the extensive use of palladacycles in catalytic processes
82
 such as carbonylation 
reactions
135
 and Heck, Suzuki
130-131
 and Stille cross-coupling,
84
 it would be interesting to 
assess the catalytic activity of the novel fluorinated palladacycles 2.8a–g and 2.9a–g 
synthesised in this study. Following the different selectivities obtained in the amino-
palladacycle systems toward C–H activation, the investigation of intermolecular C–H 
functionalisation reactions using the fluorinated palladacycles as precatalysts could lead to 
different regioselectivity in the cross-coupled products. The study could begin with the 
stoichiometric reactions of substrate 2.7c and iodotoluene using Pd(OAc)2 (Scheme 125) and 
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Li2PdCl4 as catalysts to form the palladacycles in situ and compare their catalytic behaviour 
and regioselectivity. 
 
Scheme 125: Proposed stoichiometric C–H functionalisation reaction of 2.7c with iodotoluene to 
assess regioselectivity in cross-coupling reactions. 
6.2.3 Electrochemistry and UV-studies of acetate-bridged 
palladacycles 
Bercaw and co-workers have investigated both computationally and experimentally the 
acetate-bridged and chloride-bridged palladacycles obtained from a 2-phenylpyridine ligand 
to assess the d
8–d8 interactions existing between the Pd atoms in the resulting complexes, 
thus confirming the hypothesis that an interaction between the d orbitals is present in the 
clamshell-type complexes.
127
  
A similar investigation, using UV-studies and cyclic voltammetry could be 
performed using the fluorinated acetate-palladacycles with amine and phosphine ligands to 
assess how the presence of fluorine atoms on the ring affects the electronic interactions 
between the d
8
 orbitals at Pd of these complexes. A comparison between amino- and 
phosphino-systems could also be performed. 
6.2.4 Cyclometallation reactions at Ir, Ru and Rh of fluorinated 
benzylphosphines 
As discussed earlier for the fluorinated N,N-dimethylbenzylamines 2.7c and 2.7e, the C–H 
activation reactions at Ir, Ru and Rh could be attempted with the novel fluorinated 
benzylphosphines 3.2–3.5 to assess if a different regioselectivity could be obtained for 
substrates having two possible choices toward C–H activation, as for substrate 3.3. 
It would also be interesting to attempt transcyclometallation reactions starting from 
the metallacycle obtained from Ir, Ru and Rh with amino-ligands (2.7a–g) to form the 
relevant metallacycles with a phosphino ligand, using the Pfeffer method as reported in 
Chapter 3 at Pd(II) for the synthesis of fluorinated phospha-palladacycles 3.28–3.30.115 
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6.2.5 Synthesis of hydroxyl-bridged and bromine-bridged 
palladacycles 
Following the extensive studies of halogen and hydrogen bonding carried out in the Perutz 
group,
220-221
 it would be interesting to synthesise hydroxyl-bridged palladacycles to assess 
whether a hydrogen bond, between the hydrogen of the hydroxyl group bridge and the 
fluorine substituent of the aromatic ring, could lead to a regioselective C–H activation ortho 
to fluorine (Scheme 126). Similar studies have been reported by Strauss et al. for 
functionalised arenes
222
 and by Gouverneur and co-workers in fluorinated carbohydrates.
223
 
 
Scheme 126: Cyclometallation reaction of substrate 2.7c forming in situ OH-bridged 
palladacycles 6.4 and 6.5. 
In the Fairlamb group the crystal structure of a fluorinated hydroxyl-bridged palladacycle 
(shown below) has been obtained while studying the direct transmetallation between 
palladacycles and arylboronic acids, and by analysing the packing of the crystal structure it 
is possible to observe a short contact between the fluorine atom (F(6)) and the hydrogen of 
the bridging OH group which could correspond to a hydrogen bond (Figure 105).
131
  
 
Figure 105: Molecular structure of dinuclear hydroxyl-bridged palladacycle 6.5 reported by 
Fairlamb et al.
131
 (Image taken with permission from ref. 131. Copyright 2014, RSC.) 
Palladacycle 6.4 could be obtained directly as shown in Scheme 126 or via a bridge-
conversion reaction starting from the chloride- or acetate-bridged palladacycles reacting with 
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NBu4OH in acetone and water.
224
 The regioselectivity could then be compared between the 
two different methods. 
6.2.6 Cyclometallation of fluorinated benzylamines at Mn 
Preliminary results of the C–H activation reaction of substrate 2.7c have been obtained at 
Mn, leading to a regioselective product 6.6 (95%), where the metal is ortho to the fluorine 
atom.
225
  
 
Scheme 127: Cyclometallation reaction of 2.7 at Mn leading to the formation of 6.6 (95%). 
A crystal structure confirming the regioselectivity has been obtained (Figure 106). 
 
Figure 106: Molecular structure of Mn complex 6.6. Hydrogen atoms were omitted for clarity; 
thermal ellipsoids shown with probability of 50%.  
The hypothesised mechanism of the cyclometallation at Mn is the σ-bond metathesis (σ-
CAM) and some preliminary DFT calculations concerning the suggested mechanism have 
been performed (Dr Jason Lynam), but further investigation is needed. The possibility of 
using Mn complexes as precatalysts for cross coupling reactions is also being explored. It 
would be interesting to test the behaviour of phosphine ligands such as 3.3 and compare the 
regioselectivity obtained with the amino-system.  
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Chapter 7: Experimental Section 
7.1 General experimental techniques 
7.1.1 Solvent and Reagents 
Reagents were purchased from Fluorochem, Alfa Aesar or Sigma-Aldrich and used without 
further purification unless otherwise specified. Pd(OAc)2 (>99.9%) was obtained from 
Precious Metals Online. Dry toluene and benzene were obtained by distillation over 
potassium. THF, diethyl ether, dichloromethane and acetonitrile were obtained from a Pure 
Solv MD-7 solvent machine and further dried by distillation using standard procedures. All 
dry solvents were stored under Ar in ampoules fitted with Young’s PTFE stopcocks. 
Deuterated solvents were dried over CaH2 (chloroform and acetonitrile) or potassium 
(benzene and toluene), distilled under high vacuum, and stored in small ampoules under Ar. 
The reactions discussed in Chapter 2 were carried out under an atmosphere of air while all 
others were performed under an argon or nitrogen atmosphere either in a glovebox or using 
standard Schlenk line techniques and oven- or flame-dried glassware. 
7.1.2 Melting Points 
Melting points were determined using a Stuart SMP3 melting point apparatus and a 
temperature ramp of 4 °C min
−1
. 
7.1.3 Nuclear Magnetic Resonance Spectroscopy 
1
H, 
13
C, 
19
F, 
31
P and 
11
B-NMR spectra were recorded on Jeol ECS400 (400, 100, 376, 162 
and 128 MHz, respectively) or on a Bruker AMX500 (500, 126 and 471, 202 MHz, 
respectively) as specified in the text. 
195
Pt was recorded on a Bruker AMX500 (108 MHz). 
13
C, 
31
P and 
19
F-NMR spectra were obtained with 
1
H decoupling. 
19
F-NMR spectra were 
externally referenced to CFCl3, while 
1
H and 
13
C were referenced using the chemical shifts 
of residual protiated and deuterated solvent respectively (CHCl3, δ 7.26 for 
1
H and CDCl3 δ 
77.16 for 
13
C).
 31
P-NMR spectra were referenced externally to H3PO4. Chemical shifts are 
reported in parts per million (ppm). Spectra were recorded at 298 K unless otherwise stated. 
Multiplicities are described as (s) singlet, (d) doublet, (t) triplet, (q) quartet, (m) multiplet, 
(app) apparent and (br) broad. Multiplets are reported as a range when two or more 
resonances/environments overlap; when the multiplet contains a single resonance (i.e. one 
environment) the centrepoint of the multiplet is reported only. Spectra were processed using 
MestReNova software and exported as JPEG images into the appropriate document where 
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required. Copies of the NMR spectra for all compounds are given in Appendix III (CD 
attached). 
7.1.4 X-ray Crystallography 
X-ray crystallographic data were collected on an Agilent SuperNova diffractometer with 
MoKα radiation (λ = 0.71073 Å) or CuKα radiation (λ = 1.54184 Å) at 110.00(10) K. The 
structures were solved and refined using Olex2
226
 implementing SHELX algorithms and the 
Superflip
227-229
 structure solution program. All non-hydrogen atoms were refined 
anisotropically. Hydrogen atoms were placed at calculated positions and refined using a 
“riding model”. Structures  were solved by Charge Flipping, Patterson or direct methods and 
refined with the ShelXL
230
 package using full matrix least squares minimization. 
Crystallographic parameters are given in Appendix II. Data were collected, processed and 
analysed by the author where specified. 
7.1.5 Infrared Spectroscopy 
Infrared spectra were recorded using a Unicam RS 10000E FTIR instrument. They were 
carried out as thin layer film or ATR averaging 64 scans at 1 cm
−1 
resolution. Absorption 
maxima are reported in wavenumbers (cm
−1
) and are described as (br) broad, (m) medium, 
(s) strong and (w) weak. Far-IR spectra were recorded using a Bruker Tensor 37. 
7.1.6 Mass Spectrometry 
Liquid Injection Field Desorption/Ionisation (LIFDI)
136
 and Electron Impact (EI) mass 
spectrometry were performed on a Waters GCT Premier mass spectrometer. Electrospray 
Ionisation (ESI) mass spectrometry was performed on a Bruker Daltonics microTOF 
spectrometer with an Agilent series 1200 LC with less than 5 ppm error for all HRMS 
values. Mass spectrometric data are quoted as an m/z ratio along with the relative peak 
height in parentheses (base peak = 100). In all cases the m/z ratio of the most abundant 
isotope combination is quoted. High resolution mass spectra (HRMS) are reported with error 
less than 5 ppm. 
7.1.7 Elemental Analysis 
Elemental analysis was carried out by Elemental Microanalysis Ltd (Exeter, UK) using a 
Dumas combustion method or by Dr Graeme McAllister using an Exeter Analytical CE-440 
Elemental Analyser with the percentages reported as an average of two runs. 
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7.1.8 Chromatographic methods 
Flash column chromatography was ordinarily performed using Merck 60 silica gel (particle 
size 40–63 μm). Thin layer chromatography (TLC) was carried out using Merck aluminium 
backed 5554 plates and relevant spots were visualised by ultraviolet light (λmax = 254 nm) 
and then stained with a solution of potassium permanganate and heated. Retention factors 
(Rf) are reported along with the solvent system used in parentheses.  
7.1.9 Waste and disposal 
All pyrophoric materials were quenched with a saturated solution of iodine in ethanol. All 
solid, sharps and solvent wastes were disposed following the protocol developed by the 
Chemistry Department in the University of York. 
7.2 General Procedures 
7.2.1 General procedure A: Synthesis of fluorinated 
benzylamines 
The fluorinated N,N-dimethylbenzylamines were synthesized following the procedure 
reported by Liu and co-workers.
126
 The appropriate fluorinated benzyl bromide (1 mmol, 1 
eq.) was added to a solution of dimethylamine in MeOH (2 M, 3 mL, 3 eq.) in a sealed tube 
and heated at 65 °C for 24 hours. After cooling to room temperature, the resultant yellow 
solution was concentrated under reduced pressure. The residue was dissolved in water (10 
mL) and the pH was adjusted to 12 by addition of 1 M aq. NaOH. The solution was then 
extracted with diethyl ether (3 × 15 mL) and the combined organic layers dried over MgSO4, 
filtered and evaporated to afford the product as a colourless oil which was used without 
further purification.
  
7.2.2 General procedure B: Synthesis of fluorinated amino-
derived acetate-bridged palladacycles from Pd(OAc)2 
The fluorinated chloride-bridged amino-derived palladacycles were synthesized using a 
modified version of the literature procedure reported by Heck and co-workers.
104
 To a 
solution of Pd(OAc)2 (1 eq.) in acetonitrile (20 mL mmol
−1
) was added the relevant 
fluorinated N,N-dimethylbenzylamine (1.2 eq.) and the reaction mixture was stirred for 14 
hours at 25 °C. The resulting green-to-yellow solution was filtered through cotton wool and 
reduced in vacuo. The residue was triturated with diethyl ether and dried to obtain the 
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desired product which was used without further purification. Single crystals suitable for X-
ray analysis were grown by slow diffusion of hexane into a saturated solution in chloroform. 
7.2.3 General procedure C: Synthesis of fluorinated amino-
derived chloride-bridged palladacycles from Li2PdCl4 
The fluorinated chloride-bridged amino-derived palladacycles were synthesized using a 
modified version of the literature procedure reported by Cope and co-workers.
97
 To a 
solution of lithium (or potassium) tetrachloropalladate (1 eq.) in methanol (25 mL mmol
−1
) 
was added the relevant fluorinated N,N-dimethylbenzylamine (2 eq.). The initially clear red 
reaction mixture rapidly turned slightly orange and after about 10 min at room temperature a 
yellow solid began to precipitate. After stirring for 6 hours, the yellow product was isolated 
by filtration, washed with MeOH and dried in vacuo and could be used without further 
purification. Single crystals suitable for X-ray analysis could be grown by slow diffusion of 
hexane into a saturated solution of the compound in chloroform. 
7.2.4 General procedure D: Synthesis of fluorinated amino-
derived acetate-bridged palladacycles from chloride-bridged 
palladacycles 
The fluorinated acetate-bridged palladacycles were synthesized from chloride-bridged 
palladacycles using a modified version of the procedure reported by Cotton and co-
workers.
231
 To a solution of chloride-bridged amino-derived palladacycle (1 eq.) in acetone 
(100 mL mol
−1
) was added silver acetate (2 eq.). The reaction mixture was stirred for 24 
hours at 25 °C. The resulting greenish solution was filtered through Celite to remove the 
excess silver acetate, and reduced to dryness in vacuo to obtain the product as a green 
powder, which was not purified further.  
7.2.5 General procedure E: Synthesis of fluorinated amino-
derived chloride-bridged palladacycles from acetate-bridged 
palladacycles 
The fluorinated chloride-bridged amino-derived palladacycles were synthesized from the 
appropriate acetate-bridged amino-derived palladacycles as reported by Hiraki and co-
workers.
100
 To a solution of acetate-bridged amino-derived palladacycle (1 eq.) in a solution 
of H2O/acetone (1:20, 0.34 mL mol
−1
), was added lithium chloride (8 eq.). The reaction 
mixture was stirred for 24 hours at 25 °C. The resulting yellow solution was filtered through 
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Celite and evaporated to obtain a yellow powder, which was washed with H2O to remove the 
excess lithium chloride and dried in vacuo to afford the desired compound. 
7.2.6 General procedure F: Synthesis of fluorinated 
diphenylbenzylphosphines 
The fluorinated diphenylbenzylphosphines were synthesized following the procedure 
reported by Freitag and co-workers.
168
 
n
BuLi (2.5 M, 4.2 mL, 10.5 mmol) was added 
dropwise to a solution of diphenylphosphine (10 mmol, 1.74 mL) in dry THF (20 mL) in a 
Schlenk tube at –78 °C. The colourless solution immediately turned red/orange and was 
stirred for a further 30 mins at –78 °C. It was then warmed to room temperature and stirred 
for another 30 min, before being cooled once again to –78 °C. The relevant distilled 
fluorinated benzylbromide (12 mmol) was added dropwise, and the solution turned from red 
to yellow to colourless. It was stirred at –78 °C for 30 mins then allowed to warm to room 
temperature over 12 hours. The solvent was removed under reduced pressure and the residue 
treated with dry CH2Cl2 (20 mL), the precipitated LiCl was then removed by filtration under 
N2 using a filter stick. The solvent was removed under reduced pressure and the residue 
washed with dry MeOH. The resulting white precipitate was dried in vacuo and stored in the 
glove box for further use. 
7.2.7 General procedure G: Synthesis of fluorinated phosphino-
derived chloride-bridged palladacycles 
The fluorinated chloride-bridged palladacycles were synthesised using a modified version of 
the procedure reported by Pfeffer and co-workers.
115
 All reactions were performed under an 
inert atmosphere using standard Schlenk techniques. Palladacycle di-µ-chloro-bis-[o-
dimethylaminomethyl-phenyl-C,N) dipalladium(II) (2.9a) (144 mg, 0.26 mmol) was pre-
dried in a Schlenk tube, and transferred to a glove box, where the relevant fluorinated 
phosphine (0.56 mmol) was added along with dry toluene (20 mL). The Schlenk tube was 
removed from the glovebox and CF3COOH (0.21 mmol from a stock solution 0.02 M in dry 
toluene) was added. The reaction mixture immediately changed colour from green to orange 
and was then stirred at 110 °C for 24 hours. Whilst still hot, the mixture was opened to air 
and filtered through Celite to remove traces of metallic Pd(0). The volume of solvent was 
reduced in vacuo to one half and the mixture cooled to 0 °C to leading to the formation of a 
yellow precipitate. The precipitate was filtered and washed with cold toluene to afford the 
fluorinated chloride-bridged palladacycles which were not purified further. Single crystals 
suitable for X-ray analysis were grown in air by slow evaporation the compound in toluene 
or CHCl3. 
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7.2.8 General procedure H: Synthesis of fluorinated amino-
iridacycles  
The products were synthesised according to the procedure of Davies and co-workers.
117
 In a 
Schlenk tube a mixture of [Cp*IrCl2]2 (1 eq.),
232
 NaOAc (2.4 eq.) and the relevant 
fluorinated benzylamine (2.5 eq) was stirred at room temperature for 20 h in dry CH2Cl2 
(100 mL mol
−1
). The resulting mixture was filtered through Celite and the solvent removed 
under reduced pressure. The remaining solid was washed with hexane, under Ar, to remove 
the excess ligand and dried in vacuo, affording the product as an orange powder. 
7.2.9 General procedure I: Synthesis of fluorinated amino 
metallacycles (L = CH3CN) 
The products were synthesised according to the procedure of Pfeffer and co-workers.
120
 In a 
Schlenk tube a solution of [Cp*MCl2]2 (M = Ir, Rh, Ru)
232-233
 (1 eq.), NaOH (2 eq.), KPF6 (4 
eq.) and the relevant fluorinated benzylamine (1.2 eq.) in CH3CN (100 mL mol
−1
) was 
shielded from light and stirred at 45 °C for 50 hours. Hexane (8 mL) was added and the 
resulting suspension was stirred for 2 h, under Ar, to remove the excess ligand. The layers 
were separated and the CH3CN layer was concentrated in vacuo to afford the desired 
metallacycle. 
7.2.10 General procedure J: Synthesis of fluorinated amino 
metallacycles (L = Cl)  
Metallacycles obtained from general procedure I were reacted with KCl (13 eq.) in dry 
MeOH (10 mL mmol
−1
) at room temperature for 16 hours as reported by Pfeffer and co-
workers.
120
 After this time, the solvent was removed under reduced pressure to afford the 
desired metallacycle. 
7.2.11 General procedure K: Cross-coupling reactions with 
Pd(0) 
Zinc chloride (81.1 mg, 0.6 mmol) was suspended in dry THF (5 mL) in a Schlenk tube and 
phenylmagnesium bromide (3 M in Et2O, 0.4 mL, 1.2 mmol) was added. The mixture was 
stirred until complete dissolution of the zinc chloride was observed. In another Schlenk tube, 
a solution of lithium iodide (321.2 mg, 2.4 mmol), the relevant fluorinated substrate (1 
mmol) and [Pd(PCy3)2]
234
 (33.3 mg, 0.05 mmol, 5 mol%) in dry THF (3 mL) was prepared 
and cannula-transferred into the zinc chloride solution. The mixture was stirred for 6 hours 
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at 60 °C, then HCl (1 M, 15 mL) was added and the aqueous phase was extracted with 
diethylether (3 × 5 mL). The combined organic layers were dried over MgSO4, filtered and 
evaporated to afford a brown solid, which was purified by flash chromatography. 
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7.3 Synthetic procedures and Compound Data 
7.3.1 Compounds in Chapter 2  
N,N-Dimethyl-2-fluorobenzylamine (2.7b) 
The title compound was prepared according to General Procedure A, on 
a 3.3 mmol scale, as a colourless oil (505.6 mg, 74%). 
1
H NMR (400 MHz, CDCl3) δ 7.36 (td, J = 7.5, 1.7 Hz, 1H), 7.25 (m, 
1H), 7.11 (td, J = 7.5, 1.2 Hz, 1H), 7.04 (ddd, J = 9.6, 8.2, 1.1 Hz, 1H), 3.52 (s, 2H), 2.28 (s, 
6H). 
13
C NMR (101 MHz, CDCl3) δ 161.6 (d, J = 246.3 Hz), 131.8 (d, J = 4.5 Hz), 129.1 (d, J = 
8.1 Hz), 124.0 (d, J = 3.6 Hz), 115.4 (d, J = 22.3 Hz), 56.7, 56.6, 45.3.  
19
F NMR (376 MHz, CDCl3) δ −118.10 (m).  
HRMS (ESI) m/z 154.1031 (100%, [M+H]
+
), (calculated for C9H13FN 154.1027, Δ = 0.5 
mDa). 
 IR (ATR, υ cm−1): 1618 (w), 1587 (m), 1490.1 (s), 1456 (s), 1367 (m), 1259 (m), 1228 (s), 
1218 (s), 1176 (m), 1151 (w), 1097 (m), 1020 (m, br), 941 (w), 862 (w), 835 (m), 756 (s), 
663 (w). 
Lab book reference number: JM-A-9 
N,N-Dimethyl-3-fluorobenzylamine (2.7c)  
The title compound was prepared according to General Procedure A, 
on a 2 mmol scale, as a colourless oil (245 mg, 80%). 
1
H NMR (500 MHz, CDCl3) δ 7.27 (m, 1H), 7.08 (d, J = 7.6 Hz, 1H), 
7.10–7.02 (m, 2H), 6.95 (td, J = 8.3, 1.8 Hz, 1H), 3.43 (s, 2H), 2.25 (s, 6H).  
13
C NMR (126 MHz, CDCl3) δ 163.1 (d, J = 245.5 Hz), 141.6 (d, J = 6.8 Hz), 129.8 (d, J = 
8.2 Hz), 124.7 (d, J = 2.8 Hz), 116.0 (d, J = 21.2 Hz), 114.1 (d, J = 21.1 Hz), 63.9 (d, J = 1.8 
Hz), 45.4.  
19
F NMR (376 MHz, CDCl3) δ −113.70 (m).  
HRMS (ESI) m/z 154.1029 (100%, [M+H]
+
), (calculated for C9H13FN 154.1027, difference 
Δ = 0.3 mDa).  
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IR (ATR, υ cm−1): 2925 (m, br), 2854 (m), 2819.5 (m), 2777 (m), 2362 (w), 2337 (w), 1733 
(w), 1616.1 (w), 1591 (m), 1486 (m), 1456 (m), 1456 (m), 1363 (w), 1259 (s), 1174 (w), 
1132 (w), 1097 (m), 1031 (m). 
All data are in accordance with the literature.
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Lab book reference number: JM-A-6 
N,N-Dimethyl-2,5-difluorobenzylamine (2.7d) 
The title compound was prepared according to General Procedure A, on 
a 2 mmol scale, as a colourless oil (218.4 mg, 64%). 
1
H NMR (400 MHz, CDCl3) δ 7.09 (ddd, J = 8.8, 5.7, 3.2 Hz, 1H), 6.98 
(td, J = 9.0, 4.5 Hz, 1H), 6.91 (m, 1H), 3.46 (d, J = 1.2 Hz, 2H), 2.27 (s, 6H).  
13
C NMR (101 MHz, CDCl3) δ 158.8 (dd, J = 241.9, 2.3 Hz), 157.3 (dd, J = 241.8, 2.4 Hz), 
127.4 (dd, J = 17.1, 7.3 Hz), 117.6 (dd, J = 24, 4.9 Hz), 116.3 (dd, J = 25.4, 8.6 Hz), 115.1 
(dd, J = 24.1, 8.7 Hz), 56.4 (t, J = 1.4 Hz), 45.3.
  
19
F NMR (376 MHz, CDCl3) δ −119.46 (m, 1F), −124.33 (dtd, J = 13.7, 9.1, 4.9 Hz, 1F).  
HRMS (ESI) m/z 172.0932 (100%, [M+H]
+
), (calculated for C9H12F2N 172.0938, difference 
Δ = 0.6 mDa).  
IR (ATR, υ cm−1): 2977 (m), 2946 (m), 2860 (m), 2821 (m), 2775 (m), 1737 (w), 1596 (w), 
1494 (s), 1458 (m), 1435 (m), 1367 (m), 1265 (m), 1240 (m), 1191 (m), 1135 (m), 1097 (w), 
1031 (m), 979 (w), 954 (w), 883 (m), 842 (m), 812 (m), 723 (m). 
Lab book reference number: JM-A-40 
N,N-Dimethyl-3,4-difluorobenzylamine (2.7e) 
The title compound was prepared according to General Procedure A, 
on a 5 mmol scale, as a colourless oil (546.2 mg, 64%). 
1
H NMR (500 MHz, CDCl3) δ 7.14 (m, 1H), 7.08 (m, 1H), 7.00 (m, 1H), 3.35 (s, 2H), 2.22 
(s, 6H).  
13
C NMR (126 MHz, CDCl3) δ 150.4 (dd, J = 247.7, 12.7 Hz), 149.6 (dd, J = 246.8, 12.7 
Hz), 136.3 (dd, J = 5.2, 3.9 Hz), 124.8 (dd, J = 6.2, 3.5 Hz), 117.8 (d, J = 17.1 Hz), 117.0 (d, 
J = 17.1 Hz), 63.4 (d, J = 1.1 Hz), 45.4.
  
19
F NMR (376 MHz, CDCl3) δ −138.4 (dddd, J = 19.5, 11.5, 8.1, 1 Hz, 1F), −140.4 (dddd, J 
= 17.9, 10.6, 7.8, 4.5 Hz).  
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HRMS (ESI) m/z 172.0936 (100%, [M+H]
+
), (calculated for C9H12F2N 172.0932, difference 
Δ = 0.4 mDa). 
Lab book reference number: JM-A-81 
N,N-Dimethyl-3,5-difluorobenzylamine (2.7f) 
The title compound was prepared according to General Procedure A, 
on a 5 mmol scale, as a colourless oil (646 mg, 76%). 
1
H NMR (400 MHz, CDCl3) δ 6.91–6.80 (m, 2H), 6.68 (tt, J = 8.7, 
2.2 Hz, 1H), 3.38 (s, 2H), 2.23 (s, 6H).  
13
C NMR (101 MHz, CDCl3) δ 163.1 (dd, J = 247.9, 12.7 Hz), 143.4 (t, J = 8.7 Hz), 111.7–
111.4 (m), 102.5 (t, J = 25.4 Hz), 63.7 (t, J = 2.1 Hz), 45.5.
  
19
F NMR (376 MHz, CDCl3) δ −110.55 (m).  
HRMS (ESI) m/z 172.0939 (100%, [M+H]
+
), (calculated for C9H12F2N 172.0932, difference 
Δ = −0.6 mDa). 
Lab book reference number: JM-B-124 
N,N-Dimethyl-3-chlorobenzylamine (2.7g)  
The title compound was prepared according to General Procedure A, 
on a 6.6 mmol scale, as a colourless oil (771 mg, 69%). 
1
H NMR (400 MHz, CDCl3) δ 7.32 (m, 1H), 7.24 (m, 2H), 7.19 (m, 
1H), 3.39 (s, 2H), 2.24 (s, 6H). 
13
C NMR (126 MHz, CDCl3) δ 141.3, 134.3, 129.7, 129.2, 127.4, 127.3, 63.9, 45.5.  
HRMS (ESI) m/z 170.0727 (100%, [M+H]
+
), (calculated for C9H13ClN 170.0731, difference 
Δ = 0.4 mDa). 
All data are in accordance with the literature.
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Lab book reference number: JM-C-204  
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Di-µ-acetato-bis-[o-dimethylaminomethylphenyl-C,N) dipalladium(II) (2.8a) 
 The title compound was prepared according to General 
Procedure B, on a 0.26 mmol scale, to afford the product as 
green powder (78 mg, 91%).  
M.p. 197–199 °C (dec.) (lit. 210–211 °C).104  
1
H-NMR (500 MHz, CDCl3) δ 7.02 (d, J = 7.1 Hz, 2H), 6.97 
(t, J = 7.3 Hz, 2H), 6.89 (t, J = 7.2 Hz, 2H), 6.84 (d, J = 7.2 Hz, 2H), 3.58 (d, J = 13.7 Hz, 
2H, RCH2N), 3.09 (d, J = 13.7 Hz, 2H, RCH2N), 2.80 (s, 6H, NCH3), 2.06 (s, 6H, NCH3), 
2.05 (s, 6H, CH3CO).  
13
C NMR (126 MHz, CDCl3) δ 180.9 (CO), 147.2 (Aromatic), 144.1 (Aromatic), 132.3 
(Aromatic), 124.8 (Aromatic), 124.4 (Aromatic), 121.2 (Aromatic), 72.3 (CH2), 52.7 
(NCH3), 51.3 (NCH3), 24.7 (CH3CO).  
IR (ATR, υ cm−1): 1727 (w), 1588 (m), 1569 (m), 1412 (s), 1345 (w), 1260 (s), 1072 (m, br), 
1020 (s, br), 799 (s), 737 (s), 680 (m). 
 LRMS (LIFDI) m/z 599.94 (100%, [M]
+
).  
All data are in accordance with the literature.
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Lab book reference number: JM-A-3 
Di-µ-acetato-bis-[o-dimethylaminomethyl-2-fluorophenyl-C,N) dipalladium(II)(2.8b) 
 The title compound was prepared according to General 
Procedure A, on a 0.27 mmol scale, to afford the product as 
yellow powder (72.8 mg, 85%).  
M.p. 190–193 °C (dec.).  
1
H NMR (400 MHz, CDCl3) δ 6.91 (td, J = 7.8, 5.6 Hz, 2H, 
H-4), 6.79 (d, J = 7.4 Hz, 2H, H-5), 6.71 (ddd, J = 9.5, 8.1, 
0.9 Hz, 2H, H-3), 3.50 (d, J = 14.1 Hz, 2H, CHH′), 3.45 (dd, J = 14.3, 1.4 Hz, 2H, CHH′), 
2.83 (s, 6H, NCH3), 2.07 (s, 6H, NCH3), 2.06 (s, 6H, CH3CO). 
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13
C NMR (126 MHz, CDCl3) δ 181.2 (CO), 156.4 (d, J = 250.2 Hz, C-2), 148.8 (C-6), 132.6 
(d, J = 10.1 Hz, C-1), 127.8 (d, J = 2.9 Hz, C-5), 126.3 (d, J = 6.4 Hz, C-4), 111.1 (d, J = 
20.2 Hz, C-3), 67.7 (CH2), 52.9 (NCH3), 51.6 (NCH3), 24.6 (CH3CO). 
19
F NMR (471 MHz, CDCl3) δ −115.01 (dd, J = 9.7, 5.5 Hz).  
IR (ATR, υ cm−1): 1601 (m), 1576 (s), 1558 (s), 1455 (m), 1410 (s), 1345 (m), 1232 (s), 
1127 (w), 986 (w), 874 (m), 844 (m), 769 (s), 678 (s).  
LRMS (LIFDI) m/z 636.02 (100%, [M]
+
).  
CHN Anal. Calcd for C22H28F2N2O4Pd2: C, 41.58; H, 4.39; N, 4.22. Found: C, 41.59; H, 
4.44; N, 4.51. 
Lab book reference number: JM-A-25 
Di-µ-acetato-bis-[o-dimethylaminomethyl-3-p-fluorophenyl-C,N) dipalladium(II) (2.8c6) 
The title compound was prepared according to General 
Procedure D, on a 0.17 mmol scale, to afford the product 
as yellow powder (105.4 mg, 98%).  
M.p. 191–195 °C (dec.).  
1
H NMR (500 MHz, CDCl3) δ 6.95 (dd, J = 8.3, 6.2 Hz, 
2H, H-1), 6.71–6.61 (m, 4H, H-2, H-4), 3.52 (d, J = 13.9 Hz, 2H, CHH′), 3.09 (d, J = 13.9 
Hz, 2H, CHH′), 2.79 (s, 6H, NCH3), 2.06 (s, 6H, NCH3), 2.05 (s, 6H, CH3CO).  
13
C NMR (126 MHz, CDCl3) δ 181.1 (CO), 161.3 (d, J = 240.6 Hz, C-3), 147.7 (d, J = 6.2 
Hz, C-1), 137.2 (d, J = 2.5 Hz, C-6), 133.0 (d, J = 6.8 Hz, C-5), 111.5 (d, J = 19.7 Hz, C-4), 
108.6 (d, J = 21.4 Hz, C-2), 72.0 (CH2), 52.7 (NCH3), 51.3 (NCH3), 24.6 (CH3CO). 
19
F NMR (471 MHz, CDCl3) δ −119.31 (td, J = 9.6, 6.2 Hz).  
LRMS (LIFDI) m/z 636.00 (100%, [M]
+
).  
CHN Anal. Calcd for C22H28F2N2O4Pd2·0.2AgCl: C, 39.8; H, 4.25; N, 4.22. Found: C, 
39.87; H, 4.26; N, 3.97. 
Lab book reference number: JM-B-171  
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Acetato-O-[o-dimethylaminomethyl-3-fluorophenyl-C,N)(pyridine-d5)palladium(II) 
(2.8cpyr2 and 2.8cpyr6) 
A portion of the mixture of isomers of di-µ-
acetato-bis-[o-dimethylaminomethyl-3-
fluorophenyl-C,N) dipalladium(II) (2.8c) was 
dissolved in pyridine-d5 to obtain a mixture the 
two isomers of 2.8cpyr in a 1:1 ratio. 
1
H NMR (400 MHz, CDCl3): δ 7.07 (td, J = 
5.5, 7.7 Hz, 1H), 6.92–6.88 (m, 2H), 6.77 (m, 1H), 6.65 (t, J = 8.4 Hz, 1H), 6.28 (dd, J = 8.4, 
6.2 Hz, 1H), 3.93 (s, 2H), 3.86 (s, 2H), 2.84 (s, 6H), 2.76 (s, 6H), 2.19 (s, 6H).  
19
F NMR (376 MHz, CDCl3) δ −100.98 (dd, J = 8.7, 5.4 Hz), −119.88 (dd, J = 15.9, 9.6 
Hz). 
Lab book reference number: JM-A-18-P 
Di-µ-acetato-bis-[o-dimethylaminomethyl-2,5-o,m-difluorophenyl-C,N) dipalladium(II) 
(2.8d) 
The title compound was prepared according to General 
Procedure B, on a 0.26 mmol scale, to afford the product as 
yellow/green powder (70.2 mg, 78%).  
M.p. 187–190 °C (dec.).  
1
H NMR (400 MHz, CDCl3) δ 6.67 (td, J = 8.7, 3.7 Hz, 2H, 
H-3), 6.51 (td, J = 7.7, 4 Hz, 2H, H-4), 3.76 (dd, J = 14.4, 1.8 Hz, 2H, CHH′), 3.54 (d, J = 
14.4 Hz, 2H, CHH′), 2.83 (s, 6H, NCH3), 2.23 (s, 6H, NCH3), 2.00 (s, 6H, CH3CO).  
13
C NMR (126 MHz, CDCl3) δ 182.2 (CO), 163.6 (dd, J = 235.5, 1.8 Hz, C-5), 153.1 (dd, J 
= 244.9, 2.2 Hz, C-2), 134.7 (dd, J = 15.1, 12.4 Hz, C-1), 127.9 (d, J = 36.9 Hz, C-6), 114.5 
(dd, J = 31.5, 7.6 Hz, C-4), 112.1 (dd, J =, 23.4, 8.6 Hz, C-3), 69.0 (CH2), 52.8 (NCH3), 51.9 
(NCH3), 23.6 (d, J = 2.1 Hz, CH3CO).  
19
F NMR (376 MHz, CDCl3) δ −111.12 (ddd, J = 20.9, 7.6, 3.6 Hz, 2F), −121.08 (m, 2F).  
IR (ATR, υ cm−1): 1590 (s), 1571 (s), 1458 (s), 1418 (s, br), 1349 (m), 1213 (s), 1023 (m), 
972 (m), 838 (s), 805 (s), 727 (s), 683 (m).  
LRMS (LIFDI) m/z 672.02 (100%, [M]
+
).  
CHN Anal. Calcd for C22H26F4N2O4Pd2: C, 39.36; H, 3.90; N, 4.17. Found: C, 38.99; H, 
3.91; N, 4.31. 
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Lab book reference number: JM-A-41 
Di-µ-acetato-bis-[o-dimethylaminomethyl-3,4-p,m-difluorophenyl-C,N) dipalladium(II) 
(2.8e6) 
The title compound was prepared according to General 
Procedure D, on a 0.16 mmol scale, to afford the product 
as yellow powder (102 mg, 95%).  
M.p. 188–190 °C (dec.). 
1
H NMR (500 MHz, CDCl3) δ 6.78–6.72 (m, 4H, H-2, 
H-5), 3.58 (d, J = 13.8 Hz, 2H, CHH′), 3.13 (d, J = 13.8 Hz, 2H, CHH′), 2.79 (s, 6H, NCH3), 
2.11 (s, 6H, NCH3), 2.06 (s, 6H, CH3CO).  
13
C NMR (126 MHz, CDCl3) δ 181.6 (CO), 148.3 (dd, J = 243.2, 13.7 Hz, C-3), 146.7 (dd, J 
= 250.6, 12.1 Hz, C-4), 142.0 (dd, J = 4.8, 3.7 Hz, C-6), 138.9 (dd, J = 3.7, 2.9 Hz, C-1), 
120.0 (d, J = 14.7 Hz, C-5), 110.3 (d, J = 17.5 Hz, C-2), 72.0 (CH2), 52.6 (NCH3), 51.5 
(NCH3), 24.6 (CH3CO).  
19
F NMR (471 MHz, CDCl3) δ −140.92 (m, 2F), −143.94 (ddd, J = 19.7, 10.7, 8.8 Hz, 2F).  
LRMS (LIFDI) m/z 672.00 (100%, [M]
+
).  
CHN Anal. Calcd for C22H26F4N2O4Pd2·0.1AgCl: C, 38.54; H, 3.82; N, 4.09. Found: C, 
38.56; H, 3.85; N, 3.92. 
Lab book reference number: JM-B-170 
Di-µ-acetato-bis-[o-dimethylaminomethyl-3,5-difluorophenyl-C,N) dipalladium(II) 
(2.8f) 
The title compound was prepared according to General 
Procedure A, on a 0.26 mmol scale, to afford the 
product as yellow powder (71 mg, 82%).  
M.p. 205–208 °C (dec.).  
1
H NMR (400 MHz, CDCl3) δ 6.54 (dd, J = 8.4, 2.4 Hz, 
2H, H-2), 6.34 (m, 2H, H-4), 3.56–3.46 (m, 4H, CHH′, CHH′), 2.80 (s, 6H, NCH3), 2.18 (s, 
6H, NCH3), 2.00 (s, 6H, CH3CO). 
13
C NMR (126 MHz, CDCl3) δ 182.1 (CO), 167.7 (dd, J = 242.6, 11.2 Hz, C-5), 161.4 (dd, J 
= 243.2, 11.9 Hz, C-3), 150.1 (dd, J = 17.2, 8.2 Hz, C-6), 119.1 (dd, J = 34.3, 3.2 Hz, C-1), 
105.1 (dd, J = 21.1, 3.3 Hz, C-2), 101.6 (dd, J = 32.2, 23.7 Hz, C-4), 73.5 (d, J = 3.1 Hz, 
CH2), 52.6 (NCH3), 51.6 (NCH3), 23.7 (d, J = 1.7 Hz, CH3CO).  
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19
F NMR (376 MHz, CDCl3) δ −100.81 (m, 2F), −116.37 (dd, J = 17.6, 8.2 Hz, 2F).  
LRMS (LIFDI) m/z 671.99 (100%, [M]
+
).  
CHN Anal. Calcd for C22H26F4N2O4Pd2: C, 39.36; H, 3.90; N, 4.17. Found: C, 39.28; H, 
3.89; N, 3.90. 
Lab book reference number: JM-B-125 
Di-µ-chloro-bis-[o-dimethylaminomethyl-phenyl-C,N) dipalladium(II) (2.9a) 
The title compound was prepared according to General 
Procedure D, on a 1.69 mmol scale, to afford the product as 
yellow powder (462 mg, 46%).  
M.p. 173–175 °C (dec.) (lit. 183–185 °C).97  
1
H NMR (500 MHz, CDCl3) δ 7.17 (dd, J = 19.3, 7.6 Hz, 2H), 
6.99–6.94 (m, 2H), 6.87 (t, J = 6.8 Hz, 4H), 3.93 (s, 4H), 2.87 (s, 6H), 2.84 (s, 6H).  
IR (ATR, υ cm−1): 1738 (w), 1578 (w), 1447 (m), 1259 (s). 1095 (s, br), 1043 (s), 1017 (s, 
br), 982 (m), 861 (m), 799 (s), 733 (s), 698 (m).  
Far-IR (ATR, υ cm−1): 516.04 (m), 498.64 (w), 477.33 (w), 422.85 (m), 398.60 (w), 368.37 
(w), 329.15 (m), 280.00 (m), 265.76 (m), 247.08 (s), 244.39 (m), 232.86 (w), 217.42 (s). 
 LRMS (LIFDI) m/z 551.96 (100%, [M]
+
).  
All data are in accordance with the literature.
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Lab book reference number: JM-B-163 
Di-µ-chloro-bis-[o-dimethylaminomethyl-2-m-fluorophenyl-C,N) dipalladium(II) (2.9b) 
 The title compound was prepared according to General 
Procedure C, on a 0.26 mmol scale, to afford the product 
in a mixture of geometrical isomers (syn and anti) as a 
yellow powder (74 mg, 86%). 
M.p. 180–182 °C (dec.).  
1
H NMR (500 MHz, CDCl3) δ 6.94 (dd, J = 20.1, 7.7 Hz, 
2H), 6.70 (dd, J = 13.6, 4.9 Hz, 2H), 6.87 (td J = 7.9, 5,6 
Hz, 2H), 4.01 (d, J = 2.3 Hz, 4H), 2.88 (s, 6H), 2.86 (s, 6H). 
 
13
C NMR (126 MHz, CDCl3) δ 156.1 (J = 249.6, 2.4 Hz), 144.9 (d, J = 13.12 Hz), 132.8 (t, 
J = 11.1 Hz), 128.8 (dd, J = 67.6, 2.9 Hz), 126.5 (dd, J = 13.4, 6.6 Hz), 111.6 (d, J = 20.2 
Hz), 68.6 (d, J = 22.3 Hz), 53.3, 53.0.  
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19
F NMR (376 MHz, CDCl3) δ −113.97 (m).  
LRMS (LIFDI) m/z 587.92 (100%, [M]
+
).  
CHN Anal. Calcd for C18H22F2N2Cl2Pd2: C, 36.76; H, 3.77; N, 4.76. Found: C, 36.63; H, 
3.64; N, 4.40. 
Lab book reference number: JM-B-198 
Di-µ-chloro-bis-[o-dimethylaminomethyl-3-p-fluorophenyl-C,N) dipalladium(II) (2.9c6) 
The title compound was prepared according to General 
Procedure C, on a 0.77 mmol scale, to afford the product 
in a mixture of geometrical isomers (syn and anti) as a 
yellow powder (171 mg, 76%).  
M.p. 174.4−176.2 °C (dec).  
1
H NMR (500 MHz, CDCl3) δ 7.17–6.98 (m, 2H), 6.65 
(d, J = 9.2 Hz, 4H), 3.90 (br s, 4H), 2.86 (s, 6H), 2.83 (s, 
6H).  
13
CNMR (126 MHz, CDCl3) δ 161.4 (d, J = 241.5 Hz, major isomer), 161.4 (d, J = 241.6 
Hz, minor isomer), 147.6 (d, J = 6.3 Hz, major isomer), 147.6 (d, J = 6.5 Hz, minor isomer), 
136.1 (d, J = 2.2 Hz, major isomer), 136.0 (d, J = 2.2 Hz, minor isomer), 134.3 (d, J = 7.0 
Hz, minor isomer), 133.8 (d, J = 6.9 Hz, major isomer), 112.0 (d, J = 9.8 Hz, major isomer), 
111.9 (d, J = 9.8 Hz, minor isomer), 109.0 (s, major isomer), 108.8 (s, minor isomer), 73.2 
(d, J = 2.6 Hz, major isomer), 73.0 (d, J = 2.9 Hz, major isomer), 53.1 (s, major isomer), 
52.8 (s, minor isomer).  
19
F NMR (471 MHz, CDCl3) δ −119.01 (m, minor isomer), −119.10 (m, major isomer).  
Far-IR (ATR, υ cm−1): 576.72 (m), 553.97 (w), 518.76 (w), 441.67 (m), 427.53 (m), 337.55 
(m), 316.09 (s), 274.60 (m), 255.36 (w), 252.25 (w), 239.54 (s), 215.26 (s), 196.34 (m). 
LRMS (LIFDI) m/z 587.89 (100%, [M]
+
).  
CHN Anal. Calcd for C18H22F2N2Cl2Pd2: C, 36.76; H, 3.77; N, 4.76. Found: C, 36.61; H, 
3.77; N, 4.53. 
Lab book reference number: JM-B-167, JM-B-179 
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Chloro-κO-[o-dimethylaminomethyl-3-p-fluorophenyl-C,N)(pyridine-d5)palladium(II) 
(2.9c6pyr) 
A portion of di-µ-chloro-bis-[o-dimethylaminomethyl-3-p-
fluorophenyl-C,N) dipalladium(II) (2.19c6) was dissolved in pyridine-
d5 to obtain the title compound.  
1
H NMR (500 MHz, CDCl3) δ 6.93 (dd, J = 9.6, 2.5 Hz, 1H), 6.78 (t, 
J = 7.8 Hz, 1H), 6.27–6.17 (m, 1H), 3.91 (s, 2H), 2.94 (s, 6H).  
19
F NMR (471 MHz, CDCl3): δ −119.35–−119.46 (dd, J = 16.4, 10.3 
Hz). 
Lab book reference number: JM-B-168-P 
Di-µ-chloro-bis-[o-dimethylaminomethyl-2,5-o,m-difluorophenyl-C,N) dipalladium(II) 
(2.9d). 
The title compound was obtained according to General 
Procedure C, with a reaction time of 1 week, on a 0.1 
mmol scale, to afford the product in a mixture of 
geometrical isomers (syn and anti) as a yellow product 
(21 mg, 67%).  
M.p. 172.9–174 °C (dec.).  
1
H NMR (500 MHz, CDCl3) δ 6.66 (qd, J = 8.5, 3.6 Hz, 
2H), 6.52 (m, 2H), 4.05 (d, J = 4.1 Hz, 4H), 2.77 (s, 6H), 
2.75 (s, 6H).  
13
C NMR (126 MHz, CDCl3, major isomer) δ 162.3 (dd, J = 239.3, 19.6 Hz), 152.7 (d, J = 
244.6 Hz), 134.2 (m), 126.8 (m), 114.7 (m), 112.4 (m), 69.4 (d, J = 9.3 Hz), 53.1, 52.7.  
19
F NMR (376 MHz, CDCl3, minor and major isomers) δ −102.94 (ddd, J = 20.0, 7.7, 3.6 
Hz), −105.75 (ddd, J = 20.1, 7.9, 3.6 Hz), −120.49 (m), −120.90 (m).  
LRMS (LIFDI) m/z 623.94 (100%, [M]
+
).  
CHN Anal. Calcd for C18H20F4N2Cl2Pd2: C, 34.64; H, 3.23; N, 4.49. Found: C, 34.49; H, 
3.16; N, 4.25. 
Lab book reference number: JM-D-306 
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Di-µ-chloro-bis-[o-dimethylaminomethyl-3,4-p,m-difluorophenyl-C,N) dipalladium(II) 
(2.9e6) 
The title compound was prepared according to General Procedure C, on a 0.77 mmol scale, 
to afford the product in a mixture of geometrical isomers (syn and anti) as a yellow powder 
(171 mg, 71%).  
M.p. 178.6–180.2 °C.  
1
H NMR (400 MHz, CDCl3) δ 6.92 (ddd, J = 19.1, 10.6, 
8.6 Hz, 2H), 6.74 (dd, J = 10.6, 7.6 Hz, 2H), 3.88 (s, 4H), 
2.85 (s, 6H), 2.82 (s, 6H). 
 
19
F NMR (376 MHz, CDCl3): δ −140.22 (m, major 
isomer), −140.55 (m, minor isomer), −143.50 (m, major 
isomer), −143.67 (m, minor isomer).  
HSQC NMR (500, 126 MHz): δ (6.92, 121.1), (6.74, 
109.9), (3.88, 72.5), (2.85, 52.6).  
Far-IR (ATR, υ cm−1): 520.26 (w), 466.51 (w), 439.59 (m), 374.08 (m), 319.81 (s), 278.79 
(m), 263.58 (m), 236.05 (m), 211.74 (w), 180.23 (w).  
LRMS (LIFDI) m/z 623.89 (100%, [M]
+
).  
CHN Anal. Calcd for C18H20F4N2Cl2Pd2: C, 34.64; H, 3.23; N, 4.49. Found: C, 34.64; H, 
3.19; N, 4.28 
Lab book reference number: JM-B-167, JM-B-179 
Chloro-κ-[o-dimethylaminomethyl-3,4-difluorophenyl-C,N)(pyridine-d5)palladium(II) 
(2.9epyr6) 
A portion of di-µ-chloro-bis-[o-dimethylaminomethyl-3,4-p,m-
fluorophenyl-C,N) dipalladium(II) (2.19e6) was dissolved in pyridine-
d5 to obtain the title compound.  
1
H NMR (500 MHz, CDCl3) δ 7.03–6.96 (m, 1H), 6.04 (t, J = 9.5 Hz, 
1H), 3.88 (s, 2H), 2.94 (s, 6H).  
19
F NMR (471 MHz, CDCl3): δ −142.41 (m), −145.06 (m). 
Lab book reference number: JM-B-167-P  
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Dichloropalladium-bis-2,4-difluoro-N,N-dimethylbenzylamine (2.28d) 
The title compound was prepared according to general 
procedure C, on a 0.29 mmol scale, to afford the product 
as an orange powder (111 mg, 73%).  
M.p 132.0–135.4 °C (dec.).  
1
H NMR (500 MHz, CDCl3) δ 8.77 (ddd, J = 8.8, 5.5, 
3.2 Hz, 2H), 7.12 (ddd, J = 14.3, 7.3, 3.7 Hz, 4H), 3.90 
(s, 4H), 2.60 (s, 12H).  
13
C NMR (126 MHz, CDCl3) δ 158.4 (dd, J = 242.4, 2.2 Hz), 157.9 (dd, J = 243.70, 2.5 
Hz), 123.1 (dd, J = 16.62, 8.12 Hz), 120.5 (dd, J = 24.9, 3.7 Hz), 117.6 (dd, J = 24.1, 8.9 
Hz), 116.8 (dd, J = 26.1, 8.6 Hz), 60.1, 54.0 (d, J = 0.6 Hz).  
19
F NMR (376 MHz, CDCl3) −118.22 (m), −121.50 (m).  
HRMS (ESI) m/z 483.0453 (100%, [M+H−Cl]+), (calculated for C18H22F4N2PdCl 483.0441, 
difference Δ = −1.2 mDa).  
CHN Anal. Calcd for C18H22F4N2Cl2Pd: C, 41.60; H, 4.27; N, 5.39. Found: C, 41.28; H, 
4.14; N, 5.13.  
Lab book reference number: JM-C-292 
Di-µ-chloro-bis-[o-dimethylaminomethyl-3-p-chlorophenyl-C,N) dipalladium(II) (2.8g6) 
The title compound was prepared according to General 
Procedure C, on a 0.12 mmol scale, to afford the 
product in a mixture of geometrical isomers (syn and 
anti) as a dark green powder (23.8 mg, 63%).  
M.p. 178.5−179.6 °C (dec).  
1
H NMR (400 MHz, CDCl3) δ 7.08 (m, 2H) 6.90–6.85 
(m, 4H), 3.89 (s, 4H), 2.85 (s, 6H), 2.82 (s, 6H).  
13
C NMR (100 MHz, CDCl3) δ, 148.2 (s, major 
isomer), 148.1 (s, minor isomer), 140.5 (s, major isomer), 140.4 (s, minor isomer), 134.6 (s, 
minor isomer), 134.1 (s, major isomer), 131.6 (s, minor isomer), 130.9 (s, major isomer), 
125.2 (s, minor isomer), 125.1 (s, major isomer), 121.7 (s, major and minor isomers), 73.0 
(s, minor isomer), 72.9 (s, major isomer), 53.1 (s, major isomer), 52.8 (s, minor isomer).  
LRMS (LIFDI) m/z 621.82 (100%, [M]
+
). 
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CHN Anal. Calcd for C18H22N2Cl4Pd2·CH3OH: C, 33.88; H, 3.63; N, 4.39. Found: C, 33.69; 
H, 3.40; N, 4.23. 
Lab book reference: JM-C-209 
Di-µ-acetato-bis-[o-dimethylaminomethyl-3-p-
chlorophenyl-C,N) dipalladium(II) (2.9g6) 
 The title compound was prepared according to General 
Procedure D, on a 0.18 mmol scale, to afford the 
product as green powder (52.6 mg, 87%).  
M.p. 175.8–176.6 °C (dec.).  
1
H NMR (400 MHz, CDCl3) δ 6.97–6.87 (m, 2H, H-1), 6.74 (m, 4H, H-2, H-4), 3.55 (d, J = 
13.9 Hz, 2H, CHH′), 3.10 (d, J = 13.9 Hz, 2H, CHH′), 2.78 (s, 6H, NCH3), 2.08 (s, 6H, 
NCH3), 2.05 (s, 6H, CH3CO).  
13
C NMR (126 MHz, CDCl3) δ 181.2 (CO), 148.8, 141.6, 133.3, 130.2, 124.8, 121.4, 72.0 
(CH2), 52.6 (NCH3), 51.4 (NCH3), 24.5 (CH3CO). 
LRMS (LIFDI) m/z 667.97 (100%, [M]
+
).  
CHN Anal. Calcd for C22H28Cl2N2O4Pd2: C, 39.54; H, 4.22; N, 4.19. Found: C, 39.27; H, 
4.21; N, 3.95. 
Lab book reference: JM-C-208 
Biological tests 
A2780 ovarian cancer cells were grown in RPMI 1640 medium enriched with 10% FBS and 
1% L-glu. They were cultured with 0.25% EDTA-trypsin when 70–80% confluent. Cells 
were centrifuged for 5 min at 1000 rpm, suspended in 10 mL of medium and counted using a 
Vi-cell machine (Tot viable cells 1.27∙106 cells/mL). Cells were diluted in order to have a 
concentration of 3000 cells per well (236 μL in 10 mL); 100 μL of dilute cells suspension 
were added to each well and the plates were left incubating overnight (21/08/2014). 
[Di-μ-chloro-(p-3-fluoro-dimethylbenzylamine- C,N) dipalladium(II)] (2.9c6) was dissolved 
in 0.1 mL of DMSO (0.44 %) and medium was added (total volume of 10 mL). The solution 
was sterilised through a filter and diluted as reported in Table 23. An aliquot (100 μL) of the 
prepared solution were added to each well. On the plate two controls were set up (one 
positive and one negative), and the plate was left incubating for three days. 
 203 
 
MTT was dissolved in PBS (around 10.6 mg in 5.5 mL for each plate), filtered through 
sterilising filters and 50 μL of the solution was added to each well. The plate was left 
incubating for 2 hours and then centrifuged for 10 mins at 500 rpm. A portion (220 μL) of 
medium was removed from wells and DMSO (150 μL) was added to dissolve the formazan 
(precipitate formed after metabolism, see Section 2.5 in Chapter 2). Absorbance was 
recorded at 540 nm using the plate reader and cell viability plotting as percentage from 
negative to positive controls. The fitting was done using Origin Functions (Non linear 
fitting: Growth/ Sigmoidal –Logistic curve) and X0 on the graphs is the IC50. 
All biological tests were carried out in collaboration with Dr Luisa Ciano (member of Paul 
Walton research group in York). 
Table 23: Dilution of compound 2.9c6 for biological tests 
  
MTT Calculator
Experiment Identifier: JM-C-244
The Drug and experiment JM-B-178
Mr 588.12 g / mol Mass 4.3 mg conc range 2 %
# plates 1 Drug Vol. / well 100 uL Well Vol. 200 uL
Vol Req 800 uL Vol. make 1000 uL Drug:Well 2
The Stock Solution Dilute Solution A Dilute Solution B
Volume 10 mL Volume 5 mL Volume 5 mL
Conc. Fact. 1 x Conc. Fact 0.1 x Conc Fac 0.2 x
Target Conc. 516 uM Target Conc. 51.6 uM Target Conc. 103.2 uM
Target Mass 3.034699 mg Vol. Stock 0.355 mL Vol. A 9.945 mL
Vol. PBS 4.645 mL Vol. PBS -4.945 mL
Real Conc. 731.1 uM Real Conc. 51.9 uM Real Conc. 103.3 uM
Vol. Req 1.435 mL Vol. Req 19.79 mL Vol. Req 9.945 mL
Concentrations to test
2 3 4 5 6 7 8 9 10 11
258 128 64 32 16 8 4 2 1 0.5 uM
2.412 2.107 1.806 1.505 1.204 0.903 0.602 0.301 0.000 -0.301
Solution Prep - Stock Solution
2 3 4 5 6 7 8 9 10 11
259.556 129.778 65.803 32.901 16.451 9.139 5.484 3.656 1.828 1.828 uM
710 355 180 90 45 25 15 10 5 5 uL
290 645 820 910 955 975 985 990 995 995 uL
Solution Prep - Stock Solution
2 3 4 5 6 7 8 9 10 11
258.128 128.091 64.110 32.055 16.092 8.046 4.023 2.076 1.038 0.519 uM
9945 4935 2470 1235 620 310 155 80 40 20 uL
-8945 -3935 -1470 -235 380 690 845 920 960 980 uL
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7.3.2 Compounds in Chapter 3 
2-Fluoro-diphenylbenzyphosphine (3.2) 
The title compound was prepared according to General Procedure F, 
on a 10 mmol scale, as white powder (1.33 g, 45%). 
M.p. 76.9–85.9 °C.  
1
H NMR (400 MHz, C6D6) δ 7.40–7.33 (m, 4H), 7.06–7.01 (m, 6H), 
6.91 (m, 1H), 6.76 (m, 2H), 6.66 (td, J = 1.6, 7.3 Hz, 1H), 3.34 (s, 
2H, CH2). 
31
P NMR (161.8 MHz, C6D6) δ −10.91 (d, JP–F = 13.2 Hz). 
19
F NMR (376 MHz, C6D6) δ −116.84 (m). 
13
C NMR (126 MHz, CDCl3) δ 161.0 (dd, J = 245.4, 4.3, Hz), 138.1 (d, J = 15.0 Hz), 133.1 
(d, J = 18.8 Hz), 131.4 (dd, J = 7.8, 4.3, Hz), 129.1 (s), 128.5 (d, J = 6.6 Hz), 127.8 (dd, J = 
8.1, 2.6 Hz), 124.8 (dd, J = 15.3, 8.3, Hz), 123.9 (dd, J = 3.5, 1.7, Hz), 115.4 (dd, J = 22.2, 
1.4 Hz), 28.6 (d, J = 16.2 Hz).  
HRMS (ESI) m/z calculated for C19H17FP 295.1046 [M–H]
+
, found m/z 295.1053 (Δ = −0.6 
mDa).  
CHN Anal. Calcd for C19H16FP: C, 77.54; H, 5.48; Found: C, 77.76; H, 5.52. 
Lab book reference number: JM-B-142, JM-C-316 
3-Fluoro-diphenylbenzyphosphine (3.3) 
The title compound was prepared according to General Procedure F, 
on a 10 mmol scale, as white powder (1.14 g, 39%). 
M.p. 57.3–57.8 °C. 
1
H NMR (400 MHz, CDCl3) δ 7.43–7.36 (m, 4H), 7.15–7.11 (m, 
6H), 6.91–6.81 (m, 2H), 6.78 (m, 1H), 6.73 (ddd, J = 9.7, 2.4, 1.2 Hz, 
1H), 3.20 (s, 2H, CH2). 
31
P NMR (161.8 MHz, C6D6) δ −9.94 (s). 
19
F NMR (376 MHz, C6D6) δ −113.47 (m). 
13
C NMR (126 MHz, CDCl3) δ 163.2 (dd, J = 245.2, 1.9 Hz), 140.7 (dd, J = 8.4, 7.7 Hz), 
138.7 (d, J = 16.3 Hz), 133.3 (d, J = 18.8 Hz), 129.9 (dd, J = 8.4, 1.6, Hz), 129.0 (s), 128.7 
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(d, J = 6.4 Hz), 125.3  (dd, J = 6.8, 2.8 Hz), 116.6 (dd, J = 21.4, 6.6, Hz), 113.1 (dd, J = 
21.0, 2.6 Hz), 36.1 (dd, J = 17.2, 1.9 Hz).  
HRMS (ESI) calculated for C19H17FP m/z 295.1046 [M−H]
+
, found m/z 295.1039 [M−H]+ 
(Δ= 0.7 mDa). 
CHN Anal. Calcd for C19H16F1P1: C, 77.54; H, 5.48; Found: C, 77.12; H, 5.46.  
Lab book reference number: JM-B-148, JM-C-317 
3,4-Difluoro-diphenylbenzyphosphine (3.4) 
The title compound was prepared according to General Procedure F, 
on a 10 mmol scale, as white powder (1.74 g, 51%). 
M.p. 140.6–147.5 °C. 
1
H NMR (500 MHz, C6D6) δ 7.31–7.24 (m, 4H), 7.10–7.01 (m, 6H), 
6.64 (ddt, J = 11.2, 7.6, 1.7 Hz, 1H), 6.55 (m, 1H), 6.41 (m, 1H), 2.99 
(s, 2H, CH2). 
31
P NMR (202.5 MHz, C6D6) δ −10.00 (s). 
19
F NMR (470.6 MHz, C6D6) δ −138.14 (m), −141.68 (m), 
13
C NMR (126 MHz, C6D6) δ 150.4 (ddd, J = 247.3, 12.7, 1.8 Hz), 149.1 (ddd, J = 245.9,  
12.7, 3.0 Hz), 138.4 (d, J = 16.0 Hz), 135.0 (ddd, J = 9.0, 5.8, 3.9 Hz), 133.2 (d, J = 18.7 
Hz), 129.1 (s), 128.7 (d, J = 6.5 Hz), 125.5 (td, J = 6.3, 3.5 Hz), 118.3 (dd, J = 17.2, 6.6 Hz), 
117.0 (d, J = 17.6 Hz), 35.3 (dd, J = 17.2, 1.0 Hz).  
HRMS (ESI) m/z calculated for C19H16F2P 313.0952 [M−H]
+
, found m/z 313.0942 [M−H]+ 
(Δ = 1.0 mDa). 
CHN Anal. Calcd for C19H16F2P1: C, 73.07; H, 4.84; Found: C, 73.76; H, 4.94;  
Lab book reference number: JM-C-270-3 
3,5-Difluoro-diphenylbenzyphosphine (3.5) 
The title compound was prepared according to General Procedure F, 
on a 11 mmol scale, as white powder (1.82 g, 53%). 
1
H NMR (500 MHz, CDCl3) δ 7.41–7.31 (m, 10H), 6.61–6.51  (m, 
3H), 3.37 (s, 2H, CH2). 
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31
P NMR (203 MHz, CDCl3) δ −8.99 (s). 
19
F NMR (470.6 MHz, CDCl3) δ −110.49 (m). 
13
C NMR (126 MHz, CDCl3) δ 162.9 (ddd, J = 247.7, 13.2, 1.6 Hz), 137.5 (d, J = 14.8 Hz), 
134.5 (t, J = 12.9 Hz), 133.0 (d, J = 18.7 Hz), 129.2 (s), 128.7 (d, J = 6.6 Hz), 112.2 (m), 
101.6 (td, J = 25.3, 2.2 Hz), 36.2 (d, J = 17.1 Hz).  
HRMS (ESI) m/z calculated for C19H16F2P 313.0952 [M−H]
+
, found m/z 313.0948 [M−H]+ 
(Δ = 0.4 mDa). 
Lab book reference number: JM-C-138, JM-C-291 
Di-µ-chloro-bis-[o-diphenylphosphinomethyl-2-difluorophenyl-C,P) dipalladium(II) 
(3.23) 
The title compound was prepared according to General 
Procedure G, on a 0.26 mmol scale, to afford the product 
in a mixture of geometrical isomers (syn and anti) as a 
yellow powder (96 mg, 42%).  
M.p. 228.0–230.1 °C.  
1
H NMR (500 MHz, CDCl3) δ 7.82 (dd, J = 11.8, 7.7 Hz, 
5H, Ph), 7.70 (dd, J = 12.0 Hz, 3H, Ph), 7.66 (dd, J = 7.8, 
4.5 Hz, 1H, benzyl), 7.52–7.40 (m, 8H, Ph), 7.39–7.32 
(m, 4H, Ph),  6.99 (dd, J = 12.7, 7.8 Hz, 1H, benzyl), 6.87 (dd, J = 13.8, 7.8 Hz, 1H, benzyl), 
6.77–6.67  (m, 2H benzyl), 3.84 (d, J = 11.8 Hz, 2H, minor isomer ), 3.83 (d, J = 11.8 Hz, 
2H major isomer). 
31
P NMR (202.5 MHz, CDCl3) δ 58.81 (s, major isomer), 58.37 (s, minor isomer). 
 
19
F NMR (470.6 MHz, CDCl3): δ −110.58 (m, major isomer), −110.70 (m, minor isomer). 
LRMS (LIFDI) m/z 869.92 (100%, [M]
+
). 
CHN Anal. Calcd for C38H30F2P2Cl2Pd2·CHCl3·C6H6: C, 50.62; H, 3.49; Found: C, 51.0; H, 
3.67. (Single crystal grown in CHCl3/benzene) 
Lab book reference number: JM-B-144, JM-D-324  
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Di-µ-chloro-bis-[o-diphenylphosphinomethyl-3-p-difluorophenyl-C,P) dipalladium(II) 
(3.28p) 
The title compound was prepared according to General 
Procedure G, on a 0.13 mmol scale, to afford the product 
in a mixture of geometrical isomers (syn and anti) as a 
yellow powder (93 mg, 84%).  
M.p. 198.5–199.7°C.  
1
H NMR (500 MHz, CDCl3) δ 7.85 (m, 1H, benzyl), 7.81 
(m, 4H, Ph), 7.73–7.65 (m, 3H, Ph), 7.56 (m, 1H, benzyl), 
7.52–7.39 (m, 10H, Ph), 7.39–7.31 (m, 5H, Ph), 6.84 (dd, 
J = 9.6, 2.8 Hz, 2H, benzyl), 6.74 (td, J = 8.9, 2.8 Hz, 1H, benzyl), 6.62 (td, J = 9.0, 2.7 Hz, 
1H, benzyl), 3.79 (d, J = 12.1 Hz, 2H, CH2, major isomer), 3.78 (d, J = 12.4 Hz, 2H, CH2, 
minor isomer). 
13
C NMR (125.8 MHz, C6D6) δ 150.4 (ddd, J = 247.3, 12.7, 1.8 Hz), 149.1 (ddd, J = 245.9, 
12.7, 3.0, Hz), 138.4 (d, J = 16.0 Hz), 135.0 (ddd, J = 9.0, 5.8, 3.9 Hz), 133.2 (d, J = 18.7 
Hz), 129.1 (s), 128.7 (d, J = 6.5 Hz), 125.5 (td, J = 6.3, 3.5 Hz), 118.3 (dd, J = 17.2. 6.6 Hz), 
117.0 (d, J = 17.6 Hz), 35.3 (dd, J = 17.2, 1.0 Hz).  
31
P NMR (202.5 MHz, CDCl3) δ 54.99 (s, major isomer), 54.59 (s, minor isomer). 
 
19
F NMR (470.6 MHz, CDCl3): δ −118.52 – −118.60 (m, minor isomer), −118.62–−118.70 
(m, major isomer).  
LRMS (LIFDI) m/z 869.92 (100%, [M]
+
).  
CHN Anal. Calcd for C38H30F2P2Cl2Pd2·C7H8: C, 56.16; H, 3.98; Found: C, 55.39; H, 3.92. 
Lab book reference number: JM-B-149, JM-D-323 
Di-µ-chloro-bis-[o-diphenylphosphinomethyl-3,5-p,o-
difluorophenyl-C,P) dipalladium(II) (3.30p) 
The title compound was prepared according to General 
Procedure G, on a 0.15 mmol scale, to afford the product 
in a mixture of geometrical isomers (syn and anti) as a 
yellow powder (47 mg, 42%).  
M.p. 194.5–195.8 °C.   
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1
H NMR (500 MHz, CDCl3) δ 7.90–7.61 (m, 6 H), 7.60–7.33 (m, 14H), 7.23–7.16 (m, 2H, 
minor and major isomers), 6.99–6.89 (m, 2H, minor and major isomers), 3.76 (d, J = 12.2 
Hz, 4H, minor and major isomers, CH2). 
31
P NMR (202.5 MHz, CDCl3) δ 54.54 (s, major isomer), 54.07 (s, minor isomer). 
 
19
F NMR (470.6 MHz, CDCl3): δ −142.61 – −142.79 (m, major isomer), −141.14 – 
−141.31 (m, major isomer), −140.66 – −140.75 (m, minor isomer), −142.43 – −142.59 (m, 
minor isomer). 
LRMS (LIFDI) m/z 905.93 (100%, [M]
+
).  
CHN Anal. Calcd for C38H28F4P2Cl2Pd2·0.65CHCl3: C, 47.18; H, 2.94; Found: C, 47.25; H, 
2.95. 
Lab book reference number: JM-D-296, JM-D-322 
Di-µ-acetato-bis-[o-diphenylphosphinomethyl-2-
difluorophenyl-C,P) dipalladium(II) (3.31) 
The title compound was synthesized from chloride-bridged 
palladacycle 3.23 using a modified version of the procedure 
reported by Cotton and co-workers (General procedure 
B).
231
  
To a solution of chloride-bridged amino-derived palladacycle 3.23 (0.034 mmol, 1 eq.) in 
acetone (100 mL mol
−1
), was added silver acetate (0.068 mmol, 2 eq.). The reaction mixture 
was stirred for 24 hours at 25 °C. The resulting yellowish solution was filtered through 
Celite to remove the excess silver acetate, and reduced to dryness in vacuo to obtain the 
product as yellow powder (23 mg, 68% yield). The product was crystallized by slow 
diffusion of hexane into a saturated solution in chloroform. 
1
H NMR (400 MHz, CDCl3) δ 7.54–7.39 (m, 6H), 7.36–7.21(m, 6H), 7.21–7.07 (m, 8H), 
6.77 (ddd, J = 7.5, 4.3, 1.0 Hz, 2H), 6.68–6.52 (m, 4H), 3.21 (t, J = 15.3 Hz, 2H, CHH′), 
2.83 (dd, J = 15.3, 9.7 Hz, 2H, CHH′), 1.96 (s, 6H, CH3CO). 
13
C NMR (126 MHz, CDCl3) δ 180.0 (CO), 133.8 (d, J = 13.64 Hz), 133.1 (m), 132.7 (d, J 
= 1.5 Hz), 131.9 (d, J = 11.0 Hz), 131.02 (d, J = 12.0 Hz), 128.4 (m), 127.5 (d, J = 6.4 Hz), 
111.01 (d, J = 21.0 Hz), 24.9 (d, J = 3.6 Hz, CH3CO). 
31
P NMR (161.8 MHz, C6D6) δ 53.71.  
19
F NMR (471 MHz, CDCl3) δ −112.50 (m).  
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HRMS (LIFDI) m/z 918.0127 (100%, [M]
+
).  
Lab book reference number: JM-C-249 
7.3.3 Compounds in Chapter 4 
[(6-C10H15)Ir(2F-C6H3-6-CH2NMe2)Cl] (4.7) 
The title compound was prepared according to General Procedure I, on a 
0.11 mmol scale, as an orange powder (36.8 mg, 68%). 
1
H NMR (400 MHz, CDCl3) δ 7.35 (d, J = 7.5 Hz, 1H), 6.99 (dd, J = 
13.9, 7.6 Hz, 1H), 6.55 (m, 1H), 4.27 (d, J = 13.3 Hz, 1H), 3.54 (dd, J = 
13.3, 1.1 Hz, 1H), 3.07 (s, 3H), 2.90 (s, 3H), 1.63 (s, 15H). 
19
F NMR (376 MHz, CDCl3) δ −117.48 (dd, J = 9.7, 6.0 Hz).  
13
C NMR (126 MHz, CDCl3) δ 158.4 (d, JC–F = 247.0 Hz, C-2), 155.0 (C-6), 134.0 (d, J = 
9.1 Hz, C-1), 130.0 (d, J = 2.5 Hz, C-4), 127.8 (d, J = 6.8 Hz, C-5), 108.8 (d, J = 20.6 Hz,  
C-3), 87.8 (C5Me5), 68.1 (NCH2), 57.7 (NMe), 51.9 (NMe), 9.4 (C5Me5). 
HRMS (LIFDI) m/z 515.1376 (100%, [M]
+
).  
Lab book reference number: JM-D-334 
Mixture of isomers of [(6-C10H15)Ir(3F-C6H3-6-CH2NMe2)Cl] (4.8) 
The title compound was prepared according to General Procedure I, 
on a 0.11 mmol scale, as an orange powder (27.4 g, 49%,ratio 
ortho:para = 1:0.6). 
1
H NMR (400 MHz, CDCl3) δ 7.49 (dd, J = 8.3, 6.3 Hz, 1H, ortho 
isomer), 6.87–6.77 (m, 4H, ortho and para isomers), 6.77–6.67, m, 
2H, ortho and para isomers), 4.38 (d, J = 13.0 Hz, 1H, NCHH para 
isomer), 4.08 (d, J = 12.8 Hz, 1H, NCHH ortho isomer), 3.52 (d, J = 
12.9 Hz, 1H, NCHH, ortho isomer), 3.20 (d, J = 12.4 Hz, 1H, 
NCHH, para isomer), 3.04 (s, NMe, 3H, para isomer), 3.02 (s, NMe, 
3H, ortho isomer), 2.87 (s, NMe, 3H, para isomer), 2.77 (s, NMe, 
3H, ortho isomer), 1.65 (d, J = 0.7 Hz, 15H, ortho isomer), 1.62 (s, 
15H, para isomer). 
19
F NMR (376.2 MHz, CDCl3) δ −123.78 (td, J = 9.7, 6.3 Hz, para isomer), −94.21 (m, 
ortho isomer). 
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13
C NMR (125.76 MHz, CDCl3) ortho isomer δ 166.7 (d, J C–F = 234.5 Hz, C-5), 150.0 (d, J 
= 15.0 Hz, C-6), 136.8 (d, J = 39.6 Hz, C-4), 124.1 (d, J = 7.8 Hz, C-2), 117.5 (d, J = 2.3 Hz, 
C-1), 113.3 (d, J = 29.8 Hz, C-3), 88.2 (C5Me5), 75.0 (d, J = 1.3 Hz, NCH2), 57.5 (NMe), 
52.0 (NMe), 9.9 (d, J = 3.4 Hz C5Me5). 
para isomer δ 160.34 (d, J = 237.8 Hz, C-3), 149.6 (d, J = 6.1 Hz, C-6), 144.6 (d, J = 3.1 Hz, 
C-5), 134.8 (d, J = 6.3 Hz, C-1), 113.0 (d, J = 18.5 Hz, C-2), 108.8 (d, J = 20.5 Hz, C-4), 
87.4 (C5Me5), 73.3 (d, J = 2.9 Hz, NCH2), 57.3 (NMe), 51.7 (NMe), 9.4 (d, J = 3.4 Hz 
C5Me5). 
HRMS (LIFDI) m/z 515.1358 (100%, [M]
+
).  
Lab book reference number: JM-D-333 
[(6-C6H6)Ru(2-F-C6H3-6-CH2NMe2)(CH3CN)]PF6 (4.11) 
The title compound was prepared according to General 
Procedure J, on a 0.1 mmol scale, as a white powder (38.5 mg, 
74%). 
1
H NMR (500 MHz, CD3CN) δ 7.88 (d, J = 7.5 Hz, 1H), 7.09 
(dd, J = 13.6, 7.6 Hz, 1H), 6.70 (m, 1H), 5.68 (s, 6H), 3.66 (d, 
J = 13.5 Hz, 1H), 3.53 (d, J = 14.2 Hz, 1H), 3.03 (s, 3H), 2.76 
(s, 3H). 
19
F NMR (470.6 MHz, CD3CN) δ −117.34 (m). 
LRMS (LIFDI) m/z 373.06 (100%, [M]
+
).  
Lab book reference number: JM-D-302-1 
[(6-C6H6)Ru(2-F-C6H3-6-CH2NMe2)Cl] (4.12) 
The title compound was prepared according to General Procedure J, 
on a 0.06 mmol scale, as an orange powder (15.5 mg, 55%). 
1
H NMR (500 MHz, CD3CN) δ 7.99 (d, J = 7.38 Hz, 1H), 6.99 (m, 
1H), 6.53 (dd, J = 23.9, 15.3 Hz, 1H), 5.39 (s, 6H), 3.99 (d, J = 13.3 
Hz, 1H), 3.24 (s, 3H), 3.13 (d, J = 13.3 Hz, 1H), 2.66 (s, 3H). 
19
F NMR (400 MHz, C6D6) δ −118.76 (dd, J = 9.6, 5.7 Hz). 
13
C NMR (125.76 MHz, CDCl3) δ 161.0 (dd, J = 245.4, 4.3 Hz), 138.1 (d, J = 15.0 Hz), 
133.1 (d, J = 18.8 Hz), 131.4 (dd, J = 7.8, 4.3 Hz), 129.1 (s), 128.5 (d, J = 6.6 Hz), 127.8  
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(dd, J = 8.1, 2.6 Hz), 124.8 (dd, J = 15.3, 8.3 Hz), 123.9 (dd, J = 3.5, 1.7 Hz), 115.4 (d, J = 
22.2, 1.4 Hz), 28.6 (d, J = 16.2 Hz).  
HRMS (LIFDI) m/z 367.0053 (100%, [M]
+
). 
Lab book reference number: JM-D-302-2 
Mixture of isomers of [(6-C6H6)Ru(3-F-C6H3-6-CH2NMe2)(CH3CN)]PF6 (4.13) 
The title compound was prepared according to General 
Procedure J, on a 0.10 mmol scale, as a dark orange powder 
(32.7 mg, 63%, ratio ortho : para = 10:90). 
1
H NMR (500 MHz, CD3CN) ortho isomer δ 7.01 (m, 1H), 
6.87 (m, 2H), 5.81 (s, 6H), 3.73 (d, J = 13.9 Hz, 1H), 3.38 
(d, J = 13.9 Hz, 1H), 2.97 (s, 3H), 2.75 (s, 3H).  
para isomer δ 8.01 (dd, J = 8.2, 6.3 Hz, 1H), 6.81 (m, 3H), 
5.65 (s, 6H), 3.68 (d, J = 14.0 Hz, 1H), 3.29 (d, J = 13.9 Hz, 
1H), 2.98 (s, 3H), 2.73 (s, 3H). 
19
F NMR (471MHz, CD3CN) δ −123.03 (m) ortho isomer, 
−93.55 (m) para isomer. 
LRMS (LIFDI) m/z 373.06 (100%, [M]
+
).  
Lab book reference number: JM-D-303-1 
Mixture of isomers of [(6-C6H6)Ru(3-F-C6H3-6-CH2NMe2)Cl] (4.14) 
The title compound was prepared according to General Procedure J, 
on a 0.06 mmol scale, as a white powder (14.1 mg, 50%, ratio 
ortho:para = 10:1.0 
1
H NMR (500 MHz, CD3CN) ortho isomer δ 6.87 (dd, J = 13.4, 7.3 
Hz, 1H), 6.76 (m, 2H), 5.56 (s, 6H), 4.16 (d, J = 13.0 Hz, 1H), 3.19 
(s, 3H), 2.90 (d, J = 13.0 Hz, 1H), 2.66 (s, 3H).  
para isomer δ 7.01 (m, 1H), 6.87 (dd, J = 13.4, 7.3 Hz, 1H), 6.76 
(m, 2H), 5.81 (s, 6H), 3.73 (d, J = 13.9 Hz, 1H), 3.38 (d, J = 14.0 
Hz, 1H), 2.96 (s, 3H), 2.75 (s, 3H). 
19
F NMR (470.6 MHz, CD3CN) δ −93.11 (m) ortho isomer. −93.53 
(m) para isomer. 
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HRMS (LIFDI) m/z 367.0058 (100%, [M]
+
).  
Lab book reference number: JM-D-303-2 
[(6-C10H15)Rh(2-F-C6H3-6-CH2NMe2)Cl (4.15) 
The title compound was prepared according to General Procedure J, on 
a 0.06 mmol scale, as a brown powder that was purified by 
recrystallisation from CH2Cl2/pentane. The filtrate was collected and 
the solvent removed under reduced pressure to give the product as a 
dark orange powder (18.4 mg, 69%). 
1
H NMR (500 MHz, CDCl3) δ 7.35 (d, J = 7.5 Hz, 1H), 7.05 (d, J = 13.5, 7.6 Hz, 1H), 6.59 
(t, J = 8.9 Hz, 1H), 4.02 (d, J = 13.4 Hz, 1H), 3.49 (d, J = 13.3 Hz, 1H), 2.76 (s, 3H), 2.75 (s, 
3H), 1.59 (s, 15H). 
19
F NMR (400 MHz, CDCl3) δ −117.41 (m) 
13
C NMR (125.76 MHz, CDCl3) δ 169.4 (d, J = 33.0 Hz, C-6), 157.6 (d, J C–F = 248.9 Hz, C-
2), 131.7 (d, J = 9.4 Hz, C-1), 130.6 (d, J = 2.7 Hz, C-4), 127.7 (d, J = 6.3 Hz, C-5), 109.4 
(d, J = 20.7 Hz, C-3), 95.5 (d, J = 6.6 Hz, NCH2), 66.7 (C5Me5), 55.1 (NMe), 52.1 (NMe), 
9.7 (C5Me5). 
HRMS (LIFDI) m/z 425.0803 (100%, [M]
+
).  
Lab book reference number: JM-C-274-3 
7.3.4 Compounds in Chapter 5 
2,3,4,5,6-Pentafluoro-N,N-dimethylbenzylamine (5.26)  
2,3,4,5,6-Pentafluoro-benzylbromide (0.5 mL, 6.6 mmol) was added to 
dimethylamine solution (2 M in MeOH, 5 mL, 19.8 mmol) in a sealed 
tube. The mixture was stirred for 4 hours at 20 °C. The solvent was then 
removed in vacuo, the residue dissolved in H2O (30 mL) and adjusted to 
pH 12with 1 M NaOH. The solution was then extracted with diethylether 
(3 × 60 mL), and the organic extracts dried with MgSO4 and evaporated to 
obtain the title compound as a colourless oil (1.21 g, 82%). 
1
H-NMR (500 MHz, CDCl3) δ 3.64 (t, J = 1.9 Hz, 2H), 2.27 (t, J = 1.0 Hz, 6H).  
13
C-NMR (126 MHz, CDCl3) δ 145.7 (dm 
1
JC–F = 248.0 Hz, C-3, C-5), 140.7 (dm 
1
JC–F = 
252.5 Hz, C-4), 137.6 (dm, 
1
JC–F = 252.5 Hz, C-2, C-6), 111.0 (tm, 
1
J C–F = 19.6 Hz, C-1), 
49.7 (d, 
3
JC–F = 0.7 Hz, NCH2), 44.8 (s, NMe) 
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19
F-NMR (470.6 MHz, CDCl3) δ −141.89 (dd, J = 22.1, 6.2 Hz), −155.02 (t, J = 20.6 Hz), 
−162.29 (m).  
HRMS (ESI) m/z 226.0650 (100%, [M+H]
+
), (calculated for C9H9F5N 226.0650, difference 
Δ = −0.5 mDa). 
Lab book reference number SF-A-10 and JM-C-217 
N,N-Dimethyl-2,6-difluorobenzylamine (5.25) 
The title compound 5.25 was prepared according to General Procedure 
A, on a 6.6 mmol scale, as a colourless oil (658 mg, 58%). 
1
H NMR (400 MHz, CDCl3) δ 7.22 (m, 1H), 6.88 (m, 2H), 3.57 (s, 2H), 
2.27 (s, 6H). 
13
C NMR (125 MHz, CDCl3) δ 162.2 (d, JC–F = 248.0 Hz), 129.3 (t, J = 10.0 Hz), 113.8 (t, J 
= 20.0 Hz), 111.2 (dd, J = 26.0, 15.0 Hz), 49.8, 45.0.  
19
F NMR (376 MHz, CDCl3) δ −114.03 (t, J = 6.4 Hz).  
HRMS (ESI) m/z 172.0932 (100%, [M+H]
+
), (calculated for C9H12F2N 172.0937, difference 
Δ = −0.5 mDa). 
Lab book reference number: SF-A-17 
N,N-Dimethyl-2,3,4,5,6-pentafluoropyridine-4-phenylbenzylamine (5.30) 
 The title compound was prepared according to General 
Procedure K, on a 1 mmol scale, and isolated after flash 
chromatography (SiO2, CH2Cl2/MeOH, 10:1) as a yellow/orange 
powder (37.6 mg, 20%). 
Rf:0.23 (CH2Cl2:MeOH, 10:1). 
1
H NMR (400 MHz, CDCl3) δ 7.52–7.43 (m, 5H), 3.71(s, 2H). 2.34 (s, 6H). 
13
C NMR (125 MHz, CDCl3) δ 145.9 (dm, J = 247.0 Hz), 143.6 (dm, J = 248.0 Hz), 130.3 
(t, J = 2.0 Hz), 129.2, 128.7, 127.7 (t, J = 2.0 Hz), 120.2 (t, J = 17.0 Hz), 115.2 (t, J = 19.0 
Hz), 50.0 (t, J = 2.0 Hz), 45.0. 
19
F NMR (376 MHz, CDCl3) δ −142.93 (dd, J = 23.0, 13.1 Hz), −144.52 (dd, J = 23.0, 13.1 
Hz), −162.13 (m). 
HRMS (ESI) m/z 284.1060 (100%, [M+H]
+
), (calculated for C15H14F4N) 284.1057, Δ = −1.1 
mDa). 
Lab book reference number: SF-A-7C  
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2,3,4,5,6-Pentafluoro-diphenylbenzyphosphine (Jess-Phos, 5.48) 
A solution of TMEDA (1.2 eq, 0.33 mL, 2.4 mmol) in dry THF ((5 
mL) was cooled to −78 °C and sec-BuLi (1.3 M in hexane, 1.69 mL, 
2.4 mmol, 1.2 eq,) was added dropwise. After the solution has been 
stirred for 25 mins, a solution of Ph2PMe (0.37 mL, 2 mmol, 1 eq) in 
dry THF (5 mL), prepared in the glovebox, was added dropwise. The 
mixture changed colour from colourless to orange and was left stirring 
for 2 hours at –78 °C, after which time it was allowed to warm to room 
temperature. After 15 mins the solution was cooled to –78 °C and transferred by cannula 
dropwise into a solution of C6F6 (2.30 mL, 20 mmol, 10 eq) in dry THF (5 mL) at  –78 °C. 
The addition was carefully controlled and slow enough to avoid any temperature rise. Soon 
after the beginning of the addition, the colourless solution began to change from orange to 
green and at the end of the addition became blue. The reaction was allowed to warm slowly 
to room temperature overnight. After 14 hours the orange solution was reduced to one third 
of its volume before being quenched with dry MeOH (10 mL) at 0 °C. The addition of dry 
hexane (8 mL) led to the formation of a yellow precipitate, which was removed by filtration. 
The hexane solution was evaporated in vacuo and the residue sublimed on in a Schlenk tube 
under an inert atmosphere using a cold finger filled with liquid nitrogen. The pure product 
sublimed onto the side of the Schlenk tube and was collected (205 mg, 28%) while the 
unreacted starting material Ph2PMe sublimed directly onto the cold finger. 
1
H NMR (500 MHz, C6D6) δ 7.31–7.04 (m, 10H, phenyl), 3.08 (br s, 2H, PCH2). 
 
13
C-NMR (126 MHz, C6D6) 145.2 (dtt 
1
JC–F = 247 Hz, 
2
JC–F = 11.7 Hz, 
3
JC–F = 3.8 Hz), 
139.7 (dm 
1
JC–F = 251 Hz), 137.7 (dm, 
1
JC–F = 249 Hz), 137.4 (d, 
1
JC–P = 16.3 Hz), 133.1 (d, 
2
JC–P = 19.7 Hz), 129.5 (s), 128.8 (d, 
3
JC–P = 6.8 Hz), 112.3 (tdd , 
2
JC–F = 18 Hz, 
3
JC–F = 3.3 
Hz , 
3
JC–P = 9 Hz), 23.1 (d, 
1
JC–P = 20.9 Hz). 
31
P NMR (202 MHz, C6D6) δ −10.00 (td, 
4
JP–F = 21 Hz, , 
6
JP–F = 4.6 Hz). 
19
F NMR (471 MHz, C6D6) δ −141.9 (tdd J = 22.4, 7.5, 3.2 Hz), −157.8 (td J = 21.4, 4.6 
Hz), −163.5 app td (J = 21.1, 6.7, 2.9 Hz). 
HRMS (LIFDI) m/z (rel%) 366.0591 [M]
+
 (100), 366.0597 calcd for C19H12F5P. 
CHN Anal. Calcd for C19H12F5P1: C, 62.31; H, 3.30; Found: C, 59.29; H, 3.40. CHN sample 
was contaminated during preparation in the glove box. See NMR spectra for purity. 
Lab book reference number: JM-C-258 
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Appendix I: Published paper  
Reprinted with permission from [Organometallics, 2015, 34 (17), pp 4376–4386]. Copyright 
[2016] American Chemical Society. 
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Appendix II: X-Ray diffraction data 
Crystallographic data for compound 2.8a 
 
Identification code  ijsf1206c  
Empirical formula  C22H30N2O4Pd2  
Formula weight  599.28  
Temperature/K  109.95(10)  
Crystal system  monoclinic  
Space group  P21  
a/Å  9.31342(13)  
b/Å  20.6214(2)  
c/Å  13.02840(18)  
α/°  90  
β/°  110.8594(16)  
γ/°  90  
Volume/Å
3
  2338.18(6)  
Z  4  
ρcalcg/cm
3
  1.702  
μ/mm-1  1.567  
F(000)  1200.0  
Crystal size/mm
3
  0.2346 × 0.1923 × 0.1448  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  6.126 to 64.542  
Index ranges  -13 ≤ h ≤ 10, -30 ≤ k ≤ 30, -18 ≤ l ≤ 19  
Reflections collected  26130  
Independent reflections  14096 [Rint = 0.0255, Rsigma = 0.0427]  
Data/restraints/parameters  14096/1/553  
Goodness-of-fit on F
2
  1.228  
Final R indexes [I>=2σ (I)]  R1 = 0.0442, wR2 = 0.0868  
Final R indexes [all data]  R1 = 0.0499, wR2 = 0.0891  
Largest diff. peak/hole / e Å
-3
  1.68/-1.58  
Flack parameter -0.005(16) 
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Crystallographic data for compound 2.8b 
 
Identification code ijsf1301 
Empirical formula C22H28F2N2O4Pd2 
Formula weight 635.26 
Temperature/K 110.00(10) 
Crystal system monoclinic 
Space group P21 
a/Å 8.34276(13) 
b/Å 14.9448(2) 
c/Å 9.77429(16) 
α/° 90.00 
β/° 106.0050(17) 
γ/° 90.00 
Volume/Å
3
 1171.43(3) 
Z 2 
ρcalcmg/mm
3
 1.801 
m/mm
-1
 1.581 
F(000) 632.0 
Crystal size/mm
3
 0.2526 × 0.1866 × 0.1103 
2Θ range for data collection 5.7 to 64.32° 
Index ranges -11 ≤ h ≤ 12, -22 ≤ k ≤ 22, -14 ≤ l ≤ 14 
Reflections collected 14799 
Independent reflections 7245[R(int) = 0.0300] 
Data/restraints/parameters 7245/1/295 
Goodness-of-fit on F
2
 1.037 
Final R indexes [I>=2σ (I)] R1 = 0.0267, wR2 = 0.0501 
Final R indexes [all data] R1 = 0.0293, wR2 = 0.0520 
Largest diff. peak/hole / e Å
-3
 0.41/-0.58 
Flack parameter -0.031(17) 
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Crystallographic data for compound 2.8c6 
 
 
Identification code  rnp1401  
Empirical formula  C22H28F2N2O4Pd2  
Formula weight  635.26  
Temperature/K  110.05(10)  
Crystal system  monoclinic  
Space group  C2/c  
a/Å  17.4700(4)  
b/Å  7.50467(16)  
c/Å  17.5432(3)  
α/°  90  
β/°  92.9917(19)  
γ/°  90  
Volume/Å
3
  2296.90(8)  
Z  4  
ρcalcg/cm
3
  1.837  
μ/mm-1  1.613  
F(000)  1264.0  
Crystal size/mm
3
  0.1975 × 0.139 × 0.1055  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  5.91 to 64.19  
Index ranges  -26 ≤ h ≤ 23, -10 ≤ k ≤ 11, -21 ≤ l ≤ 25  
Reflections collected  6007  
Independent reflections  3621 [Rint = 0.0239, Rsigma = 0.0428]  
Data/restraints/parameters  3621/0/148  
Goodness-of-fit on F
2
  1.055  
Final R indexes [I>=2σ (I)]  R1 = 0.0283, wR2 = 0.0577  
Final R indexes [all data]  R1 = 0.0346, wR2 = 0.0625  
Largest diff. peak/hole / e Å
-3
  0.50/-0.73  
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Crystallographic data for compound 2.8d 
 
Identification code  ijsf1230a  
Empirical formula  C22H26F4N2O4Pd2  
Formula weight  671.25  
Temperature/K  110.00(10)  
Crystal system  monoclinic  
Space group  C2/c  
a/Å  20.2373(7)  
b/Å  9.09573(16)  
c/Å  15.6668(5)  
α/°  90  
β/°  127.316(5)  
γ/°  90  
Volume/Å
3
  2293.53(19)  
Z  4  
ρcalcg/cm
3
  1.944  
μ/mm-1  1.633  
F(000)  1328.0  
Crystal size/mm
3
  0.3141 × 0.1863 × 0.1693  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  6.54 to 63.96  
Index ranges  -29 ≤ h ≤ 28, -12 ≤ k ≤ 13, -23 ≤ l ≤ 22  
Reflections collected  6669  
Independent reflections  3642 [Rint = 0.0228, Rsigma = 0.0422]  
Data/restraints/parameters  3642/0/157  
Goodness-of-fit on F
2
  1.087  
Final R indexes [I>=2σ (I)]  R1 = 0.0274, wR2 = 0.0551  
Final R indexes [all data]  R1 = 0.0386, wR2 = 0.0658  
Largest diff. peak/hole / e Å
-3
  0.52/-0.63  
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Crystallographic data for compound 2.8e6 
 
Identification code  rnp1402  
Empirical formula  C22H26F4N2O4Pd2  
Formula weight  671.25  
Temperature/K  110.05(10)  
Crystal system  monoclinic  
Space group  C2/c  
a/Å  17.6919(3)  
b/Å  7.43257(15)  
c/Å  17.7733(3)  
α/°  90  
β/°  92.3531(17)  
γ/°  90  
Volume/Å
3
  2335.14(7)  
Z  4  
ρcalcg/cm
3
  1.909  
μ/mm-1  1.604  
F(000)  1328.0  
Crystal size/mm
3
  0.2194 × 0.1447 × 0.1195  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  5.946 to 60.046  
Index ranges  -24 ≤ h ≤ 22, -10 ≤ k ≤ 4, -24 ≤ l ≤ 25  
Reflections collected  5735  
Independent reflections  3399 [Rint = 0.0191, Rsigma = 0.0359]  
Data/restraints/parameters  3399/0/157  
Goodness-of-fit on F
2
  1.053  
Final R indexes [I>=2σ (I)]  R1 = 0.0240, wR2 = 0.0536  
Final R indexes [all data]  R1 = 0.0289, wR2 = 0.0566  
Largest diff. peak/hole / e Å
-3
  0.50/-0.75  
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Crystallographic data for compound 2.8f 
 
Identification code  rnp1335_twin1_hklf4  
Empirical formula  C22H26F4N2O4Pd2  
Formula weight  671.25  
Temperature/K  110.05(10)  
Crystal system  monoclinic  
Space group  P2/n  
a/Å  10.9551(4)  
b/Å  8.3786(6)  
c/Å  12.6805(4)  
α/°  90  
β/°  95.351(3)  
γ/°  90  
Volume/Å
3
  1158.85(10)  
Z  2  
ρcalcg/cm
3
  1.924  
μ/mm-1  1.616  
F(000)  664.0  
Crystal size/mm
3
  0.3204 × 0.0568 × 0.055  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  5.836 to 60.428  
Index ranges  -15 ≤ h ≤ 15, -11 ≤ k ≤ 11, -17 ≤ l ≤ 17  
Reflections collected  3553  
Independent reflections  3553 [Rint = ?, Rsigma = 0.0296]  
Data/restraints/parameters  3553/0/158  
Goodness-of-fit on F
2
  0.997  
Final R indexes [I>=2σ (I)]  R1 = 0.0277, wR2 = 0.0727  
Final R indexes [all data]  R1 = 0.0336, wR2 = 0.0746  
Largest diff. peak/hole / e Å
-3
  1.42/-1.17  
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Crystallographic data for compound 2.9b 
 
Identification code  rnp1502  
Empirical formula  C18H22Cl2F2N2Pd2  
Formula weight  588.07  
Temperature/K  110.05(10)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  7.5434(4)  
b/Å  16.2089(5)  
c/Å  8.2984(3)  
α/°  90  
β/°  106.421(4)  
γ/°  90  
Volume/Å
3
  973.26(7)  
Z  2  
ρcalcg/cm
3
  2.007  
μ/mm-1  2.145  
F(000)  576.0  
Crystal size/mm
3
  0.1846 × 0.1174 × 0.1041  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  6.924 to 64.354  
Index ranges  -8 ≤ h ≤ 11, -23 ≤ k ≤ 20, -11 ≤ l ≤ 12  
Reflections collected  5624  
Independent reflections  3060 [Rint = 0.0299, Rsigma = 0.0508]  
Data/restraints/parameters  3060/0/120  
Goodness-of-fit on F
2
  1.140  
Final R indexes [I>=2σ (I)]  R1 = 0.0389, wR2 = 0.0812  
Final R indexes [all data]  R1 = 0.0505, wR2 = 0.0865  
Largest diff. peak/hole / e Å
-3
  1.73/-1.08  
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Crystallographic data for compound 2.9c6 
 
Identification code  rnp1501  
Empirical formula  C18H22Cl2F2N2Pd2  
Formula weight  588.07  
Temperature/K  110.05(10)  
Crystal system  triclinic  
Space group  P-1  
a/Å  7.1636(7)  
b/Å  8.0381(8)  
c/Å  9.4603(9)  
α/°  70.599(9)  
β/°  72.092(9)  
γ/°  80.881(8)  
Volume/Å
3
  487.95(9)  
Z  1  
ρcalcg/cm
3
  2.001  
μ/mm-1  2.139  
F(000)  288.0  
Crystal size/mm
3
  0.23 × 0.1067 × 0.0992  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  6.546 to 64.28  
Index ranges  -5 ≤ h ≤ 10, -11 ≤ k ≤ 12, -13 ≤ l ≤ 14  
Reflections collected  5092  
Independent reflections  3033 [Rint = 0.0234, Rsigma = 0.0455]  
Data/restraints/parameters  3033/0/120  
Goodness-of-fit on F
2
  1.051  
Final R indexes [I>=2σ (I)]  R1 = 0.0257, wR2 = 0.0522  
Final R indexes [all data]  R1 = 0.0296, wR2 = 0.0557  
Largest diff. peak/hole / e Å
-3
  0.64/-0.92  
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Crystallographic data for compound 2.9d 
 
Identification code  ijsf1452  
Empirical formula  C18H20Cl2F4N2Pd2  
Formula weight  624.06  
Temperature/K  110.05(10)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  5.67526(12)  
b/Å  26.5650(6)  
c/Å  6.85327(14)  
α/°  90  
β/°  94.9534(19)  
γ/°  90  
Volume/Å
3
  1029.36(4)  
Z  2  
ρcalcg/cm
3
  2.013  
μ/mm-1  2.048  
F(000)  608.0  
Crystal size/mm
3
  0.4419 × 0.0621 × 0.0294  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  6.134 to 64.306  
Index ranges  -7 ≤ h ≤ 8, -39 ≤ k ≤ 39, -10 ≤ l ≤ 9  
Reflections collected  18211  
Independent reflections  3380 [Rint = 0.0405, Rsigma = 0.0305]  
Data/restraints/parameters  3380/0/129  
Goodness-of-fit on F
2
  1.352  
Final R indexes [I>=2σ (I)]  R1 = 0.0390, wR2 = 0.0650  
Final R indexes [all data]  R1 = 0.0428, wR2 = 0.0662  
Largest diff. peak/hole / e Å
-3
  1.03/-0.95  
Structure solved by Jessica Milani / Natalie Pridmore 
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Crystallographic data for compound 2.9e6 
 
Identification code  ijsf1412  
Empirical formula  C18H20Cl2F4N2Pd2  
Formula weight  624.06  
Temperature/K  110.00(14)  
Crystal system  triclinic  
Space group  P-1  
a/Å  7.3719(12)  
b/Å  8.4847(12)  
c/Å  9.1417(13)  
α/°  81.053(12)  
β/°  66.775(15)  
γ/°  73.087(13)  
Volume/Å
3
  502.19(14)  
Z  1  
ρcalcmg/mm
3
  2.064  
m/mm
-1
  2.099  
F(000)  304.0  
Crystal size/mm
3
  0.1223 × 0.0586 × 0.0309  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection  6.21 to 63.694°  
Index ranges  -10 ≤ h ≤ 10, -12 ≤ k ≤ 10, -12 ≤ l ≤ 13  
Reflections collected  4767  
Independent reflections  3097 [Rint = 0.0269, Rsigma = 0.0515]  
Data/restraints/parameters  3097/0/129  
Goodness-of-fit on F
2
  1.162  
Final R indexes [I>=2σ (I)]  R1 = 0.0384, wR2 = 0.0891  
Final R indexes [all data]  R1 = 0.0422, wR2 = 0.0914  
Largest diff. peak/hole / e Å
-3
  1.31/-0.85  
 
Structure solved by Natalie Pridmore 
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Crystallographic data for compound 2.28d 
 
Identification code  rnp1516  
Empirical formula  C18H22Cl2F4N2Pd  
Formula weight  519.67  
Temperature/K  110.05(10)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  8.8260(2)  
b/Å  11.8134(2)  
c/Å  10.0300(2)  
α/°  90  
β/°  108.378(3)  
γ/°  90  
Volume/Å
3
  992.44(4)  
Z  2  
ρcalcg/cm
3
  1.739  
μ/mm-1  1.246  
F(000)  520.0  
Crystal size/mm
3
  0.2084 × 0.1004 × 0.0873  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  6.898 to 60.052  
Index ranges  -11 ≤ h ≤ 12, -15 ≤ k ≤ 16, -13 ≤ l ≤ 14  
Reflections collected  5221  
Independent reflections  2573 [Rint = 0.0215, Rsigma = 0.0334]  
Data/restraints/parameters  2573/0/126  
Goodness-of-fit on F
2
  1.076  
Final R indexes [I>=2σ (I)]  R1 = 0.0242, wR2 = 0.0508  
Final R indexes [all data]  R1 = 0.0294, wR2 = 0.0550  
Largest diff. peak/hole / e Å
-3
  0.55/-0.64  
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Crystallographic data for compound 2.9g 
 
 
 
Identification code  ijsf1474  
Empirical formula  C18H22Cl4N2Pd2  
Formula weight  620.97  
Temperature/K  110.05(10)  
Crystal system  monoclinic  
Space group  I2/c  
a/Å  14.1764(4)  
b/Å  5.54107(16)  
c/Å  26.6827(7)  
α/°  90  
β/°  98.324(3)  
γ/°  90  
Volume/Å
3
  2073.91(11)  
Z  4  
ρcalcg/cm
3
  1.989  
μ/mm-1  2.255  
F(000)  1216.0  
Crystal size/mm
3
  0.2683 × 0.1982 × 0.0378  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  6.962 to 64.422  
Index ranges  -20 ≤ h ≤ 17, -7 ≤ k ≤ 6, -39 ≤ l ≤ 29  
Reflections collected  5671  
Independent reflections  3276 [Rint = 0.0260, Rsigma = 0.0433]  
Data/restraints/parameters  3276/0/120  
Goodness-of-fit on F
2
  1.063  
Final R indexes [I>=2σ (I)]  R1 = 0.0281, wR2 = 0.0535  
Final R indexes [all data]  R1 = 0.0363, wR2 = 0.0587  
Largest diff. peak/hole / e Å
-3
  0.57/-0.46  
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Crystallographic data for compound 2.30 
 
Identification code  ijsf1454  
Empirical formula  C22H24F6N2O4Pd2  
Formula weight  707.23  
Temperature/K  110.05(10)  
Crystal system  orthorhombic  
Space group  Pna21  
a/Å  13.9642(5)  
b/Å  16.9116(6)  
c/Å  10.4352(5)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å
3
  2464.33(16)  
Z  4  
ρcalcg/cm
3
  1.906  
μ/mm-1  1.537  
F(000)  1392.0  
Crystal size/mm
3
  0.3626 × 0.1099 × 0.0941  
Radiation  MoKα (λ = 0.7107)  
2Θ range for data collection/°  5.828 to 64.474  
Index ranges  -9 ≤ h ≤ 20, -25 ≤ k ≤ 11, -8 ≤ l ≤ 15  
Reflections collected  10081  
Independent reflections  5264 [Rint = 0.0307, Rsigma = 0.0417]  
Data/restraints/parameters  5264/37/339  
Goodness-of-fit on F
2
  1.178  
Final R indexes [I>=2σ (I)]  R1 = 0.0334, wR2 = 0.0787  
Final R indexes [all data]  R1 = 0.0368, wR2 = 0.0809  
Largest diff. peak/hole / e Å
-3
  0.95/-0.80  
Flack parameter -0.04(3) 
 239 
 
Crystallographic data for compound 3.3 
 
Identification code  rnp1343  
Empirical formula  C19H16FP  
Formula weight  294.29  
Temperature/K  110.05(10)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  12.2509(3)  
b/Å  18.1309(5)  
c/Å  7.0183(2)  
α/°  90  
β/°  101.841(3)  
γ/°  90  
Volume/Å
3
  1525.73(7)  
Z  4  
ρcalcmg/mm
3
  1.281  
m/mm
-1
  0.181  
F(000)  616.0  
Crystal size/mm
3
  0.1592 × 0.0947 × 0.0197  
Radiation  MoKα (λ = 0.7107)  
2Θ range for data collection  5.628 to 55.98°  
Index ranges  -16 ≤ h ≤ 10, -22 ≤ k ≤ 10, -9 ≤ l ≤ 8  
Reflections collected  5326  
Independent reflections  3075 [Rint = 0.0262, Rsigma = 0.0482]  
Data/restraints/parameters  3075/0/190  
Goodness-of-fit on F
2
  1.084  
Final R indexes [I>=2σ (I)]  R1 = 0.0425, wR2 = 0.0943  
Final R indexes [all data]  R1 = 0.0584, wR2 = 0.1035  
Largest diff. peak/hole / e Å
-3
  0.45/-0.27  
 
Structure solved by Natalie Pridmore 
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Crystallographic data for compound 3.5 oxide 
 
Identification code  ijsf1475  
Empirical formula  C19H15F2OP  
Formula weight  328.28  
Temperature/K  110.05(10)  
Crystal system  triclinic  
Space group  P-1  
a/Å  5.7921(4)  
b/Å  10.8895(9)  
c/Å  13.5552(9)  
α/°  68.131(7)  
β/°  80.824(6)  
γ/°  80.864(7)  
Volume/Å
3
  778.66(11)  
Z  2  
ρcalcg/cm
3
  1.400  
μ/mm-1  1.772  
F(000)  340.0  
Crystal size/mm
3
  0.4485 × 0.0756 × 0.0286  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  7.07 to 142.568  
Index ranges  -6 ≤ h ≤ 7, -13 ≤ k ≤ 11, -15 ≤ l ≤ 16  
Reflections collected  8403  
Independent reflections  2944 [Rint = 0.0461, Rsigma = 0.0480]  
Data/restraints/parameters  2944/0/208  
Goodness-of-fit on F
2
  1.060  
Final R indexes [I>=2σ (I)]  R1 = 0.0438, wR2 = 0.1156  
Final R indexes [all data]  R1 = 0.0558, wR2 = 0.1275  
Largest diff. peak/hole / e Å
-3
  0.59/-0.56  
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Crystallographic data for compound 3.24 
 
Identification code  ijsf1483  
Empirical formula  C38H32Cl2F2P2Pd  
Formula weight  765.87  
Temperature/K  110.05(10)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  10.30231(13)  
b/Å  12.86918(12)  
c/Å  12.84340(13)  
α/°  90  
β/°  99.1419(11)  
γ/°  90  
Volume/Å
3
  1681.18(3)  
Z  2  
ρcalcg/cm
3
  1.513  
μ/mm-1  0.844  
F(000)  776.0  
Crystal size/mm
3
  0.2301 × 0.1582 × 0.132  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  7.006 to 64.314  
Index ranges  -15 ≤ h ≤ 15, -18 ≤ k ≤ 19, -18 ≤ l ≤ 18  
Reflections collected  18463  
Independent reflections  5447 [Rint = 0.0254, Rsigma = 0.0268]  
Data/restraints/parameters  5447/0/205  
Goodness-of-fit on F
2
  1.079  
Final R indexes [I>=2σ (I)]  R1 = 0.0272, wR2 = 0.0710  
Final R indexes [all data]  R1 = 0.0317, wR2 = 0.0740  
Largest diff. peak/hole / e Å
-3
  1.03/-0.90  
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Crystallographic data for compound 3.26 
 
Identification code  rnp1327  
Empirical formula  C28H29ClNPPd  
Formula weight  552.34  
Temperature/K  110.05(10)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  10.3589(4)  
b/Å  9.2275(4)  
c/Å  25.5444(10)  
α/°  90.00  
β/°  92.686(4)  
γ/°  90.00  
Volume/Å
3
  2439.03(16)  
Z  4  
ρcalcmg/mm
3
  1.504  
m/mm
-1
  0.952  
F(000)  1128.0  
Crystal size/mm
3
  0.102 × 0.0773 × 0.0437  
2Θ range for data collection  5.92 to 56°  
Index ranges  -8 ≤ h ≤ 13, -5 ≤ k ≤ 11, -31 ≤ l ≤ 32  
Reflections collected  9223  
Independent reflections  4939[R(int) = 0.0298]  
Data/restraints/parameters  4939/0/291  
Goodness-of-fit on F
2
  1.049  
Final R indexes [I>=2σ (I)]  R1 = 0.0319, wR2 = 0.0603  
Final R indexes [all data]  R1 = 0.0432, wR2 = 0.0648  
Largest diff. peak/hole / e Å
-3
  0.56/-0.43  
 
Structure solved by Natalie Pridmore 
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Crystallographic data for compound 3.27 
 
Identification code  ijsf1316  
Empirical formula  C38H34Cl2P2Pd  
Formula weight  729.89  
Temperature/K  110.3(4)  
Crystal system  triclinic  
Space group  P-1  
a/Å  9.5620(4)  
b/Å  13.3839(6)  
c/Å  14.7428(7)  
α/°  66.077(4)  
β/°  73.025(4)  
γ/°  88.110(3)  
Volume/Å
3
  1641.63(14)  
Z  2  
ρcalcmg/mm
3
  1.477  
m/mm
-1
  0.852  
F(000)  744.0  
Crystal size/mm
3
  0.2309 × 0.1586 × 0.1109  
2Θ range for data collection  5.82 to 60.06°  
Index ranges  -12 ≤ h ≤ 13, -18 ≤ k ≤ 18, -20 ≤ l ≤ 19  
Reflections collected  15464  
Independent reflections  9526[R(int) = 0.0215]  
Data/restraints/parameters  9526/0/388  
Goodness-of-fit on F
2
  1.022  
Final R indexes [I>=2σ (I)]  R1 = 0.0273, wR2 = 0.0609  
Final R indexes [all data]  R1 = 0.0321, wR2 = 0.0640  
Largest diff. peak/hole / e Å
-3
  0.52/-0.57  
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Crystallographic data for compound 3.23 
 
Identification code  ijsf1449  
Empirical formula  C40H34Cl6F2P2Pd2  
Formula weight  1040.11  
Temperature/K  110.00(14)  
Crystal system  monoclinic  
Space group  C2/c  
a/Å  29.7555(4)  
b/Å  9.10694(10)  
c/Å  14.89351(19)  
α/°  90  
β/°  102.3937(12)  
γ/°  90  
Volume/Å
3
  3941.82(8)  
Z  4  
ρcalcg/cm
3
  1.753  
μ/mm-1  1.440  
F(000)  2064.0  
Crystal size/mm
3
  0.2747 × 0.1422 × 0.1057  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  5.596 to 64.362  
Index ranges  -43 ≤ h ≤ 44, -13 ≤ k ≤ 13, -21 ≤ l ≤ 22  
Reflections collected  35361  
Independent reflections  6563 [Rint = 0.0290, Rsigma = 0.0214]  
Data/restraints/parameters  6563/1/239  
Goodness-of-fit on F
2
  1.038  
Final R indexes [I>=2σ (I)]  R1 = 0.0257, wR2 = 0.0607  
Final R indexes [all data]  R1 = 0.0297, wR2 = 0.0632  
Largest diff. peak/hole / e Å
-3
  1.00/-0.97  
Structure solved by Jessica Milani and Natalie Pridmore 
Molecule of toluene in the unit cell not shown in the image above 
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Crystallographic data for compound 3.28p 
 
Identification code  ijsf1451  
Empirical formula  C45H38Cl2F2P2Pd2  
Formula weight  962.39  
Temperature/K  110.05(10)  
Crystal system  triclinic  
Space group  P-1  
a/Å  8.3240(7)  
b/Å  9.1137(5)  
c/Å  14.4204(6)  
α/°  82.369(4)  
β/°  88.656(5)  
γ/°  64.142(7)  
Volume/Å
3
  974.98(13)  
Z  1  
ρcalcg/cm
3
  1.639  
μ/mm-1  1.184  
F(000)  482.0  
Crystal size/mm
3
  0.3105 × 0.1274 × 0.0431  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  5.7 to 64.302  
Index ranges  -11 ≤ h ≤ 10, -12 ≤ k ≤ 13, -20 ≤ l ≤ 21  
Reflections collected  10050  
Independent reflections  6094 [Rint = 0.0266, Rsigma = 0.0484]  
Data/restraints/parameters  6094/3/266  
Goodness-of-fit on F
2
  1.054  
Final R indexes [I>=2σ (I)]  R1 = 0.0363, wR2 = 0.0823  
Final R indexes [all data]  R1 = 0.0435, wR2 = 0.0886  
Largest diff. peak/hole / e Å
-3
  1.48/-0.96  
Structure solved by Natalie Pridmore and Jess Milani  
Molecule of toluene in the unit cell not shown in the image above 
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Crystallographic data for compound 3.29 
 
 
Identification code  rnp1421  
Empirical formula  C42.62H33.28Cl2F4P2Pd2  
Formula weight  967.05  
Temperature/K  110.05(10)  
Crystal system  trigonal  
Space group  R-3  
a/Å  26.323(3)  
b/Å  26.323(3)  
c/Å  15.0669(11)  
α/°  90  
β/°  90  
γ/°  120  
Volume/Å
3
  9041.0(19)  
Z  9  
ρcalcg/cm
3
  1.599  
μ/mm-1  9.605  
F(000)  4329.0  
Crystal size/mm
3
  0.0831 × 0.0468 × 0.0264  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  7.032 to 142.198  
Index ranges  -23 ≤ h ≤ 31, -31 ≤ k ≤ 23, -17 ≤ l ≤ 18  
Reflections collected  10890  
Independent reflections  3821 [Rint = 0.0588, Rsigma = 0.0561]  
Data/restraints/parameters  3821/3/264  
Goodness-of-fit on F
2
  1.062  
Final R indexes [I>=2σ (I)]  R1 = 0.0585, wR2 = 0.1374  
Final R indexes [all data]  R1 = 0.0765, wR2 = 0.1527  
Largest diff. peak/hole / e Å
-3
  1.94/-2.07  
Structure solved by Natalie Pridmore 
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Crystallographic data for compound 3.30 
 
 
Identification code  rnp1519  
Empirical formula  C39.99H29.99Cl7.97F4P2Pd2  
Formula weight  1143.78  
Temperature/K  110.05(10)  
Crystal system  monoclinic  
Space group  P21/c  
a/Å  15.0141(5)  
b/Å  9.1642(2)  
c/Å  15.2815(4)  
α/°  90  
β/°  103.856(3)  
γ/°  90  
Volume/Å
3
  2041.43(10)  
Z  2  
ρcalcg/cm
3
  1.861  
μ/mm-1  1.531  
F(000)  1126.8  
Crystal size/mm
3
  0.364 × 0.1613 × 0.0501  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  6.732 to 64.43  
Index ranges  -22 ≤ h ≤ 15, -13 ≤ k ≤ 13, -21 ≤ l ≤ 22  
Reflections collected  14204  
Independent reflections  6505 [Rint = 0.0266, Rsigma = 0.0389]  
Data/restraints/parameters  6505/19/292  
Goodness-of-fit on F
2
  1.031  
Final R indexes [I>=2σ (I)]  R1 = 0.0327, wR2 = 0.0725  
Final R indexes [all data]  R1 = 0.0420, wR2 = 0.0786  
Largest diff. peak/hole / e Å
-3
  1.06/-1.01  
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Crystallographic data for compound 3.31 
 
Identification code  ijsf1476  
Empirical formula  C85H73Cl3F4O8P4Pd4  
Formula weight  1954.26  
Temperature/K  110.00(14)  
Crystal system  monoclinic  
Space group  P21/n  
a/Å  21.5641(3)  
b/Å  12.31614(12)  
c/Å  30.4374(4)  
α/°  90  
β/°  101.2766(12)  
γ/°  90  
Volume/Å
3
  7927.70(16)  
Z  4  
ρcalcg/cm
3
  1.637  
μ/mm-1  9.443  
F(000)  3912.0  
Crystal size/mm
3
  0.118 × 0.1043 × 0.0262  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  7.766 to 142.714  
Index ranges  -26 ≤ h ≤ 26, -13 ≤ k ≤ 14, -32 ≤ l ≤ 37  
Reflections collected  31513  
Independent reflections  15014 [Rint = 0.0338, Rsigma = 0.0457]  
Data/restraints/parameters  15014/0/977  
Goodness-of-fit on F
2
  1.073  
Final R indexes [I>=2σ (I)]  R1 = 0.0382, wR2 = 0.0861  
Final R indexes [all data]  R1 = 0.0502, wR2 = 0.0919  
Largest diff. peak/hole / e Å
-3
  0.90/-0.85  
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Crystallographic data for compound 5.30 
 
Identification code  rnp1520  
Empirical formula  C15H13F4N  
Formula weight  283.26  
Temperature/K  110.05(10)  
Crystal system  monoclinic  
Space group  C2  
a/Å  17.9962(10)  
b/Å  5.8727(3)  
c/Å  12.0479(8)  
α/°  90  
β/°  101.698(6)  
γ/°  90  
Volume/Å
3
  1246.85(13)  
Z  4  
ρcalcg/cm
3
  1.509  
μ/mm-1  1.130  
F(000)  584.0  
Crystal size/mm
3
  0.4733 × 0.0884 × 0.0355  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  7.494 to 141.752  
Index ranges  -22 ≤ h ≤ 22, -5 ≤ k ≤ 7, -14 ≤ l ≤ 14  
Reflections collected  3699  
Independent reflections  1845 [Rint = 0.0292, Rsigma = 0.0397]  
Data/restraints/parameters  1845/1/183  
Goodness-of-fit on F
2
  1.075  
Final R indexes [I>=2σ (I)]  R1 = 0.0345, wR2 = 0.0836  
Final R indexes [all data]  R1 = 0.0378, wR2 = 0.0876  
Largest diff. peak/hole / e Å
-3
  0.15/-0.28  
Flack parameter -0.08(14) 
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Crystallographic data for compound 5.44 
 
Identification code  rnp1427  
Empirical formula  C20H42NiP2  
Formula weight  403.18  
Temperature/K  110.05(10)  
Crystal system  orthorhombic  
Space group  P212121  
a/Å  9.79470(18)  
b/Å  12.5653(2)  
c/Å  18.1315(4)  
α/°  90  
β/°  90  
γ/°  90  
Volume/Å
3
  2231.51(7)  
Z  4  
ρcalcg/cm
3
  1.200  
μ/mm-1  2.571  
F(000)  880.0  
Crystal size/mm
3
  0.1112 × 0.1105 × 0.0191  
Radiation  CuKα (λ = 1.54184)  
2Θ range for data collection/°  8.562 to 142.662  
Index ranges  -11 ≤ h ≤ 11, -15 ≤ k ≤ 11, -20 ≤ l ≤ 22  
Reflections collected  15032  
Independent reflections  4270 [Rint = 0.0316, Rsigma = 0.0306]  
Data/restraints/parameters  4270/0/214  
Goodness-of-fit on F
2
  1.035  
Final R indexes [I>=2σ (I)]  R1 = 0.0223, wR2 = 0.0510  
Final R indexes [all data]  R1 = 0.0253, wR2 = 0.0525  
Largest diff. peak/hole / e Å
-3
  0.24/-0.27  
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Crystallographic data for compound 5.48 oxide 
 
Identification code  rnp1509  
Empirical formula  C22H15F5OP  
Formula weight  421.31  
Temperature/K  110.05(10)  
Crystal system  monoclinic  
Space group  P21/n  
a/Å  5.71790(18)  
b/Å  12.5516(5)  
c/Å  25.6946(8)  
α/°  90  
β/°  94.884(3)  
γ/°  90  
Volume/Å
3
  1837.37(11)  
Z  4  
ρcalcg/cm
3
  1.523  
μ/mm-1  0.210  
F(000)  860.0  
Crystal size/mm
3
  0.2064 × 0.1378 × 0.1017  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  6.684 to 64.466  
Index ranges  -8 ≤ h ≤ 8, -18 ≤ k ≤ 18, -38 ≤ l ≤ 37  
Reflections collected  23024  
Independent reflections  6045 [Rint = 0.0325, Rsigma = 0.0296]  
Data/restraints/parameters  6045/0/262  
Goodness-of-fit on F
2
  1.070  
Final R indexes [I>=2σ (I)]  R1 = 0.0403, wR2 = 0.0957  
Final R indexes [all data]  R1 = 0.0529, wR2 = 0.1025  
Largest diff. peak/hole / e Å
-3
  0.39/-0.34  
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Crystallographic data for compound 6.6 
 
Identification code  ijsf1517  
Empirical formula  C13H11FMnNO4  
Formula weight  319.17  
Temperature/K  110.05(10)  
Crystal system  monoclinic  
Space group  C2/c  
a/Å  27.0737(8)  
b/Å  6.5891(2)  
c/Å  15.3507(5)  
α/°  90.00  
β/°  93.243(3)  
γ/°  90.00  
Volume/Å
3
  2734.04(14)  
Z  8  
ρcalcg/cm
3
  1.551  
μ/mm-1  0.988  
F(000)  1296.0  
Crystal size/mm
3
  0.2923 × 0.1824 × 0.1058  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  6.86 to 63.92  
Index ranges  -39 ≤ h ≤ 39, -9 ≤ k ≤ 9, -22 ≤ l ≤ 22  
Reflections collected  23045  
Independent reflections  4465 [Rint = 0.0259, Rsigma = 0.0150]  
Data/restraints/parameters  4465/0/183  
Goodness-of-fit on F
2
  1.088  
Final R indexes [I>=2σ (I)]  R1 = 0.0238, wR2 = 0.0656  
Final R indexes [all data]  R1 = 0.0254, wR2 = 0.0667  
Largest diff. peak/hole / e Å
-3
  0.44/-0.33  
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Abbreviations 
aq. aqueous 
Ac acetyl 
acac acetylacetone 
AMLA ambiphilic metal ligand activation 
ATR attenuated total reflectance 
Bn benzyl 
σ-CAM sigma-complex-assisted metathesis 
CMD concerted metalation deprotonation  
COD 1,5-cyclooctadiene 
Cp* pentamethylcyclopentadienyl 
Cy cyclohexyl 
DCE dichloroethane 
DCM dichloromethane 
dec. decomposition 
dmba dimethylbenzylamine 
DMF dimethylformamide 
DMSO dimethylsulfoxide 
eq. equivalent 
ESI electrospray ionisation 
Et ethyl 
Het heteroatom 
HFIP hexafluoroisopropanol 
HSQC heteronuclear single quantum coherence spectroscopy 
IC50 half maximal inhibitory concentration 
IR infrared 
KIE kinetic isotopic effect  
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L ligand 
LIFDI Liquid Injection Field Desorption/Ionization 
lit. literature 
m- meta  
[M] metal 
M.P. melting point 
Me methyl 
MTT 
 
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide 
Mw molecular weight 
NBE norbornene 
n
BuLi n-butyllithium 
NMR nuclear magnetic resonance 
o- ortho- 
p- para- 
PBS phosphate-buffered saline 
Ph phenyl 
ppm parts per million 
Pr propyl 
PTFE polytetrafluoroethylene 
pyr pyridine 
Rf retention factor 
RT room temperature 
s- secondary 
SEAr electrophilic aromatic substitution 
TFE 2,2,2-trifluoroethanol 
THF tetrahydrofuran 
TLC Thin Layer Chromatography 
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TMEDA N,N,N′,N′-tetramethylethylenediamine 
TMS trimethylsilane 
tol toluene 
w.r.t with respect to 
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